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Multicomponent hospital-led interventions to reduce
hospital stay for older adults following elective surgery:
a systematic review
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Background: Elective older adult inpatient admissions are increasingly common. Older adults are at an
elevated risk of adverse events in hospital, potentially increasing with lengthier hospital stay. Hospital-led
organisational strategies may optimise hospital stay for elective older adult inpatients.
Objectives: To evaluate the effectiveness and cost-effectiveness of hospital-led multicomponent
interventions to reduce hospital stay for older adults undergoing elective hospital admissions.
Data sources: Seven bibliographic databases (MEDLINE, MEDLINE In-Process & Other Non-Indexed
Citations, EMBASE, Health Management Information Consortium, Cochrane Central Register of Controlled
Trials, Cumulative Index to Nursing and Allied Health Literature and Allied and Complementary Medicine
Database) were searched from inception to date of search (August 2017), alongside carrying out of web
searches, citation searching, inspecting relevant reviews, consulting stakeholders and contacting authors.
This search was duplicated, with an additional cost-filter, to identify cost-effectiveness evidence.
Review methods: Comparative studies were sought that evaluated the effectiveness or cost-effectiveness
of relevant interventions in elective inpatients with a mean or median age of ≥ 60 years. Study selection,
data extraction and quality assessment were completed independently by two reviewers. The main outcome
was length of stay, but all outcomes were considered. Studies were sorted by procedure, intervention
and outcome categories. Where possible, standardised mean differences or odds ratios were calculated.
Meta-analysis was performed when multiple randomised controlled trials had the same intervention,
treatment procedure, comparator and outcome. Findings were explored using narrative synthesis.
Findings: A total of 218 articles were included, with 80 articles from 73 effectiveness studies (n = 26,365
patients) prioritised for synthesis, including 34 randomised controlled trials conducted outside the UK
and 39 studies from the UK, of which 12 were randomised controlled trials. Fifteen studies included
cost-effectiveness data. The evidence was dominated by enhanced recovery protocols and prehabilitation,
implemented to improve recovery from either colorectal surgery or lower limb arthroplasty. Six other
surgical categories and four other intervention types were identified. Meta-analysis found that enhanced
recovery protocols were associated with 1.5 days’ reduction in hospital stay among patients undergoing
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colorectal surgery (Cohen’s d = –0.51, 95% confidence interval –0.78 to –0.24; p < 0.001) and with 5 days’
reduction among those undergoing upper abdominal surgery (Cohen’s d = –1.04, 95% confidence interval
–1.55 to –0.53; p < 0.001). Evidence from the UK was not pooled (owing to mixed study designs), but it
echoed findings from the international literature. Length of stay usually was reduced with intervention or
was no different. Other clinical outcomes also improved or were no worse with intervention. Patient-reported
outcomes were not frequently reported. Cost and cost-effectiveness evidence came from 15 highly
heterogeneous studies and was less conclusive.
Limitations: Studies were usually of moderate or weak quality. Some intervention or treatment types were
under-reported or absent. The reporting of variance data often precluded secondary analysis.
Conclusions: Enhanced recovery and prehabilitation interventions were associated with reduced hospital
stay without detriment to other clinical outcomes, particularly for patients undergoing colorectal surgery,
lower limb arthroplasty or upper abdominal surgery. The impacts on patient-reported outcomes, health-
care costs or additional service use are not well known.
Future work: Further studies evaluating of the effectiveness of new enhanced recovery pathways are
not required in colorectal surgery or lower limb arthroplasty. However, the applicability of these pathways
to other procedures is uncertain. Future studies should evaluate the implementation of interventions to
reduce service variation, in-hospital patient-reported outcomes, impacts on health and social care service
use, and longer-term patient-reported outcomes.
Study registration: This study is registered as PROSPERO CRD42017080637.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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Glossary
Abdominal Relating to the abdomen, that is, the anatomical region between the thorax (chest) and
pelvis, including the stomach, small and large intestines, pancreas, liver and gallbladder.
Cardiac Relating to the physiology of the heart.
Care pathway (or patient care pathway) Separated into five distinct phases in relation to a hospital
admission: pre admission; after admission but before treatment; perioperative/during treatment;
postoperative but before discharge; and post discharge.
Colorectal Relating to the physiology of the rectum, anus and colon.
Comprehensive geriatric assessment A multidisciplinary diagnostic and treatment process that identifies
the medical, psychosocial and functional limitations of an older person. The aim of a Comprehensive
Geriatric Assessment is to develop a co-ordinated and integrated plan for the needs of the patient.
Enhanced recovery after surgery A multidisciplinary approach to caring for surgical patients involving
surgeons, anaesthetists, nurses and allied health professionals. Enhanced recovery after surgery programmes
typically follow a protocol involving preoperative assessment, minimally invasive surgery wherever possible,
and a structured approach to postoperative care. The aims of enhanced recovery after surgery include
improving patient experience and reducing postoperative complications and hospital length of stay. It is
associated with the ERAS Society.
Enhanced recovery protocol (or programme or pathway) A multicomponent intervention that includes
the delivery of health-care components at multiple stages of the patient care pathway.
Hospitalist A physician in the USA who specialises in the general medical care of hospitalised patients,
both within hospital and in related outpatient care.
Inpatient A person admitted to hospital for at least one night.
Kinesiologist A care professional with training in kinesiology, which is the study of human body
movements, performance and function, combining knowledge from biomechanics, anatomy, physiology,
psychology and neuroscience. It is not a licensed or officially recognised profession in most countries.
Length of stay The time a patient stays in hospital, usually measured in days.
Lower limb arthroplasty The surgical reconstruction or replacement of joints of the lower limb, most
commonly the hip or knee.
Multicomponent intervention An intervention that has two or more components that could otherwise
be delivered as independent interventions.
Pedometry The measurement of distance (usually walking distance within a given time) or another
physical activity using a pedometer.
Pelvic Relating to the pelvis, that is, the lower part of the torso between the abdomen and thighs.
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Prehabilitation (or ‘prehab’) The process of preparing a patient for a medical intervention such as a
surgical procedure. This can involve physical strengthening, making dietary changes or engaging with
learning materials. The aim of prehabilitation is to optimise the patient’s physical health and well-being
before a medical intervention with a view to facilitating a rapid recovery after the intervention.
Rehabilitation (or ‘rehab’) The assisted process of recovery following a medical intervention.
Rehabilitation can involve physical, occupational and mental health therapies that aim to improve a
patient’s post-treatment recovery.
Resident In hospital systems in the USA and some other countries, a qualified doctor or physician who is
undergoing postgraduate training (e.g. in a particular medical specialty) and practises medicine in that
setting under the supervision of more senior, fully qualified, clinicians.
Staff mix In a hospital setting, the organised deployment of various clinical and non-clinical staff roles
with the aim of optimising patient care, including reducing length of hospital stay.
Thoracic Relating to the anatomical region of the chest (or thorax), in particular the heart and lungs.
Upper abdominal Relating to the upper abdomen, that is, the anatomical region containing the
stomach, spleen, pancreas, kidneys, liver and gallbladder.
Vascular Relating to the system of vessels that move fluids around the body, including the arteries, veins,
lymph vessels and lymph nodes.
GLOSSARY
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Plain English summary
The problem and why it is important
Patients aged ≥ 60 years are more likely to experience difficulties such as falls, confusion and infections
when they are admitted to hospital. To reduce risk of these difficulties, people should not spend any
longer in hospital than they need to. We do not know if there are ways to increase the speed of recovery
that work well for older people.
What we aimed to achieve
We were interested in whether or not hospitals can reduce the unnecessary time that patients aged
≥ 60 years spend in hospital for planned treatment, and if this can save money.
How we did it
We looked at international and UK studies to gather evidence about strategies used to improve recovery
for people aged ≥ 60 years going to hospital for any planned treatment. We were interested in strategies
that combined several treatment elements to reduce time spent in hospital and improve patient recovery.
Patient and public involvement
A group of patients and members of the public were involved from the beginning of the project.
They helped us plan our research and interpret what we found.
Main messages
We found a lot of research on this topic. It showed that the different strategies either reduced time spent
in hospital and improved patient recovery or were no worse than normal care.
However, the voices of patients and the public were not widely reported. Patient satisfaction, mental health
and quality of life were rarely considered, and recovery after hospital discharge was not often measured.
What should happen next?
We need to find out more about the patient’s experience of the strategies that were looked at in this
research and to listen to the patient voice. More research is needed on the effect that these strategies
have on patient recovery and service use after discharge from hospital.
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Scientific summary
Background
Globally, life expectancy is increasing, and so is the population of older adults. The Office for National
Statistics forecasts that the population of adults aged ≥ 75 years in the UK will rise from around 5.8 million
to 10 million over the next 20 years. The mean age of hospital inpatients in the UK increased from 49 to 53
from 2006 to 2016; in the same period, the number of 60- to 65-year-olds admitted to hospital increased
by 57%. The needs of older adults undergoing planned admissions may differ significantly from those of
their younger counterparts. They may present with multimorbidity, polypharmacy, cognitive impairment
and social challenges, and are at increased risk of adverse events during and after surgery.
Such difficulties can prolong the inpatient stay or prevent discharge to home altogether. Lengthy hospital
stays can increase the risk of complications such as falls, sarcopenia, hospital-acquired infections and
cognitive decline. These complications also increase demand on bed space, resources and increased cost
of care. It is therefore important for hospitals to optimise the time that older adults spend in hospital.
An opportunity exists to develop strategies to achieve this for planned procedures.
Hospital-led, multicomponent organisational strategies to accelerate recovery and reduce inpatient length
of stay after planned admissions have been evaluated in some surgical specialties in working-age adults in
particular. However, it is not known whether or not such interventions are effective and cost-effective in
older adults.
Objectives
This review aimed to answer two questions:
1. What is the effectiveness of hospital-led multicomponent interventions to reduce length of stay for
older adults following planned admission?
2. What is the cost-effectiveness of hospital-led multicomponent interventions to reduce length of stay for
older adults following planned admission?
Methods
Data sources
The methods to identify and select evidence followed best practice. We identified effectiveness studies by
searching bibliographic databases including MEDLINE (via Ovid), MEDLINE In-Process & Other Non-Indexed
Citations (via Ovid), EMBASE (via Ovid), HMIC (Health Management Information Consortium) (via Ovid),
CENTRAL (Cochrane Central Register of Controlled Trials) (via The Cochrane Library), CINAHL (Cumulative
Index to Nursing and Allied Health Literature) (via EBSCOhost) and AMED (Allied and Complementary
Medicine Database) (via EBSCOhost); forwards and backwards citation searching included studies; inspecting
reference lists of topically similar systematic reviews; carrying out web searches; consulting stakeholders;
contacting authors of potentially relevant conference abstracts and carrying out cost-effectiveness searches.
No English-language filter was used; however, we limited retrospectively the search results to studies
published from 2000. This strategy was duplicated, with the use of a cost study design filter, to identify
cost-effectiveness evidence.
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Study selection
The following inclusion criteria were applied to records identified by both the effectiveness and the
cost-effectiveness searches.
Population
Older adults (i.e. the mean or median age of the sample was at least 60 years), undergoing planned
(i.e. elective) hospital treatment requiring inpatient admission.
Intervention
Any multicomponent, hospital-based intervention for inpatients receiving planned procedures, aiming to
reduce length of stay in hospital or improve recovery.
Comparator
Any comparator.
Outcomes
Any metric of length of stay in hospital.
Study design
We included any comparative study design. For the cost-effectiveness evidence, studies had to be economic
evaluations or comparative cost studies.
Geographical context
High-income countries as defined by the World Bank list of economies [World Bank List of Economies
(June 2017). URL: http://iccmoot.com/wp-content/uploads/2017/07/World-Bank-List-of-Economies.pdf
(accessed 20 September 2018)].
Study selection
The inclusion and exclusion criteria were independently applied to the title and abstract of each citation by
two reviewers, with disagreement resolved through discussion. This process was repeated for the full text
of each paper provisionally meeting the inclusion criteria.
Data extraction
Data extraction was performed by one reviewer and checked by a second, with disagreements settled
through discussion. Extracted data included relevant details about the study population, setting/context,
intervention, comparator and clinical and patient-reported outcome data, plus costs or cost-effectiveness
if reported.
Quality assessment strategy
Each prioritised study (see Synthesis methods) was assessed independently by two reviewers using the
Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies, and additionally
with the Consensus Health Economic Criteria list for cost-effectiveness studies. Any disagreements were
resolved through discussion. Quality assessment informed the interpretation of evidence, and was not
used to exclude studies.
Synthesis methods
We prioritised the following categories of includable effectiveness studies for synthesis: (1) randomised
controlled trials conducted in any high-income country; and (2) any includable study design conducted in
the UK. This facilitated a manageable synthesis based on both the highest-quality and the most relevant
evidence available. Cost-effectiveness evidence was synthesised if it related to studies in group (1) or
(2) above.
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Studies were categorised based on the anatomical location of the procedures (all of which were surgical):
cardiac, colorectal, lower limb arthroplasty, pelvic, thoracic, tumour removal at various locations, upper
abdominal, vascular, and mixed/various procedures. Interventions were classified into broad categories:
1. Enhanced recovery protocols: consisting of components at multiple stages of the care pathway,
such as minimal preoperative fasting, standard anaesthetic protocols, early mobilisation and early
oral nutrition.
2. Prehabilitation (prehab): focusing on preoperative (usually pre-admission) components preparing
patients for surgery, such as exercise programmes or nutritional optimisation.
3. Preoperative assessment with care plan: assessment prior to hospital admission, with subsequent care
plan, such as comprehensive geriatric assessment.
4. Rehabilitation (rehab): focusing on postoperative components to improve or speed up recovery, such as
a programme of physical exercises to improve strength and flexibility.
5. Specialist ward: patients recover in a procedure-specific and/or ring-fenced ward, with features such as
restricted opening times, specialist staff or extra infection control measures.
6. Staff mix: the main active ingredient is the provision of particular numbers or types of staff, such as a
team of geriatricians.
Comparators were grouped in the same way, with an additional category of ‘usual care’.
Outcomes were considered as ‘clinical’ or ‘patient-reported’. ‘Clinical’ outcomes included length of stay,
re-admissions, complications, use of additional care, surgical process outcomes, morbidity and mortality.
‘Patient-reported’ outcomes included mental health, quality of life, satisfaction and markers of physical
recovery. Effectiveness and cost-effectiveness outcomes of interest were tabulated and summarised in
order of procedural group.
Randomised controlled trials conducted in any high-income country were considered separately from
studies of any design that were conducted in the UK.
Between-group differences were analysed where possible, with data imputed where appropriate. A random-
effects meta-analysis was performed with data from randomised controlled trials when the procedure group,
intervention type, comparator type, and outcomes were similar and the data were available. The relative
effectiveness of different interventions was explored further with a narrative synthesis.
Publication bias was assessed across all procedure and intervention categories from randomised controlled
trials by visual inspection of funnel plots.
Expert clinical advisors and patient and public involvement
Expert clinical advisors were involved throughout the review, from development of the protocol to
interpreting preliminary results, identifying key messages for dissemination and supporting the preparation
of the final report and other outputs. We also consulted regularly with a group of older adults who had
experience of being admitted to hospital overnight for a planned procedure.
Findings
We identified 10,448 unique records. The full texts of 583 papers were sought for further consideration.
In total, 218 articles met the inclusion criteria for this review.
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Seventy-three studies, reported in 80 articles, containing data for 26,365 patients, met the criteria for further
synthesis. Thirty-four randomised controlled trials were conducted outside the UK in a total of 15 countries,
and 39 studies were from the UK, of which 12 were randomised controlled trials. The remaining 138 articles
were tabulated and summarised.
Key findings: randomised controlled trials
The majority of randomised controlled trials were evaluations of interventions to improve recovery from
colorectal surgery (n = 17) or lower limb arthroplasty (n = 13). Within the colorectal surgery evidence,
the majority of trials (n = 10) evaluated enhanced recovery protocol interventions, with pooled evidence
indicating a beneficial reduction in length of stay of around 1.5 days (Cohen’s d = –0.51, 95% confidence
interval –0.78 to –0.24, p < 0.001; n = 10 groups pooled). There was evidence that various markers of
physical recovery after colorectal surgery (mobilisation goals, passage of flatus or stool, pain control goals)
were achieved earlier in patients receiving enhanced recovery protocols than in those receiving usual care.
All other outcomes were either improved with enhanced recovery protocols or similar between enhanced
recovery protocols and usual care.
Most evidence for strategies to improve recovery from lower limb arthroplasty came from five randomised
controlled trials evaluating enhanced recovery protocol interventions and five evaluating prehab
interventions. However, only two studies in each intervention category provided length of stay data that
could be meta-analysed. In each category, the intervention was associated with a reduction in length of
stay. This effect was large and associated with a decreased stay of 3.3 days with enhanced recovery
protocols (Cohen’s d = –1.26, 95% confidence interval –1.62 to –0.89, p < 0.001, n = 2 groups pooled),
and of medium size and associated with a stay 2.5 days shorter with prehab (Cohen’s d = –0.53, 95%
confidence interval –0.77 to –0.28, p < 0.001, n = 2 groups pooled). Evidence for other outcomes was
scarce in enhanced recovery protocol trials but usually indicated no difference between groups or
improvements with enhanced recovery protocols. Studies evaluating prehab interventions collected more
evidence about patient-reported outcomes, which either were similar to those from usual care or improved
with the intervention.
Evidence from randomised controlled trials for other procedures was spread between cardiac (n = 6
randomised controlled trials), upper abdominal (n = 5), pelvic (n = 2), vascular (n = 2) and thoracic (n = 1)
surgeries, with one trial focusing on operations to remove tumours at various sites. The evidence was
dominated by enhanced recovery protocol (n = 8) and prehab (n = 5) interventions.
Where meta-analysis was performed within these procedure groups, enhanced recovery protocol
interventions were associated with a reduced length of stay of just over 5 days in patients receiving
upper abdominal surgery (d = –1.04, 95% confidence interval –1.55 to –0.53, p < 0.001; n = 5 groups
pooled), with 61% lower odds of sustaining complications in the same five studies (odds ratio 0.39,
95% confidence interval 0.24 to 0.64; p < 0.001); Prehab interventions were associated with a reduction
in length of stay of 0.7 days in patients undergoing cardiac surgery (d = –0.35, 95% confidence interval
–0.68 to –0.02, p = 0.04; n = 3 studies pooled).
The quality of evidence available was usually ‘moderate’ or ‘weak’ overall, with particular concerns over the
methods used to collect data, lack of a definition of length of stay, and unclear reporting of blinding of
assessors and participants. Despite these limitations, evidence from randomised controlled trials indicated
that interventions, particularly enhanced recovery protocols, either improved outcomes and reduced length
of stay, or did not cause detrimental effects to patients, compared with usual care.
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Evidence from the UK: key findings
Twelve randomised controlled trials, three controlled trials and 24 uncontrolled before-and-after studies
were from the UK. The largest groups of evidence from the UK were concerned with recovery from lower
limb arthroplasty (n = 15 studies) and colorectal (n = 7) or upper abdominal (n = 6) surgery.
Enhanced recovery protocol interventions dominated the UK evidence for lower limb arthroplasty, with
13 studies evaluating this type of strategy to improve recovery. Although six of these studies did not
report useable variance data, precluding secondary analysis of length of stay, all of the other seven studies
evaluating enhanced recovery protocol interventions reported a statistically significant reduction in length
of stay. Reductions in length of stay ranged from under 1 day to nearly 4.5 days. Reporting of additional
outcomes was generally poor in these studies, but there was no evidence of a detrimental effect with
enhanced recovery protocols, and some studies showed statistically significant improvements in markers
of recovery in particular.
All trials seeking to improve recovery from colorectal surgery evaluated enhanced recovery protocol
interventions. Evidence for length of stay came from only three studies, two of which indicated a
statistically significant reduction with enhanced recovery protocols. Complications were usually similar
between enhanced recovery protocol and usual care groups, except for two studies, in which the odds
of experiencing complications were reduced with the enhanced recovery protocol. Other outcomes were
unaffected by the intervention.
Five of the six studies in the upper abdominal category were enhanced recovery protocol interventions.
There were statistically significant reductions in length of stay in three of the four groups providing relevant
data, ranging from 3 to over 5 days with enhanced recovery protocols. Other outcomes were largely similar
between enhanced recovery protocol and usual care groups, but three of the four studies reporting markers
of recovery observed a statistically significant improvement with enhanced recovery protocols in at least
one outcome.
As with the evidence from randomised controlled trials, the evidence from the UK either favoured the
intervention or showed no difference from usual care. Study quality was usually rated as ‘moderate’ or
‘weak’. The large number of non-randomised studies automatically downgraded the quality rating of
these studies.
Key findings: cost-effectiveness
Only 15 prioritised studies included cost data or cost-effectiveness evaluations. Costs were largely driven
by length of stay and thus cost-effectiveness evidence broadly reflected effectiveness findings, effective
interventions being associated with reduced costs. However, the evidence was generally of low quality and
highly heterogeneous. The best evidence came from four evaluations of enhanced recovery protocols in
lower limb arthroplasty patients, all of which suggested that the intervention saved money compared with
usual care.
Summary
The findings were generally in favour of interventions to reduce length of stay and/or improve recovery in older
adults undergoing elective surgery requiring inpatient admission. The evidence was particularly focused around
colorectal surgery and lower limb arthroplasty, and enhanced recovery protocol or prehab interventions.
Enhanced recovery protocol and prehab interventions often led to improved recovery, including reduced
length of stay, or had no detrimental effect on reported wider outcomes. However, broader outcomes,
particularly relating to patient satisfaction and experiences after discharge, were lacking.
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Strengths and limitations
This is the first systematic review to bring together and evaluate evidence about multicomponent
interventions of any type aiming to improve recovery and reduce length of stay following planned
admissions in older adults. We used best practice methods to identify, select, appraise and synthesise the
evidence and throughout the review process we have incorporated the views of both clinical experts in the
field and patients with experience. Our findings are based on both the highest-quality (i.e. randomised
controlled trials) and most relevant (i.e. UK-based) evidence for the UK audience.
The quality of included studies was mostly ‘weak’ or ‘moderate’, and some interventions and procedures
remain under-researched. Outcomes were often reported in a format that precluded analysis, preventing a
large number of studies from contributing to pooled analyses of length of stay. The impact of interventions
on long-term patient outcomes or implications for the wider health and social care system were not
reported in the majority of included studies.
Conclusions
Multicomponent interventions to reduce length of stay and improve recovery in older adults undergoing
elective surgeries requiring inpatient admission were often effective and/or did not adversely affect
clinical or patient outcomes. There is clear evidence of the effectiveness of enhanced recovery protocol
interventions in colorectal surgery, lower limb arthroplasty and, to a lesser extent, upper abdominal surgery
to support this.
Research recommendations
Although the combinations of components within enhanced recovery protocol interventions may yet be
refined, this review suggests that the focus of future studies could move away from whether or not a
protocol is effective compared with usual care, and focus on factors that may affect the implementation
and uptake of interventions with consistency across institutions. Furthermore, effectiveness studies should
consider the longer-term implications of reduced length of stay for patient recovery and the health-care
system, and seek to integrate the patient voice into evaluations.
Study registration
This study is registered as PROSPERO CRD42017080637.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
National Institute for Health Research.
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Chapter 1 Background
Hospital use by older adults in the UK
Data from the World Health Organization1 indicate that most people across the world can now expect to
live until they are aged ≥ 60 years; this is attributed to reduced mortality from childbirth and childhood
illness and to declining mortality for older individuals in low-, middle- and high-income countries.2,3
In the UK, the number of people aged ≥ 60 years is expected to increase from 14.9 million in 2014 to
21.9 million in 2039, with the life expectancy for men and women being 79.4 and 83.1 years, respectively,
in 2017.4 In England, the number of treatment episodes associated with inpatient and day-case activity
recorded in NHS hospitals increased from 12.7 to 16.3 million between 2005/6 and 2015/16.5 During the
same period, there was a steady increase in the number and age of patients admitted to hospitals, with
the number of combined elective and emergency admissions of patients aged 60–65 years increasing by
57% and the mean patient age increasing from 49 to 53 years.5
In 2015/16, the largest number of elective and emergency procedures were conducted in patients aged
between 65 and 69 years, with the most common procedures in this age group involving bones and
joints, diagnostic tests, rehabilitation, the upper and lower digestive tract, and the eye.5 Older adults
admitted to hospital for elective procedures may present a different patient profile from that of younger
adults. For example, they may be more likely to have transport difficulties,6 they may be in poor physical
health or living with frailty,7 or they may be socially isolated8 or have living arrangements that require
additional support following discharge.9 Older adult hospital inpatients are also at increased risk of
peri- or postoperative complications, such as delirium, falls, hospital-acquired infection, pressure sores,
muscle wasting (sarcopenia), loss of mobility, poor nutrition and dehydration, cognitive decline and reduced
psychological well-being.10–17 Admission to hospital may also result in the recognition of a previously
unidentified frailty syndrome, which is then destabilised by an inpatient hospital stay,18 leading to additional
assessment and/or organisation of follow-up care before the patient can be discharged. Such complications
can impede patients’ recovery, increase their length of stay (LOS) in hospital and influence their discharge
destination.13 As a result, care pathways may need to be specialised to allow appropriate and effective care.
Within the current financial climate, NHS hospitals are under increased pressure to maintain or improve
their provision of care, and ensure the cost-effective delivery of services. The increased number of hospital
admissions in an increasingly ageing population indicates that there are both patient-care and financial
drivers of the need to manage the length of time older adults need to spend in hospital.
Length of hospital stay as a key outcome
Optimising the LOS in hospital does not consist solely of reducing the number of days until discharge.
Discharge should occur when the patient is physically prepared19 and is involved in the decision to discharge20
and when appropriate post-discharge support is in place.21 Thus, the LOS in hospital could be considered a
composite outcome, encompassing multiple indicators of readiness for discharge.
Although LOS is a key outcome, and the primary focus of this review, the patient care pathway does not
end on leaving the hospital, and nor does LOS encompass all aspects of patient recovery and well-being.
Measures of additional health resource use, hospital re-admissions and complications, as well as indicators
of patient recovery and well-being, are of interest when judging the success of treatment.
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Hospital-based multicomponent interventions to manage length of
hospital stay for planned admissions
Although identifying the optimal point of discharge can be a challenge for health-care practitioners to
address on an individual basis, opportunities exist to streamline organisational processes to enhance
recovery after treatment and reduce the risk of complications during hospital stay. Although LOS for patients
undergoing high-volume procedures has been decreasing overall, large variation remains among patients
undergoing the same procedure across different organisations.22 A Nuffield Trust report23 indicated that
around half of patients experiencing delayed discharge had done so because of factors under the direct
control of the hospital. In 2007, the Royal College of Surgeons of England24 suggested separating the
organisational structures and processes used for people admitted for elective surgery from those used for
emergency admissions in order to establish a more predictable workflow, improve continuity of care and
reduce LOS. Planned stays, in contrast to emergency admissions, offer hospitals and the wider health and
social care systems a more predictable opportunity to structure the organisation and delivery of their service
in order to reduce expected risks and optimise patient recovery.
Several organisational strategies or interventions have been developed and implemented both in
the NHS and worldwide with a view to standardising service delivery and improving patient recovery
and LOS. Comprehensive geriatric assessment (CGA)25 and enhanced recovery after surgery (ERAS)/
enhanced recovery protocols (ERPs)26 are examples of such interventions. These are considered to be
‘multicomponent’ interventions in that they combine several different aspects of care that could be
delivered individually otherwise.
ERAS Society guidelines27 exist for multiple planned procedures, aiming to provide explicit recommendations
for health-care professionals and detailing the care that a patient should expect to receive throughout their
inpatient journey. These include preoperative, intraoperative and postoperative aspects of care. Evidence
from several systematic reviews indicates the efficacy of the ERAS/ERP26,28 or ‘care pathways’29 and CGA30,31
approaches in reducing patient LOS, or improving other patient outcomes, among both patients undergoing
elective procedures and those undergoing emergency procedures.32 However, systematic reviews in this area
frequently do not specifically address older adults26,32 or common elective procedures requiring overnight
hospital stays in this population,28 or focus on only one specific part of the patient care pathway, for example
discharge arrangements.9,33,34 Therefore, there is currently a lack of synthesised evidence examining the
effectiveness of all multicomponent interventions to improve recovery and/or reduce LOS in older adults
undergoing elective treatments requiring inpatient admission.
Aims and objectives of the review
This review aims to assess the effectiveness of multicomponent organisational interventions that aim to
improve or accelerate the recovery of older adults undergoing planned (i.e. ‘elective’, non-emergency)
treatments requiring hospital inpatient admission.
We will address two research questions:
1. What is the effectiveness of hospital-based multicomponent interventions in reducing length of
inpatient stay in hospitals for older adults following planned admission?
2. What is the cost-effectiveness of hospital-based multicomponent interventions in reducing length of
inpatient stay in hospitals for older adults following planned admission?
BACKGROUND
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Chapter 2 Methods
The methods used to identify and select evidence followed best practice.35–37 A protocol was registeredon the PROSPERO database (PROSPERO CRD42017080637).
Search strategy
We identified effectiveness studies by searching bibliographic databases, conducting forwards and
backwards citation searching of studies that met the inclusion criteria for the review, inspecting the
reference lists of topically similar systematic reviews, carrying out web searches, consulting stakeholders,
and contacting authors of potentially relevant conference abstracts. We also identified effectiveness studies
via the cost-effectiveness searches. Cost-effectiveness studies were identified in the same way, but with
adapted search terms (see below) and by inspecting studies in the effectiveness arm of the review for
cost data.
The bibliographic database search strategy for effectiveness studies was developed using MEDLINE
(via Ovid) by an information specialist (SB) in consultation with the review team and the stakeholders.
Search terms were derived from the titles and abstracts of relevant studies identified from background
searches and supplemented with relevant synonyms. The search strategy used controlled headings
(e.g. MeSH in MEDLINE) wherever appropriate and free-text terms (i.e. terminology used in the
titles and abstracts of studies). A multistranded approach was used to maximise the sensitivity of the
search as a result of uncertainty about the specific names of procedures and interventions of interest,
as follows.
Group 1 terms: included terms for older people and elective procedures commonly undergone by older
people. Because we could not be certain of specifying all relevant elective procedures, and nor could we
rely on relevant studies describing the population group in the title or abstract, these two sets of terms
were combined using the ‘OR’ Boolean operator.
Group 2 terms: included generic terms for multimodal interventions for reducing LOS, such as ‘ERAS’
and ‘fast-track’, and common components of these interventions, such as ‘early ambulation’ and
‘nutritional support’. We also included terms that described reducing LOS, using the format ‘length’
adjacent to ‘stay’ adjacent to ‘reducing’. Because we could not be certain of specifying all relevant
interventions, we combined the intervention terms and terms that described their intended effect
(reducing LOS) using the OR Boolean operator.
The search terms in groups 1 and 2 were combined using the AND Boolean operator and limited using a
study type filter. The filter was developed using adapted versions of Royle and Waugh’s38,39 simplified
approaches to identifying randomised controlled trials (RCTs), and the Cochrane Effective Practice and
Organisation of Care (EPOC) group’s suggested terminology for identifying non-randomised trials,
controlled before-after studies and interrupted time series (Paul Miller, EPOC, 23 August 2017, personal
communication). We also inspected the titles, abstracts and controlled headings of known relevant studies.
No English-language or date filter was used; however, we retrospectively limited the search results to
studies published from 2000 to date of searches using the sort by date feature in EndNote (EndNote X7,
Thomson Reuters, New York, NY, USA). This date limit was selected because of the increasing prevalence
of so-called ‘enhanced recovery pathways’ in the early 2000s, following the work of Kehlet and
colleagues.40–43 In addition, we wanted to limit the extent to which ‘usual care’ could be considered far
removed from current day-treatment pathways.
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The MEDLINE search strategy was translated for use in a selection of bibliographic databases, chosen
because they were felt to be most likely to contain primary studies most relevant to our research questions.
The full set of bibliographic databases comprised:
l MEDLINE (via Ovid)
l MEDLINE In-Process & Other Non-Indexed Citations (via Ovid)
l EMBASE (via Ovid)
l Health Management Information Consortium (HMIC) (via Ovid)
l Cochrane Central Register of Controlled Trials (CENTRAL) (via The Cochrane Library)
l Cumulative Index to Nursing and Allied Health Literature (CINAHL) (via EBSCOhost)
l Allied and Complementary Medicine Database (AMED) (via EBSCOhost).
We also searched for studies using the Google ScholarTM and GoogleTM (Google, Inc., Mountain View,
CA, USA) web search engines. The search strategies for MEDLINE, Google Scholar and Google Search are
reproduced in Appendix 1, with the search strategies for other bibliographic databases reported in Report
Supplementary Material 1.
The bibliographic database search for the cost-effectiveness review used the same search strategy as above,
except the effectiveness study filter was replaced with a cost-effectiveness study filter. The cost-effectiveness
filter was derived from a published search for cost-effectiveness studies developed by the team’s information
specialist (SB) and refined to meet the specific requirements of our review in discussion with an experienced
health economist (RA).44 The search results were date limited from 2000 to date of search. No English-
language filter was applied.
The search strategy was translated for use in an appropriate selection of bibliographic databases, including:
l MEDLINE (via Ovid)
l MEDLINE In-Process & Other Non-Indexed Citations (via Ovid)
l HMIC (via Ovid)
l NHS Economic Evaluation Database (NHS EED) (via Ovid) (although this was discontinued in March 2015,
it can still be searched as an historical archive).
The results from the bibliographic database searches and Google Scholar were exported to EndNote X7 and
deduplicated by manually checking and using the automatic deduplication function. The results from Google
Search were copied and pasted into a Microsoft Word (version 14.0; Microsoft Corporation, Redmond,
WA, USA) document for screening, as Google Search has no export function.
We carried out forwards and backwards citation searching on all prioritised studies that met the inclusion
criteria (as detailed in Study selection). Web of Science (via Clarivate Analytics), Scopus (via Elsevier) and
Google Scholar were used for forward citation searching. If a study was not indexed in Web of Science
we searched Scopus, and if it was not indexed in Scopus we searched Google Scholar. Backwards citation
chasing was conducted manually by inspecting the reference lists of prioritised studies that met the
inclusion criteria.
The first authors of relevant conference abstracts from 2014 to date were contacted by e-mail to ascertain
whether the study had been subsequently, or was soon to be, published as a journal article. Conference
abstracts published before 2014 were not followed up on the assumption that they would have been
published as a journal article already. Finally, we screened studies and the publication lists of authors
suggested to us by our stakeholders.
Inclusion and exclusion criteria
The following inclusion and exclusion criteria were applied.
METHODS
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Population
Studies were included if patients:
l were older adults, defined by the mean or median age of study participants being ≥ 60 years, based on
the cut-off point agreed by the United Nations1
l were undergoing planned hospital admission for either surgical or non-surgical procedures/diagnostic
tests, for example –
¢ hip/knee replacement
¢ cardiac surgery
¢ oncological surgery.
Studies were excluded if patients:
l were undergoing an unplanned (i.e. non-elective or emergency) admission, as a result of an emergency
or acute incident, for example following –
¢ hip fracture
¢ stroke
¢ heart attack
¢ acute injury
l were receiving hospital treatment that did not require an overnight stay (e.g. day surgery)
l had been admitted to psychiatric hospitals
l had been admitted to hospital for a medical investigation that resulted in an unplanned
inpatient stay.
Intervention
The intervention was any multicomponent hospital-based intervention or strategy for patients receiving
planned care as an inpatient, which either explicitly aimed to reduce LOS or aimed to improve recovery
(or used equivalent language in the aims of the strategy, e.g. ‘accelerate rehabilitation’).
Studies were included if:
l the intervention had multiple components
l a pre-treatment assessment was included, as long as there was detail of how the assessment influenced
the patient care plan or care pathway in hospital
l the intervention was deemed to be hospital-led, judged subjectively on the basis of whether the
majority, or the core elements, of an intervention took place in hospital and/or were delivered by
hospital staff
l the comparison within the study related to altered care or patient recovery during the hospital stay.
Examples of potentially includable interventions were:
l ERAS as described by the ERAS Society27
l ERP
l the use of a CGA to inform a care pathway
l multidisciplinary assessment to inform a recovery plan
l a rehabilitation programme consisting of a variety of exercises
l multicomponent fast-track surgery programmes.
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Studies were excluded if:
l the intervention focus was surgical technique
l the intervention was pharmacological, unless it was part of a broader recovery pathway
l the intervention was focused only on discharge planning or only on pre-treatment assessment (e.g. CGA
alone) and did not result in actions affecting the hospital stay
l the intervention was not hospital-led (e.g. it was a community care programme, a general practitioner
(GP) assessment or an intervention based in a nursing home)
l the intervention had a single component, that is, it featured the administration of only a single dose or
bout of an intervention, or it was delivered at a single time point and modality.
Examples of excludable interventions were:
l early mobilisation in isolation
l CGA to identify odds of adverse events, without informing a care plan
l pre-treatment information materials.
Comparator(s)
The comparator was any type of control group or comparator, for example ‘treatment as usual’, ‘usual
hospital care’, ‘pre-pathway implementation’ or ‘usual best clinical practice’.
Outcomes
The outcome was any metric of LOS.
Other key outcomes that were of interest, but did not influence a study’s eligibility for inclusion, were:
l re-admission rates
l patient-reported outcomes
l feedback/experiences of patients, carers or clinicians
l additional health-care use, including re-admission or the use of primary care post discharge
l incidence of within-hospital or post-discharge complications or harms (e.g. falls, delirium, sarcopenia).
For cost-effectiveness studies, economic outcomes were defined as the amount of resources used or costs
incurred directly related to the outcome of interest where a change in that outcome directly resulted in the
use of a different amount or different type of health-care resources. In addition to the outcomes extracted
listed above, those relevant to research question 2 included:
l mean per-patient costs (and incremental cost between control and intervention)
l mean per-patient effectiveness/quality-adjusted life-years (QALYs) (and incremental effectiveness/QALYs
between control and intervention)
l total and mean intervention cost (and comparator)
l incremental cost-effectiveness ratio (from any included cost-effectiveness or cost–utility analyses
l net benefit or net monetary benefit (from cost–benefit analyses).
Study design
To answer review question 1, any of the following comparative study designs were included:
l RCT
l (non-randomised) controlled clinical trial
l controlled before-and-after study
l interrupted time series
l uncontrolled before-and-after studies.
METHODS
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The study designs included as economic studies were:
l cost-minimisation analysis
l cost–consequences analysis
l cost-effectiveness analysis
l cost–utility analysis
l cost–benefit analysis
l any comparative cost analysis comparing relevant interventions.
Studies were excluded if:
l methods of calculating cost outcomes were not reported.
Geographical context
Studies were included from any high-income country as defined by the World Bank list of economies.45
This was to ensure that the studies included in this review were evaluating health systems that were
broadly comparable.
Date of publication
The search was restricted to studies published from 2000 to date of search (see Search strategy).
Study selection
The inclusion and exclusion criteria were piloted on a sample of 100 records identified by the database
searches by four reviewers (MN, LS, SB and RA) independently. Following discussion, the criteria were
refined and applied to the title and abstract of each identified citation independently by two reviewers
(LS, MN, SB), with disagreements resolved through discussion. The full text of each potentially relevant
paper was obtained and assessed independently for inclusion by two reviewers (SB, MN, LS) using the
same method. When necessary, the opinion of a third reviewer was sought (MN, LS, RA, JTC). EndNote
software was used to support study selection. A Preferred Reporting Items for Systematic reviews and
Meta Analyses (PRISMA)-style flow chart was produced, detailing the study selection process.
We took the pragmatic step of prioritising the following categories of includable studies for full data
extraction and synthesis: (1) RCTs conducted in any high-income country and (2) studies of any of includable
trial design and conducted in the UK. This step was taken to allow us to manage the size of the synthesis
while ensuring that it was based on the highest quality of evidence available, and to allow us to focus
on the most relevant evidence within the UK setting. Only cost-effectiveness evaluations associated with
prioritised studies were of interest. Minimal data extraction (study details, design and location; sample size,
age and reason for admission; intervention type and key features; comparator type; setting; stages of care
affected by the intervention) was carried out for the studies that were not prioritised, and these features
were tabulated (see Report Supplementary Material 2, Table 1). Cost-effectiveness studies that were
eligible for inclusion but were not based on prioritised effectiveness studies are summarised in Report
Supplementary Material 7.
Data extraction
A standardised, piloted data extraction form in Microsoft Excel® (Microsoft Corporation, Redmond, WA, USA)
was used to collect data from each of the prioritised papers. Piloting the form for effectiveness studies involved
each reviewer (MN, LS, SB) extracting an included study, which was then checked by another reviewer.
Following this, all reviewers discussed ways to improve the form. This was repeated for the cost-effectiveness
form by three reviewers (RA, LS and MN).
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Data extraction was performed by one reviewer (effectiveness studies: MN, LS, SB; cost-effectiveness studies:
RA, LS, MN) and checked by a second (effectiveness studies: LS, MN, SB; cost-effectiveness studies: RA, LS), with
disagreements settled through discussion. The following data were extracted where applicable and reported.
Population
Number invited to participate, number randomised/included, dropouts and missing data, age, percentage
female, place admitted to, reason for admission, comorbidities, discharge destination, other inclusion or
exclusion criteria and any subgroup analysis.
Intervention
Intervention name, aim and description, who delivered the intervention, setting, recipient(s), use of
manual/guidelines, frequency of each intervention component, duration of each intervention component
and assessment of fidelity.
Comparator
As for intervention.
Outcome
All reported outcomes, as listed in Inclusion and exclusion criteria, Outcomes.
For cost-effectiveness studies, additional data summarising the cost methods used in each paper were
extracted.
Quality assessment strategy
The quality of all prioritised studies was independently appraised by two reviewers (LS, MN, SB) using the
Effective Public Health Practice Project (EPHPP) Quality Assessment Tool for Quantitative Studies, which is
suitable for randomised and non-randomised study designs.46 Disagreements between reviewers were
resolved through discussion. An additional item was considered during quality assessment, namely whether
or not LOS was clearly defined. This item was not included when scoring the global quality of each study.
Cost-effectiveness studies were subject to additional appraisal using the Consensus Health Economic
Criteria (CHEC) list.47 Each study was independently appraised by two reviewers (LS and MN) and checked
by a third reviewer (RA). Quality assessment informed interpretation of findings, for example by qualifying
statistically significant findings in cases of poor study quality, and was not used to exclude studies.
Non-prioritised studies were not subject to quality assessment.
Synthesis methods
All studies were grouped into categories based on the anatomical location of the procedure. These groupings
were informed by consultation with stakeholders and agreed by two researchers/clinicians (MN and AH) and
were as follows: cardiac surgery, colorectal surgery, lower limb arthroplasty, pelvic surgery, thoracic surgery,
tumour removal (various locations), upper abdominal surgery, vascular surgery and various surgeries. We
expected that this approach would lead to interventions within each group sharing common features, aiding
comparison between studies.
Interventions and outcomes were categorised by two researchers (MN and LS). Interventions were classified
according to the following broad categories, which were based on terms found in the literature.
l ERP: an intervention consisting of components at multiple stages of the care pathway (i.e. pre
admission; post admission but preoperative; perioperative; postoperative but prior to discharge;
post discharge).
METHODS
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l Prehabilitation: characterised by a focus on preoperative (usually pre-admission) components.
l Preoperative assessment with care plan (PACP): an assessment prior to hospital admission, with a
subsequent care plan for the patient.
l Rehabilitation: characterised by a focus on postoperative components to improve or speed up recovery,
delivered while the patient was still in hospital or when they had been discharged; usually based on
physical exercise.
l Specialist ward: this involved moving the patient to a different location in the hospital, or a ring-fenced
ward, with aspects such as restricted opening times, specialist staff or extra infection control measures.
l Staff mix: the main active ingredient was the provision of particular numbers or types of staff, such as a
team of geriatricians, or the provision of extra nurses at key time points.
Comparators were grouped in the same way, with the additional category ‘usual care’ available. The
following synthesis was only applied to prioritised studies.
Outcomes were grouped into categories for ease of reporting by two researchers (MN and LS) and
confirmed following discussion with stakeholders (JM, AH, DT, CL). Broadly, outcomes were considered as
either ‘clinical’ or ‘patient-reported’ in nature. ‘Clinical’ outcomes included those outcomes obtained from
patient records or accessed from a database, such as LOS, re-admissions, complications, use of additional
care, surgical processes, morbidity and mortality. ‘Patient-reported’ outcomes were considered to be those
outcomes that a patient might actively report (although some might be assessed by a third party), such
as mental health, quality of life, satisfaction and markers of physical recovery. Outcome categories are
defined, with examples, in Appendix 2.
After categorisation and collation of data, effectiveness findings were tabulated and summarised by
procedural group. Surgical outcomes were not described but are available on request.
Data processing
Between-group differences were analysed where possible. For continuous outcomes, standardised mean
differences were calculated, where possible, to assess the presence and magnitude of any differences
between groups. For dichotomous outcomes, odds ratios (ORs) were calculated to assess the relative ‘odds’
of the event occurring in the intervention group, for example re-admissions or complications. Cohen’s d
was calculated for continuous outcomes to produce an effect size, with interpretation following Cohen’s
guidance (i.e. where d = 0.2 to 0.49, class as ‘small’; where d = 0.5 to 0.79, class as ‘medium’; and
where d = 0.8 or above, class as ‘large’).48 In addition, 95% confidence intervals (CIs) for the effect were
calculated using the metan command in Stata (version 14.2, StataCorp, College Station, TX, USA).
The mean (non-standardised) difference with 95% CIs was also calculated for the outcome, and the
p-value for the difference was obtained using the ttesti command in Stata, using data from the two-tailed
analysis.
Where the mean and standard deviation (SD) were not provided for continuous effectiveness outcomes,
these were treated as described in Appendix 3 to allow the analysis of as many data as possible from the
included studies. Methods for imputing data were taken from Section 7.7.3 of the Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0,36 except for the method for imputing data from the
median and interquartile range, which was taken from the work of Wan and colleagues.49 The calculations
provided by Wan and colleagues also allow imputation to be performed when medians and ranges are
provided; however, they are most suitable when data are normally distributed.49 Based on this, we decided
not to report imputed data when medians with ranges were provided because data for outcomes such
as LOS were often highly skewed. To investigate the influence of imputed data on pooled effects, we
performed sensitivity analyses on LOS meta-analyses using three scenarios: (1) include all data in the
analysis, (2) exclude data imputed from medians and ranges and (3) exclude data imputed from medians
and any form of variance statistic.
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For dichotomous outcomes, ORs were calculated in Microsoft Excel using standard equations described
in section 9.2.2 of the Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0.36
In addition, the statistical significance of the OR was assessed by calculating a p-value from the z-score
for the difference, and ascertaining 95% CIs. CIs were calculated using the following equation:
Z =
(p^1 ‒ p^2)− 0ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
p^(1− p^)
 1
n1
+
1
n2
r , (1)
where p^1 is the proportion of ‘successes’ or occurrence in the experimental group p^2 is the proportion of
‘successes’ or occurrence in the control group; and p^ is the proportion of successes across the two groups
combined. P-values were ascertained by referencing Z against normal distribution tables using the function
normdist in Microsoft Excel. For the calculation of 95% CIs, we used the method described by Altman
and Bland.50
Throughout, p-values were reported at the levels of < 0.001, < 0.01 and < 0.05, and the actual value
if > 0.05. Interpretation of statistical significance was guided by considering the effect size, CI and
p-value and whether or not the mean difference between groups was clinically significant, where
appropriate.
Random-effects meta-analysis was performed with RCTs where, within a procedure group, studies
evaluated the same intervention type (e.g. ERP), evaluated the same comparator type (e.g. (usual care)
and reported the same outcomes (e.g. LOS) and from which useable data could be calculated. Forest plots
were produced as part of the metan command in Stata. Pooled effects with 95% CIs and p-values were
reported. Statistical heterogeneity was assessed using the I2-statistic, with greater values (range 0–100%)
indicating greater heterogeneity.51 Meta-analysis was performed only when all combinable studies were
RCTs. Meta-analysis of ORs was performed using log-transformed data.
When multiple outcomes were presented within the same outcome category, for a study included in the
meta-analysis, one outcome was chosen as the ‘best representative’. In the case of LOS, this meant the
outcome that most closely accounted for the longest portion of the hospital stay, without consideration
of re-admissions. For example, ‘total LOS’ would be chosen ahead of ‘postoperative LOS’. LOS including
re-admissions was not chosen because of the likelihood that small numbers of re-admissions, and varied
reasons for re-admission leading to unpredictable duration of additional stay, were expected to skew data.
For complication data, summary or composite outcomes were preferred, rather than incidences of specific
complications. For example, ‘total complications’ or ‘patients with complications’ would be preferred to the
breakdown of patients with specific complications. When only incidences of individual complications were
listed by study authors, a summed outcome was calculated for entry into meta-analysis.
The effectiveness of interventions at reducing LOS and improving other patient outcomes was
further explored utilising a narrative synthesis approach based on the methods used by Thomson et al.52
Within each procedural group, the intervention and outcomes of each study was summarised visually
within a table to aid comparison across multiple outcomes and intervention types. The data for each type
of intervention within a procedural grouping were examined to see if any differences between the sample,
intervention characteristics or study quality could be related to the effectiveness of the intervention.
Any characteristics that appeared to differentiate effective interventions from ineffective ones were then
compared across different procedural groups where possible. Data provided by RCTs were considered
separately from data provided by studies of any design that were conducted in the UK.
METHODS
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Publication bias
Publication bias was assessed across all procedure and intervention categories using a visual inspection of
funnel plots (effect size vs. standard error of the effect size) for LOS. This method was used in line with
the recommendations of Sterne and Egger.53 Only standardised mean differences calculated from RCTs
were entered into funnel plots. Funnel plots were produced using the metafunnel command in Stata.
Stakeholder and patient and public involvement
Stakeholder and patient and public involvement is described in Chapter 3.
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Chapter 3 Stakeholder and patient and public
involvement
Stakeholder engagement
Stakeholder involvement was incorporated throughout the review, from development of the protocol to making
sense of preliminary results, identifying key messages for dissemination and supporting the preparation of the
final report and other outputs. Consultation occurred through a series of individual face-to-face meetings,
telephone calls and e-mail correspondence with the following clinical expert advisors:
l A consultant geriatrician (AH) with expert knowledge in the management of adults with multiple
comorbidities and complex needs, frailty syndromes and polypharmacy, and with expertise in achieving
successful discharge planning and supportive home-based post-discharge interventions.
l A consultant urological surgeon in the UK (JM), who was National Clinical Advisor to the UK
Department of Health for the Enhanced Recovery Partnership Programme, and chaired the ERAS
Guideline Development Group for the British Association of Urological Surgeons and authored the
specialty guidelines. Recognised internationally for work in Enhanced Recovery following major
urological surgery and has published widely within this field.
l A clinical lead occupational therapist (CL) in neurology and neurorehabilitation in the UK. His clinical
interests include Parkinson’s disease, brain injury and cognitive neuroscience.
l A deputy chief nurse at Royal Devon and Exeter hospital (DT) with 29 years’ experience in nursing,
almost entirely within the surgical specialties, and with clinical understanding of the ERP processes and
patient journey during the hospital stay.
Stakeholder engagement is documented and the impact of this involvement on the review is described in
Table 1.
Patient and public involvement
We met with a group of four adults aged > 60 years for three 2-hour meetings during this review. Each
individual had experience of being admitted to hospital overnight for a planned procedure. We planned
to learn from their knowledge and experiences to help us identify important outcomes and aspects of
care, particularly where they may have been overlooked in the included evidence. We elicited feedback
from the group at key stages of the review and aimed to co-produce the plain English summary to maximise
readability. The impact of the patient and public involvement on this review is also described in full in Table 1.
TABLE 1 Involvement of stakeholders and patients and public in the review
Stage Stakeholder/PPI involvement Impact on review
Protocol development Individual 60-minute meeting
with AH
Development of reviewer understanding of pathway
of care for older adults admitted to hospital for
planned procedures
Preparation of website and
advertisement materials
(September 2017)
Proofreading of materials by three
individuals
Project information for display on project website
and advertisement for PPI group sense checked by
people aged > 60 years who had experience of
planned hospital stay
continued
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TABLE 1 Involvement of stakeholders and patients and public in the review (continued )
Stage Stakeholder/PPI involvement Impact on review
Protocol revisions
(October 2017)
All expert clinical advisors reviewed
the draft project protocol by e-mail
Telephone conversation with JM
Revision of review inclusion/exclusion criteria,
specifically:
l date restriction of 2000 onwards
l clarification of our definition of ‘hospital-based’
interventions
l support for the definition ‘older adult’ used in
the review
l identification of elective procedures relevant to
the review
l identification of different types of interventions
of interest
l identification of additional outcomes of interest
Identification of several studies relevant for inclusion
in the review
Checking review focus
(January 2018)
1 × 2-hour meeting with four
patients/members of the public
Discussion of interventions that the group felt were
most important to patients facing a planned hospital
stay, which could have an impact on their LOS in
hospital, including clear communication, provision
of information, provision of transport, receiving
medication on discharge and support at home
Planning analysis and
feedback on search
results (June 2018)
3 × 60-minute meetings with
AH, JM and CL individually
E-mail correspondence with DT
Meeting with AH:
l Informed how studies were grouped according
to type of planned procedure. This enabled
opportunities for meta-analysis to be identified.
Procedural groupings approved by other
stakeholders
l Discussed how to present tables describing
interventions. Agreed full description too detailed
for readers and best placed in supplementary
material
l Agreed tables mapping components used within
ERP studies onto existing ERAS guidelines made a
useful addition to synthesis. Identified issue
regarding comparator groups not being
described well
l Identified other important outcomes to consider
(e.g. discharge destination)
Meeting with JM:
l Identified planned admissions not represented in
identified literature (e.g. non-surgical populations)
l Identified other authors from US literature to
check via grey-literature searches to see if
published anything eligible for inclusion in review
l Decided not to analyse compliance data
l Discussed the impact of implementing an agreed
protocol of care and measuring outcomes. Used
to inform discussion of review
l Identified potential for qualitative research/review
of implementation evidence as areas where
further research required
l Confirmed that can present ERAS/ERP
data together
l Discussed how certain components within ERAS/
ERP mapping tables could be combined with one
another
STAKEHOLDER AND PATIENT AND PUBLIC INVOLVEMENT
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TABLE 1 Involvement of stakeholders and patients and public in the review (continued )
Stage Stakeholder/PPI involvement Impact on review
Meeting with CL
l Identified procedural groupings not included
within the review (e.g. neurosurgery)
l Made introduction to specialists working within
neurosurgery to enquire about any research
within this specialty that may have been eligible
for inclusion in the review but was not identified
with initial search strategy
1 × 2-hour meeting with four
patients/members of the public
Identification of outcomes that were particularly
important to patients, including:
l Complications when the patient has been
discharged home
l Associated difficulties that may affect LOS
(e.g. frailty, dementia)
l Support available at home
Plan of how to approach dissemination of project
results to members of the public, including:
l Creation of leaflets for display in GP surgeries
l Plain-language summaries for the final project
report
Ideas for press releases and conferences
Feedback on initial
findings (June 2018)
1 × 2-hour meeting with three
patients/members of the public
Identified that patient satisfaction, mental health and
quality-of-life outcomes are poorly reported and a
research priority. Gave the patient perspective on
overnight stays for elective procedures, highlighting
a number of factors that the study authors had not
considered. These points helped the team to
understand gaps in the evidence and provided
materials for the discussion section
Dissemination activities
(August–October 2018)
2 × members of the public
contributed towards a conference
abstract
Provided content used on a poster presentation
delivered at the Cochrane Colloquium in Edinburgh,
September 2018, reflecting on PPI involvement in
the systematic review
Co-creation of plain-language summaries for the
main report and to use as basic structure for further
dissemination materials
Reading of draft report
(October 2018)
3 × 1-hour meetings with AH, JM and
CL individually
All stakeholders:
l commented on preliminary findings of review
l discussed the review findings within an
NHS context
l identified opportunities for further research
l checked that the reporting of results in the final
report was clear
Discussion regarding dissemination plan and
publication of academic papers with JM
AH, Anthony Hemsley; CL, Chris Lovegrove; DT, David Thomas; ERP, enhanced recovery pathway; JM, John McGrath;
PPI, patient and public involvement.
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Chapter 4 Results
Study selection
This section presents the findings from the effectiveness searches. The cost-effectiveness search results are
presented in Synthesis of cost-effectiveness evidence, Study selection.
The PRISMA flow chart in Figure 1 summarises the study selection process. Bibliographic database searches
identified 17,150 records and supplementary search methods identified 3501 records. Following the removal
of duplicates, a total of 10,448 unique records were screened at title and abstract level. The full texts of 583
papers was sought for further consideration. Of these, 579 full texts were successfully retrieved (99.3%).
Following full-text screening, 361 papers were excluded for the reasons specified in Figure 1.
Records after duplicates removed
(n = 10,448)
Records identified through database
searching
(n = 17,150)
Additional records identified
through other sources
(n = 3501)
• Author reference lists, n = 1
• Backwards citation searching, n = 15
• Cost searches, n = 44
• Forwards citation searching, n = 2316
• Google, n = 23
• Google Scholar, n = 999
• SR included studies, n = 102
• Stakeholders, n = 1
Records screened
(n = 10,448)
Records excluded
(n = 9865)
Full-text articles screened
(n = 583)
Articles included overall
(n = 218)
RCTs and UK non-RCT
articles included in
synthesis
(n = 80)
Non-RCT, non-UK
articles not prioritised for
synthesis
(n = 138)
Full-text articles excluded,
with reasons
(n = 365)
• Average age < 60 years or
   NR, n = 104
• Foreign language, n = 5
• Full text not obtained, n = 4
• Intervention, n = 28
• No suitable LOS data, n = 49
• No overnight stay, n = 1
• Not all elective, n = 88
• Not high income, n = 29
• Not hospital based, n = 5
• Protocol/ongoing, n = 3
• Retraction, n = 1
• Study type, n = 48
FIGURE 1 The PRISMA flow chart. NR, not reported; SR, systematic review.
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In total, 208 studies, reported in 218 articles, met the inclusion criteria for inclusion in this review
(not prioritised,40,54–190 prioritised31,191–269).
As described in Chapter 2, Synthesis methods, only RCTs and studies of any design from the UK were
prioritised for quality assessment and further synthesis. Studies that were not RCTs and that were conducted
outside the UK are described in Report Supplementary Material 2, including the stages of care targeted by
each intervention, along with a brief description of the intervention and comparator. The descriptions in
Sample characteristics, Intervention characteristics: prioritised studies and Quality assessment apply only to
prioritised studies.
The results from the RCTs conducted in any high-income country are presented in Synthesis of evidence
from randomised controlled trials. The results from the studies of any comparative trial design that were
conducted in the UK are then presented in Synthesis of evidence from the UK. Evidence within these
sections is further broken down by procedural type. Within each procedural subsection, key findings
are summarised at the start, followed by a detailed analysis. Full tables of outcome data are located in
Report Supplementary Material 5 (RCTs) and Report Supplementary Material 6 (UK evidence).
Sample characteristics
Of the 73 prioritised studies (reported in 80 articles), 39 (40 articles) were conducted in the UK,31,191,192,194,195,
197,201,203,205–208,210,212,213,215,216,218,224,226,228–232,236–238,241,244,245,250,253,256,257,259,260,262,263,269 13 of which were RCTs.
Thirty-four (41 articles) were RCTs conducted in one of 15 other countries, the most common of which
were six studies from Germany,202,217,227,240,246–249,255 five from the Netherlands,204,219–221,265,266,268 four from
Denmark196,225,233,234,267 and four from Canada.193,198,200,214 The remaining studies consisted of 24 uncontrolled
before-and-after (UBA) trials191,194,195,197,201,203,206–208,212,216,218,228,230,232,237,238,241,245,250,253,257,262,263 and three
controlled trials224,229,259 from the UK.
All of the prioritised articles were published in peer-reviewed journals, apart from one, which was a PhD
thesis.233 The majority of articles (81.5%) were published from 2008 onwards, with 50 (61.7%) published
since 2011.31,191,195,197,199,201–203,205–209,211,212,214,216,219,220,222,225–230,235–243,249,250,252,253,255,257–260,262–265,267,268 Data were
collected from 26,365 patients across 73 studies, with a mean number of 366 patients per study, ranging
from 21 within a RCT221 to 5319 within a controlled trial229 utilising database sampling. The mean proportion
of female participants in studies was 44.9% across 70 studies. Eight studies had an upper age limit for
inclusion as follows: 75 years,254,256 80 years235,265,268 and 85 years.202,243,264 By contrast, nine studies199,204,207,218,
220,221,223,242,267 exclusively recruited patients aged ≥ 60 years. Studies explicitly excluded patients who lived
with cognitive impairment (n = 6200,218,229,254,261,262), had ‘psychiatric illness’ (n = 6196,202,210,231,254,266), had a
history of stroke (n = 2218,259), had ‘mental disability’ (n = 2234,267), had periods of dizziness/confusion (n = 2210,244)
or were unable to consent (n = 431,209,226,236). By contrast, seven studies199,200,207,215,218,221,223 selected individuals
who were at elevated risk of postoperative complications or who were likely to have complex needs or
multimorbidities.
The reasons for admission, according to our broad procedural categories, were lower-limb arthroplasty
(n = 25 studies195,196,200,202,206,216,218,221–224,230,234,237,238,241,244,245,253,254,256,261,262,267,269), colorectal surgery (n = 19
studies192,198,203,204,209,211,213,214,229,231,232,235,236,239,242,243,251,252,265), cardiac surgery (n = 8 studies193,208,210,215,255,258,259,266),
upper abdominal surgery (n = 8 studies191,201,205,226,227,257,263,264), pelvic surgery (n = 3 studies217,225,250), thoracic
surgery (n = 4 studies 197,212,228,248), vascular surgery (n = 2 studies31,247), solid tumour removal at various
anatomical sites (n = 1 study220), abdominal surgery (n = 1 study199) and a mix of various different surgeries
(n = 1 study207).
Table 2 provides a broad overview of the sample characteristics of studies prioritised for synthesis.
RESULTS
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TABLE 2 Sample summary table, by broad procedural category
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Abdominal surgery
Chen 2017,199
Taiwan
RCT 535 43.2 74.54 (5.89) [NR] On admission to
gastrointestinal wards
Urban medical
centre
Surgery type: total/subtotal
gastrectomy, right hemicolectomy,
left hemicolectomy/lower anterior
resection/anterior resection,
pancreaticoduodenectomy,
other (open splenectomy,
transverse colon partial resection,
Hartmann’s procedure with
adhesiolysis and bladder lithotripsy,
abdominoperineal resection, or
laparoscopic debulking surgery),
enrolled if expected LOS of > 6 days
and aged ≥ 65 years
Cardiac surgery
Arthur 2000,193
Canada
RCT 249 15 62.8 (8.2) [NR] Waiting lists General hospital Previous myocardial
infarction: 52.6% vs.
52.1%
Diabetes: 16.4% vs.
25.6%
Current smoker:
20.3% vs. 13%
Aortocoronary bypasses
(mean/median): 2.6/3
vs. 2.6/3
First CABG, low-risk surgery date
> 10 weeks away. Excluded if had
combined CABG and valve
surgery, had ejection fractions
< 0.40, could not attend exercise
classes, or was unable to
participate because of physical
limitations
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Fleming 2016,208
UK
UBA 105 27.6 67.4 (11.4) [NR] NR Teaching hospital Mean/SD:
NYHA heart failure,
2.2 (0.5) vs. 2.2 (0.5)
CCVS angina pectoris,
2.2 (0.5) vs. 2 (0.7)
Normal LVF, n = 35 vs.
n = 34; impaired LVF,
n = 14 vs. n = 11; poor
LVF, n = 3 vs. n = 8
Non-insulin-dependent
diabetes, n = 10 vs.
n = 6
Insulin-dependent
diabetes, n = 1 vs.
n = 2; receiving
treatment for
hypertension, n = 30
vs. n = 36; history of
myocardial infarctions,
n = 22 vs. n = 19
Hypercholesterolemia,
n = 33 vs. n = 30;
COPD requiring
treatment, n = 6 vs.
n = 5; history of PONV,
n = 4 vs. n = 1
Cardiac surgery including CABG,
aortic valve replacement and
mitral valve/aortic root surgery,
as well as redo cardiac surgeries.
Excluded: emergency surgery/
thoracic procedures
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Furze 2009,210
UK
RCT 204 19.6 64.8 (8.7) [42–83] Waiting list Tertiary centre in
northern England
NR CABG, ability to give informed
consent. Exclusion criteria: exercise
induced arrhythmias, loss of
systolic BP of > 20mmHg during
exercise stress testing, unstable
angina, score of 4 on the CCVS/
NYHA classification for angina/
heart failure, current psychiatric
problems, dementia, self-reported
periods of dizziness/confusion,
life-threatening comorbidities,
concurrent participation in other
research
Goodman
2008,215 UK
RCT 188 18.7 64.7 (NR) [NR] NR Hospital At least one poorly
controlled risk factor
(blood pressure
140 mmHg systolic or
80 mmHg diastolic,
non-fasting serum
cholesterol 4 mmol/l or
BMI of 28 kg/m2)
CABG with or without valve
surgery, able to understand
English, and had specified risk
factors needing control (blood
pressure 140 mmHg systolic or
80 mmHg diastolic, non-fasting
serum cholesterol 4 mmol/l or BMI
of 28 kg/m2). Excluded if lived
outside designated geographical
area or had life-threatening
significant non-cardiovascular
disease (e.g. cancer)
continued
D
O
I:10.3310/hsdr07400
H
EA
LTH
SERVICES
A
N
D
D
ELIVERY
RESEA
RCH
2019
VO
L.7
N
O
.40
©
Q
ueen
’s
Printer
and
C
ontroller
of
H
M
SO
2019.
This
w
ork
w
as
produced
by
N
unns
et
al.
under
the
term
s
of
a
com
m
issioning
contract
issued
by
the
Secretary
of
State
for
H
ealth
and
SocialC
are.
This
issue
m
ay
be
freely
reproduced
for
the
purposes
of
private
research
and
study
and
extracts
(or
indeed,
the
fullreport)
m
ay
be
included
in
professional
journals
provided
that
suitable
acknow
ledgem
ent
is
m
ade
and
the
reproduction
is
not
associated
w
ith
any
form
of
advertising.
A
pplications
for
com
m
ercialreproduction
should
be
addressed
to:
N
IH
R
Journals
Library,
N
ationalInstitute
for
H
ealth
Research,
Evaluation,
Trials
and
Studies
C
oordinating
C
entre,
A
lpha
H
ouse,
U
niversity
of
Southam
pton
Science
Park,
Southam
pton
SO
16
7N
S,
U
K
.
21
TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Probst 2014,255
Germany
RCT 200 29 Median: 65.5 (NR)
[IQR 55–72]
Patients screened for
inclusion during
premedication visit
1 day before surgery,
final decision made by
anaesthesiologist and
cardiac surgeon at
end of surgery
University hospital COPD, 8% vs. 10%;
neurological deficit,
9% vs. 5%; peripheral
vascular disease, 13 vs.
8%; diabetes mellitus,
25% vs. 31%; renal
insufficiency, 6% vs.
14%
CABG, valve surgery or
combined CABG/valve surgery
haemodynamically stable,
normothermic, no bleeding.
Excluded if was in cardiogenic
shock, was dialysis dependent or
had an additive EuroSCORE of
> 10, had impaired left ventricular
function (ejection fraction < 35%),
cardiac assist devices pre or post
operation, cardiopulmonary
instability post operation, lack of
bed in either PACU or ICU
Rosenfeldt
2011,258
Australia
RCT 117 26 Experimental group:
median age 62.5 (NR)
[59–68.5]
Comparator group:
median age 68 (NR)
[58–77]
NR Public hospital Diabetes, 20% vs.
29%; previous MI,
28% vs. 31%
CABG. Excluded if urgent/
emergency surgery, severe aortic
valve stenosis, limited English,
NYHA class IV heart failure
Salhiyyah
2011,259 UK
CT 136 18.4 63.1 (9.0) [40–80] Invited on admission General hospital NR Cardiac surgery: CABG, valve,
atrial septal defect. Excluded
if mitral valve replacement,
redo grafts/valves, history of
cerebrovascular accident,
emergency operation, Swan–Ganz
catheter, inadequate haemostasis
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
van der Peijl
2004,266 The
Netherlands
RCT 309 21.1 62.7 (10.2) [NR] NR University medical
centre
Diabetes mellitus, 19%
vs. 19%; COPD 12%
vs. 6%; peripheral or
CVD, 9% vs. 5%;
hypertension, 47% vs.
33%; main stem lesion
(> 50%), 20% vs .21%
CABG. Excluded if concomitant
surgical procedures, severe
comorbidity interfering with daily
life, insufficient Dutch language,
mental disorders, postoperative
complications jeopardising
standardised exercise programme
Colorectal surgery
Anderson
2003,192 UK
RCT 25 56 Median: intervention,
64 [IQR 55–68];
comparator, 68
[IQR 65–75]
Consecutive patients
invited to participate
at surgical outpatient
department
General hospital Malignant disease,
78.57% vs. 63.64%
Left or right hemicolectomy
Carli 2010,198
Canada
RCT 133 42 60.5 (15.5) [NR] Identified by colorectal
surgeons
University health
centre
NR Resection of benign or
malignant colorectal lesions,
or for colonic reconstruction of
non-active inflammatory bowel
disease, aged > 18 years, receiving
preoperative chemo-/radiotherapy.
Excluded if had health conditions
prohibiting participation in
exercise programmes/testing
procedures
Dronkers
2010,204 The
Netherlands
RCT 42 25 70 (6.7) [NR] Referred by
gastroenterologist,
or surgeon went to
outpatient department
of physical therapy
General hospital COPD, 3/21 vs. 3/17;
coughing: 2/20 vs.
2/18; diabetes: 8/14
vs. 1/19
First elective colon surgery
for gastric cancer, minimum
waiting period of 2 weeks, aged
≥ 60 years, adequate cognitive
functioning. Excluded if had heart
disease/orthopaedic conditions
that impede exercise, had severe
systemic illness, had recent
embolism, thrombophlebitis, had
uncontrolled diabetes (fasting
blood glucose of 4400 mg/dl) or
was wheelchair-dependent
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Forsmo 2016,209
Norway
RCT 324 46.3 Median 65.5 (NR)
[19–93]
Contacted on waiting
list
University hospital NR Elective open or laparoscopic
colorectal surgery (including
patients with rectal cancer
previously treated with pelvic
radiation) for malignant or benign
disease, aged ≥ 18 years. Excluded
if had multivisceral resection
planned/ASA grade IV, was
pregnant, had emergency
operations, had difficulty providing
informed consent owing to
impaired mental capacity, was
unable to adapt to ERAS criteria.
Randomised patients were
excluded if intended colonic or
rectal surgery not performed
García-Botello
2011,211 Spain
RCT 125 39 Median: intervention,
62 [27–85];
comparator, 60
[28–88]
Outpatient care clinics University hospital Cancer, n = 46 vs.
n = 40; diverticular
disease: intervention,
n = 10 vs. n = 9, chronic
inflammatory bowel
disease, n = 5 vs. n = 9
Elective colorectal surgery
requiring colon/rectum resections
(including reoperations) using
laparotomy or laparoscopy, aged
> 18 years, ASA score of 1–4,
living in metropolitan area of
Valencia, informed consent.
Excluded if non-independent daily
lifestyle (unable to walk, bathe
or eat on own), undergoing
emergency surgery
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Gatt 2005,213
UK
RCT 39 41 67 (NR) [59–76] Consecutive patients
on waiting list
contacted
General hospital NR Colorectal resection, living
independently at home. Excluded
if was pregnant, was intolerant
to probiotics and/or prebiotics,
had contraindication to one or
more optimisation strategy, had
contraindications to early
postoperative discharge, had
been prescribed medications
that may prolong hospital stay,
had advanced malignancy on
preoperative assessment, had
palliative surgery, had emergency
surgery, or if there was a failure to
perform colonic/rectal resection
Gillis 2014,214
Canada
RCT 89 37.7 65.9 (11.3) [NR] Consecutive patients
approached at initial
office visit with
surgeon
University-affiliated
tertiary centre
Ischaemic heart
disease: n = 3 (7.5%)
vs. n = 2 (5%)
Hypertension: n = 8
(21%) vs. n = 12 (31%)
Diabetes: n = 3 (7.5%)
vs. n = 5 (13%)
Curative resection of non-
metastatic colorectal cancer.
Excluded if did not speak English/
French or had premorbid
conditions that contraindicated
exercise
Khan 2013,229
UK
CT 83 50.6 Median: intervention,
75 (NR) [IQR 59–76];
comparator, 64 (NR)
[IQR 60–70]
Consecutive patients
contacted
District hospital or
tertiary referral
centre
Colorectal cancer: n = 1
vs. n = 35
Inflammatory bowel:
n = 7 vs. n = 5
Diverticular disease:
n = 4 vs. n = 1
Elective colorectal surgery.
Excluded if no informed
consent, inability to complete
questionnaires owing to
cognitive impairment, poor
English comprehension
continued
D
O
I:10.3310/hsdr07400
H
EA
LTH
SERVICES
A
N
D
D
ELIVERY
RESEA
RCH
2019
VO
L.7
N
O
.40
©
Q
ueen
’s
Printer
and
C
ontroller
of
H
M
SO
2019.
This
w
ork
w
as
produced
by
N
unns
et
al.
under
the
term
s
of
a
com
m
issioning
contract
issued
by
the
Secretary
of
State
for
H
ealth
and
SocialC
are.
This
issue
m
ay
be
freely
reproduced
for
the
purposes
of
private
research
and
study
and
extracts
(or
indeed,
the
fullreport)
m
ay
be
included
in
professional
journals
provided
that
suitable
acknow
ledgem
ent
is
m
ade
and
the
reproduction
is
not
associated
w
ith
any
form
of
advertising.
A
pplications
for
com
m
ercialreproduction
should
be
addressed
to:
N
IH
R
Journals
Library,
N
ationalInstitute
for
H
ealth
Research,
Evaluation,
Trials
and
Studies
C
oordinating
C
entre,
A
lpha
H
ouse,
U
niversity
of
Southam
pton
Science
Park,
Southam
pton
SO
16
7N
S,
U
K
.
25
TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Khoo 2007,231
UK
RCT 81 61 Median: intervention,
69.3; comparator,
73.0 [overall range
46.3–87.7]
NR Hospital NR Colorectal resection for cancer
between May 2003 and
October 2004. Excluded if unable
to mobilise independently over
100 m at preoperative assessment,
contraindications to thoracic
epidurals, pre-existing clinical
depression, palliative care only,
undergoing joint operation
involving another surgical specialty
King 2006,232
UK
UBA 146 47.9 70.8 (11.0) [NR] Comparator group:
prospectively entered
into the multicentre
CLASICC trial
Experimental group:
consecutive patients
presenting to a single
consultant assessed
for eligibility
Hospital NR Colorectal cancer resection.
Historic control: aged > 18 years,
suitable for elective colorectal
cancer resection, no malignancy
within past 5 years, no intestinal
obstruction, ability to provide
written consent. Excluded if had
tumours of transverse colon
Prospective cohort inclusion
criteria: aged > 18 years, elective
resection, no preoperative
radiological or clinical evidence
of metastases. Patients with
transverse colon cancers or with
malignancy within last 5 years
were included
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Lee 2011,235
South Korea
RCT 100 44 61.2 (7.6) [NR] NR University hospital NR Laparoscopic resection for
colonic tumour, suitable for
laparoscopic colonic resection,
aged 20–80 years. Excluded if
synchronous distant metastasis,
intestinal obstruction/perforation,
previous major abdominal surgery,
severe pulmonary disease/
cardiovascular disease
Lidder 2013,236
UK
RCT 57 43.9 Median: intervention,
70 (NR) [IQR 65–78],
comparator, 73 (NR)
[IQR 63.8–81]
NR General hospital NR Colorectal resection, planned
curative resection with primary
anastomosis. Excluded if was aged
< 18 years, was unable to give
informed consent, had frailty,a was
participating in another trial, was
pregnant, had diabetes, had a
preoperative fasting glucose of
> 7 mmol/l, was using steroids or
immunosuppressants, had history
of abnormal gastric emptying,
had intestinal obstruction, had
concurrent parenteral or enteral
nutrition
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Maggiori
2017,239 France
RCT
(multicentre)
270 47.6 61.5 (11) [31–90] NR Clinic NR Laparoscopic resection for
colorectal cancer, aged
≥ 18 years, functional capacity of
≥ 4 METS, histologically proven
colorectal cancer with curative
intent, in absence of evidence of
metastatic disease. Excluded if
BMI < 18 kg/m2 or > 30 kg/m2,
preoperative albumin blood level
< 30 g/l, weight loss of > 10%
during 6 months preceding surgery,
emergency surgery, very low rectal
tumours requiring abdominoperineal
excision, scheduled sub/total
colectomy, scheduled total
proctocolectomy, scheduled
associated resection of another
organ, pregnant, or allergic to
ropivacaine, xylocaine, droperidol
or ketamine
Mari 2014,243
Italy
RCT 52 52 Median: overall
sample, 66 (NR)
[29–83]
NR General hospital Overall sample:
hypertension, 5; BMI
close to 30 kg/m2, 2;
liver metastasis, 3;
multinodular struma, 1;
dyslipidaemia, 1
High anterior resection for
benign/oncologic disease – HAR
with transanal anastomosis;
colorectal laparoscopic surgery,
ASA score of 1–3, aged
18–85 years, BMI of < 30 kg/m2,
no intestinal diversion
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Mari 2016,242
Italy
RCT 83 21.7 76.5 (NR) [70–85] NR General hospital NR Colorectal laparoscopic surgery,
aged ≥ 70 years, autonomous
mobilisation and walking, eligible
for laparoscopic technique, ASA
score of I to III, with indication for
major colorectal surgery
Muller 2009,251
Switzerland
RCT 156 49 Median: intervention,
62 [27–91];
comparator, 59
[39–89]
NR Four surgical
departments in
teaching hospitals
Malignant, n = 67 vs.
n = 64; benign, n = 9
vs. n = 11
Open colonic resection with
a primary anastomosis, aged
> 18 years. Excluded if emergency
surgery, contraindication to
epidural anaesthesia, scheduled
total colectomy or rectum resection,
preoperatively immobile patients
Pappalardo
2016,252 Italy
RCT 50 48 66.65 (NR) [45–83] NR NR Pulmonary, 48% vs.
56%; cardiovascular/
hypertension, 64% vs.
60%; diabetes, 24%
vs. 20%
Open extra-peritoneal rectal
cancer surgery, January 2009
through December 2013, without
a primary derivative stoma with or
without a secondary derivative
stoma, extraperitoneal tumour
location,b cT2–T4 tumours, with or
without positive lymph nodes, use of
modified FTP, neoadjuvant therapy
where indicated (T3–T4 or N+)
Excluded if tumours located
> 12 cm above the anal verge,
cT1 or M1, urgent procedures;
had ASA of > 3, operated on with
abdominoperineal resection or
Hartmann’s procedure, refusing
neoadjuvant therapy, refusing or
unable to follow FTP, coagulation
disorders contraindicating epidural
catheter insertion
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Dhruva Rao
2015,203 UK
UBA 506 43.9 Median: intervention,
71 (NR); control, 69
(NR) [overall range:
23–93]
Retrospective review
of prospectively
maintained database
General hospital NR Colorectal resections,
January 2008–December 2012.
Excluded if it was felt patient
could not achieve > 50% of
targets during counselling or
preoperative assessment, requiring
postoperative intensive treatment
unit management. Patients were
withdrawn from programme
whenever clinically indicated
van Bree
2011265 and
Vlug 2011,268
the Netherlands
RCT 93; 427c 43.6; 41.5 65.2 (9.1) [NR]; 66.5
(8.7) [NR]
Invited to participate Academic medical
centre; three
university hospitals,
six teaching
hospitals
NR; % with
comorbidities per
group: lap + FT = 71%;
open + FT = 59%;
lap + standard = 68%;
open + standard = 68%
Segmental colectomy for
histologically confirmed
adenocarcinoma or adenoma
without evidence of metastatic
disease, aged 40–80 years,
ASA status < IV. Excluded if
neoadjuvant radiotherapy, prior
midline laparotomy, unavailability
of a laparoscopic surgeon,
emergency surgery, planned
stoma
Lower limb arthroplasty
Barlow 2013,195
UK
UBA 410 NR 70.6 (NR) [29–93] Consecutive patients
6 months before and
after implementation
of ring-fenced ward
University hospital ASA scores
(intervention, 214;
comparator, 261):
Fit and healthy, 27 vs.
21; mild disease not
incapacitating, 165 vs.
165; incapacitated by
systemic disease, 48 vs.
59; life-threatening
disease, 1 vs. 6;
moribund, 0 vs. 0
Primary lower limb
arthroplasty
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Borgwardt
2009,196
Denmark
RCT 50 55 65.6 (NR) [44–86] Consecutive patients
asked to participate
University hospital NR UKR, resident in Copenhagen,
ASA of I or II, no medical history
of GI bleeding, care arranged after
discharge. Excluded if major
psychiatric disease, incapable
of managing own affairs,
inflammatory joint disease,
neurological/other disease(s)
affecting lower limbs, previous
major knee surgery
Crowe 2003,200
Canada
RCT 133 80 68.8 (11.3) [NR] Consecutive patients
asked to participate
Home,
physiotherapy
clinic, hospital
Preoperative diagnosis
(n):
Osteoarthritis, 61 vs.
65; rheumatoid
arthritis, 4 vs. 3
Existing comorbidities
(n):
Hypertension, 33 vs.
35; cardiac, 7 vs. 7,
cognitive/psychiatric,
5 vs. 4; stroke/transient
ischaemic attacks, 2 vs.
0; other (hiatus hernia,
diabetes, asthma,
chronic obstructive
pulmonary disease,
epilepsy, urinary tract
disease and chronic
lumbar pain), 10 vs. 9
Hip/knee arthroplasty, high
score on Oxford Questionnaire,
coexisting medical conditions,
suboptimal social support,
requiring home alterations to
enable the client to return home.
Excluded if functioning well
despite joint dysfunction,
managing activities of daily living
well with good caregiver support,
limited English-language skills,
marked cognition problems, joint
replacement as management for
cancer, undergoing revision or
second joint replacement < 2 years
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
den Hertog
2012,202
Germany
RCT 160 70.8 67.4 (8.11) [40–85] NR Non-academic
hospital
specialising in
orthopaedic
surgery
Diagnoses (n):
Degenerative arthritis,
72 vs. 72; post-
traumatic arthritis, 0 vs.
1; Ahlback’s disease,
2 vs. 0; athritis in knee
without surgical
procedure, 38 vs. 34
Secondary disorders/
concomitant diseases
(n):
Cardiac, 50 vs. 39;
gastrointestinal, 16 vs.
14; allergies, 4 vs. 5;
kidney/urinary tract,
2 vs. 4
TKA. Excluded if missing informed
consent, lack of co-operation
capability, ASA score of > 3, RA,
cancer, substance abuse, previous
major surgery on affected joint,
neurological or psychiatric disease,
pregnant, participating in other
clinical studies
Dwyer 2012,206
UK
UBA 127 61.4 71.5 (8.8) [48–91] Intervention:
consecutive patients
on an enhanced
recovery programme
Comparator: data
collected retrospectively
from patient records
District hospital NR THA
Gordon 2011,216
UK
UBA 847 66 71 (10.3) [27–98] Retrospective chart
review
General hospital NR Hip or knee arthroplasty
RESU
LTS
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
32
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Harari 2007,218
UK
UBA 108 60 74.5 (6.2) [NR] Intervention:
consecutive patients
Historical comparator:
consecutive cases
reviewed
Teaching hospital % (n):
Rheumatoid arthritis,
9.3 (5) vs. 7.4 (4)
Ischaemic heart
disease, 37.0 (20) vs.
24.1 (13)
Heart failure (present/
past), 1.9 (1) vs. 3.7 (2)
Atrial fibrillation, 14.8
(8) vs. 5.6 (3)
Diabetes, 20.4 (11) vs.
13.0 (7)
Renal impairment
(plasma creatinine
> 104mmol/l), 22.2
(12) vs. 3.7 (2)
Hypertension, 80.0 (43)
vs. 51.9 (28)
Chronic lung disease,
11.1 (6) vs. 7.4 (4)
Symptomatic prostate
or bladder problems,
35.2 (19) vs. 18.5 (10)
Cerebrovascular disease,
7.4 (4) vs. 3.7 (2)
Orthopaedic hip replacement;
aged ≥ 65 years with any of
uncontrolled hypertension (blood
pressure > 160/90 mmHg); MI in
past 2 years; unstable angina,
undergoing treatment for heart
failure; poorly controlled diabetes;
previous stroke; currently taking
warfarin; chronic lung disease;
poor nutritional status;d ≥ 2 falls
from standing height in past year;
significant memory problems;
history of confusion, known
dementia; needs personal help
with getting to the toilet, moving
from bed to chair, standing up,
dressing and walking; likely to
need complex discharge package
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Hoogeboom
2010,221
Netherlands
RCT 21 67 76 (4.1) [69–90] Patients pre-screened
by anaesthetist.
Eligible patients
informed about study
and consent obtained
by orthopaedic nurse
Hospital Mean of 1.5 and 1 in
experimental and
comparator groups;
range 0–4
Primary THA, aged ≥ 70 years,
OA of hip, minimum waiting time
of 3 weeks, score of 2 on Clinical
Frailty Scale. Excluded if unable to
communicate or had severe heart
disease
Huang 2012,222
Taiwan
RCT 243 71.6 70.2 (7.3) [NR] NR Tertiary hospital NR Unilateral, primary TKA for
advanced OA, ability to follow
rehabilitation programme, interval
of 4 weeks between enrolment
and time to surgery. Excluded if
had inflammatory arthritis or
any medical condition where
moderate exercise was
contraindicated (e.g. heart failure
or hypertension), or had bilateral
joint replacements
Huddleston
2004,223 USA
RCT 505e 53.7 73.2 (9.6) [NR] Eligible patients
identified during
initial outpatient
orthopaedic
evaluation
Academic medical
centre
n (%):
Diabetes, 53 (22.8) vs.
38 (16.0)
Congestive heart
failure, 13 (5.6) vs.
16 (6.8)
CAD, 98 (42.5) vs.
102 (43.0)
Dementia, 4 (1.7) vs.
6 (2.1)
COPD, 33 (14.2) vs.
30 (12.7)
Immunosuppression,
26 (11.2) vs. 34 (14.4)
Primary or revision THA/TKA,
at elevated odds for perioperative
complications, aged > 75 years
with either one or more major
comorbid conditions or two or
more ‘less disabling’ comorbid
conditions considered at elevated
odds. Excluded if was aged
< 18 years, was a non-US resident
or was an inmate of local
correctional facility at time of
surgery
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Renal failure or dialysis,
28 (12.0) vs. 25 (10.6)
Deep-vein thrombosis/
pulmonary embolus,
28 (12.0) vs. 42 (17.7)
Cerebrovascular
accident/transient
ischaemic attack, 24
(10.3) vs. 13 (5.5)
Peripheral vascular
disease, 8 (3.5) vs.
11 (4.6)
Hunt 2009,224
and Salmon
2013,260 UK
CT
(multicentre)
Total
across
three sites:
579; 560
54.3; 58.4 67.4 (NR) [23–93];
67.8 (10.5) [NR]
Consecutive patients
attending preoperative
assessment clinics by
participating surgeons
at three centres;
additional consecutive
patients recruited in
hospital 2–5 days
postoperatively in one
control centre
One of three sites:
General Hospital,
SWLEOC, University
Hospital
Comorbidities (%) in
intervention vs.
comparator 1 vs.
comparator 2:
Hypertension, 47 vs.
45 vs. 51; CAD, 14 vs.
12 vs. 5; COPD, 16 vs.
12 vs. 20; diabetes,
9 vs. 10 vs. 13; thyroid
disorders, 10 vs. 4 vs.
3; CVD, 7 vs. 3 vs. 2;
GI disease, 14 vs. 14
vs. 10; psychiatric
disorders, 6 vs. 3 vs. 7
Unilateral primary hip
arthroplasty, over 12 months
from July 2006
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Khan 2014,230
UK
UBA 6000
procedures
in 5319
patients
46 68.5 (10) [NR] Unselected
consecutive
arthroplasty
procedures
Two sites in same
trust
Hypertension, 1409 vs.
936; atrial fibrillation,
162 vs. 143; ischaemic
heart disease, 249 vs.
213; insulin-dependent
diabetes mellitus, 33
vs. 21; non-insulin-
dependent diabetes
mellitus, 293 vs. 212;
COPD, 133 vs. 87;
Alzheimer’s disease,
9 vs. 7
Total hip and/or total knee
arthroplasty. Only patients of
ASA grades 1 and 2 were
operated on at site 1. Patients
of all ASA grades underwent
procedures at site 2
Larsen
2008,233,234
Denmark
RCT 90 50.6 65 (10) [NR] Consecutive patients
invited to participate
in the study
Regional hospital NR Primary THA, TKA or UKA.
Excluded if had mental disability or
severe neurological disease
Maempel
2015,238 UK
UBA 165 52.1 69.9 (9.7) [NR] Database examined.
All patients under care
of senior author were
selected
Hospital NR Prosthetic total knee
replacement, January 2010–
April 2013. Excluded if UKR,
patellofemoral replacements and
revision TKRs
Maempel
2016,237 UK
UBA 1161 60.9 Median age 65 (NR)
[IQR 25–94]
Review of patients
under care of the
senior authors
General hospital NR Primary THA, April 2005 to
May 2013. Excluded if undergoing
THA April-December 2010,
simultaneous bilateral THA,
transferred from a medical ward
for planned semiurgent THA and
returned to the medical ward
postoperatively, sustained a per
prosthetic femoral fracture,
requiring further surgery and
prolonged rehabilitation
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Malviya 2011,241
UK
UBA 4500 51 68.5 (NR) [NR] NR General hospital (n):
Hypertension, 673 vs.
921; atrial fibrillation,
84 vs. 143; ischaemic
heart disease, 113 vs.
211; insulin-dependent
diabetes mellitus,
18 vs. 20; non-insulin-
dependent diabetes
mellitus, 150 vs. 205;
COPD, 67 vs. 85;
Alzheimer’s disease,
5 vs. 6
Primary THR and TKR. Unit 1:
exclusively relatively fitter patients
(ASA 1 and 2), unit 2: all grades
of ASA status. All patients under
care of nine surgeons at two units
in same hospital. Intervention:
first 1500 patients May 2008–
November 2009. Comparator:
unselected, consecutive series of
3000 patients before introduction
of protocol
McGregor
2004,244 UK
RCT 39 71.4 71.9 (9.3) [51–92] Via authors’
institution/hospital
Hospital NR THA. Excluded if revision or
bilateral arthroplasty, previous hip
arthroplasty, coexisting morbidity
for example history of severe
cardiovascular, respiratory,
neuromuscular disease, RA,
mentally confused, inadequate
comprehension of English
Mertes 2013,245
UK
UBA 607f Overall
sample
63.6%;
aged ≥ 75
years 72.2%
70.5 (8.9) [NR] NR Hospital NR THA or TKA. Excluded if revision
arthroplasty, simultaneous bilateral
arthroplasty, medically unrelated
confounding factors (e.g.
diagnosis of a brain tumour in the
postoperative period)
Pengas 2015,253
UK
UBA 791 48.2 67.5 (11.0) [27–92] NR Hospital NR Hip/knee arthroplasty. Excluded
if complex, bilateral/revision
arthroplasty, hospital stay of
> 10 days due to infection or
social circumstances, complications
preventing mobilisation
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Pour 2007,254
USA
RCT 100 46.9 60.8 (8.9) [NR] Consecutive patients
screened for inclusion
in the study
University hospital NR Unilateral THA, aged 18–75 years,
underlying diagnosis of OA,
informed consent. Excluded if BMI
> 30 kg/m2, cognitive impairment/
severe psychiatric illness precluding
participation in the protocol
procedures
Reilly 2005,256
UK
RCT 41 41.5 63 (NR) [NR] NR Nuffield
Orthopaedic
Centre
NR UKA, diagnosed with
anteromedial OA,
g
good
understanding of procedure,
tolerance of large doses of
non-steroidal anti-inflammatory
drugs, suitable home situation
within 25-mile radius, aged
≤ 75 years. Excluded if diagnosis
of diabetes/severe respiratory
disease/deep-vein thrombosis,
previous heart surgery,
tri-compartmental arthritis
Siggeirsdottir
2005,261 Iceland
RCT 50 52 68 (NR) [28–86] Waiting list. Patients
living in another town
were also invited to
participate
University hospital
or general hospital
Diagnosis:
Osteoarthrosis,
24 vs. 21; RA, 1 vs. 1;
previous fractures,
2 vs. 0; deformity after
Perthes disease, 0 vs. 1
Primary hip replacement,
diagnosed with OA of hip, RA,
primary segmental collapse of
femoral head, and sequelae after
developmental diseases and hip
trauma, living in their own home.
Excluded if primary hip fracture,
metastatic tumours, dementia
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Starks 2014,262
UK
UBA 2128 64.5 71 (NR) [28–93] Hospital episode
statistics data
reviewed
General hospital NR Primary joint arthroplasty,
August 2007–May 2009. Excluded
if cognitive impairment, medical
comorbidities requiring ongoing
medical supervision during
inpatient stay, complex surgery,
bilateral arthroplasties, hip
resurfacing
Vesterby
2017,267
Denmark
RCT 73 46.6 Median: intervention,
63 (NR) [43–80];
comparator, 64 (NR)
[45–84]
Consecutive patients
invited
Urban teaching
hospital
NR Primary fast-track elective THR.
Excluded if distance to hospital
> 60 km, previous hip surgery,
mental disability, inability to
communicate in Danish, no
support person, no internet
connection
Williamson
2007,269 UK
RCT 181 54 70.7 (8.8) [NR] Waiting list General hospital NR Knee replacement surgery
(total, unicondylar, unilateral,
bilateral). Excluded if taking
anticoagulants; within 2 months
of intra-articular steroid injection;
experiencing back pain associated
with referred leg pain; suffering
from ipsilateral OA of the hip;
psoriasis or other skin disease in
the region of knee; RA, received
acupuncture or PT within last year
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Pelvic surgery
Arumainayagam
2008,194 UK
UBA 112 23 65.9 (NR) [NR] Retrospective
database search
General hospital NR Radical cystectomy
Gralla 2007,217
and Magheli
2011,240
Germany
RCT 50 0 62 (5.9) [NR] NR University hospital;
hospital
NR Laparoscopic radical
prostatectomy, patients up to
ASA III included. Excluded if severe
reduced renal function (creatinine
levels preoperatively > 1.6 mg/dl)
due to analgesic treatment
with COX-2 inhibitors; ASA score
of IV; use of cytotoxic drugs,
immunosuppressants, or
anticonvulsives; severe general
or nervous system diseases
Jensen 2015,225
Denmark
RCT 129 26 70.1 (NR) [46–91] NR University hospital Comorbidity score,
n (%):
None: 1 (2) vs. 0
1–2 (low): 16 (32) vs.
14 (25)
3–4 (high): 23 (46) vs.
31 (54)
≥ 5 (severe): 10 (20) vs.
12 (21)
Radical cystectomy
Mukhtar
2013,250 UK
UBA 77 22.1 68.4 (8.0) [49–85] NR Hospital NR Radical cystectomy and
reconstruction, from October
2007 onwards. No specific
inclusion/exclusion criteria
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Thoracic surgery
Brunelli 2017,197
UK
UBA 600 59.2 Median: intervention,
69.7 (NR) [IQR
63–76]; comparator,
68.8 (NR) [IQR 63–75]
Retrospective analysis
of a prospectively
maintained database
University hospital Coronary artery
disease, 22% vs. 15%;
cerebrovascular
disease, 4.3% vs. 7.1%
VATS lobectomy or VATS
anatomic segmentectomies,
included if surgery commenced via
a VATS approach but converted to
open surgeryh
Gatenby
2015,212 UK
UBA 132 30 65.1 (NR) [IQR
intervention, 13;
comparator, 14]
All patients fit for
surgery proceeded
along intervention
pathway as default
Teaching hospital NR Open oesophageal and
gastric resections
(oesophagogastrectomy,
total gastrectomy, subtotal
gastrectomy). Excluded if not
deemed fit enough for
oesophagogastric resection
surgery
Karran 2016,228
UK
UBA 252 23.4 Median: intervention,
66 (NR) [24–86];
comparator, 65.5
(NR) [42–89]
Retrospective analysis
of prospectively
maintained database
University hospital Tumour site (n):
Oesophageal, 64 vs.
53; gastro-oesophageal
junction, 35 vs. 13;
gastric body, 26 vs. 14;
gastric antrum, 29 vs. 11;
linitis plastica, 6 vs. 1
UGI cancer surgery (including
total and subtotal gastrectomy,
oesophagostomy)
Muehling
2008,248
Germany
RCT 62 NR 66.7 (NR) [NR] NR University hospital Underlying disease:
Non-small cell lung
cancer, 25 vs. 19;
metastases, 3 vs. 4;
carcinoid, 1 vs. 1;
aspergilloma, 0 vs. 1;
pneumonia, 0 vs. 1;
bulla, 0 vs.1;
mesothelioma, 0 vs. 1;
PECOM,i 1 vs. 0
Lung resection, all patients
admitted with suspected lung
neoplasms with indication for lung
resection
continued
D
O
I:10.3310/hsdr07400
H
EA
LTH
SERVICES
A
N
D
D
ELIVERY
RESEA
RCH
2019
VO
L.7
N
O
.40
©
Q
ueen
’s
Printer
and
C
ontroller
of
H
M
SO
2019.
This
w
ork
w
as
produced
by
N
unns
et
al.
under
the
term
s
of
a
com
m
issioning
contract
issued
by
the
Secretary
of
State
for
H
ealth
and
SocialC
are.
This
issue
m
ay
be
freely
reproduced
for
the
purposes
of
private
research
and
study
and
extracts
(or
indeed,
the
fullreport)
m
ay
be
included
in
professional
journals
provided
that
suitable
acknow
ledgem
ent
is
m
ade
and
the
reproduction
is
not
associated
w
ith
any
form
of
advertising.
A
pplications
for
com
m
ercialreproduction
should
be
addressed
to:
N
IH
R
Journals
Library,
N
ationalInstitute
for
H
ealth
Research,
Evaluation,
Trials
and
Studies
C
oordinating
C
entre,
A
lpha
H
ouse,
U
niversity
of
Southam
pton
Science
Park,
Southam
pton
SO
16
7N
S,
U
K
.
41
TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Surgery to remove tumours (various locations)
Hempenius
2013220 and
2016,219
the Netherlands
RCT 297; 260c 64; 62 77.54 (7.21) [NR];
77.4 (7.3)
NR University medical
centre, medical
centre, community
hospital
Surgery for solid tumour,
aged > 65 years, scheduled for
surgery between June 2007 and
June 2010
Upper abdominal surgery
Abu Hilal
2013,191 UK
UBA 44 54 Median: 69.3 (NR)
[IQR 61–76]
Consecutive patients
invited
University hospital Diagnosis (n):
Ductal
adenocarcinoma,
12 vs. 12; duodenal
adenocarcinoma,
1 vs. 3; ampullary
adenocarcinoma, 2 vs.
6; cholangiocarcinoma,
2 vs. 1; neuroendocrine
tumour, 1 vs. 1;
intraductal papillary
mucinous neoplasm,
1 vs. 1; metastatic
cancer, 1 vs. 0
Pancreatoduodenectomy.
Excluded if total or distal
pancreatectomy not eligible for
intervention pathway
Dasari 2015,201
UK
UBA 211 37 64.3 (11.6) [NR] Review of
prospectively
maintained database
General hospital Reason for resection
(n):
Colorectal metastases,
60 vs. 61; hepatocellular
carcinoma, 4 vs. 17;
other, 27 vs. 15;
presence of background
cirrhosis, 0 vs. 4
Liver resection. Excluded if
complex procedures, specifically
liver donation, associating liver
partition with portal vein ligation
for staged hepatectomy,
concomitant colonic, vascular
or a bile duct resection
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Dunne 2016,205
UK
RCT 38 31.6 Median: 62 (NR)
[IQR 54–69]
All patients referred to
service were screened
for potential eligibility
University hospital Comorbidity (n):
Cardiovascular: 10 vs.
8; respiratory: 3 vs. 4;
diabetes: 2 vs. 2; renal
disease: 1 vs. 0; none:
1 vs. 3; primary tumour:
node-positive; 12 vs. 10;
adjuvant or neoadjuvant
treatment: 11 vs. 7;
metastatic presentation;
synchronous
presentation: 8 vs. 10;
extrahepatic metastatic
disease: 3 vs. 4;
> 3 hepatic metastases;
5 vs. 7; metastasis of
> 5 cm in diameter;
7 vs. 6
Liver resection, aged > 18 years
and able to give informed
consent, partake in cycle-based
exercise and complete the exercise
programme before proposed
surgery date, metastases deemed
surgically treatable with curative
intent, Excluded if known
pre-existing chronic liver disease
Jones 2013,226
UK
RCT 104 41 65.5 (NR) [27–84] Patients were first
approached in the
outpatient clinic and
given information
sheet
Hospital NR Open liver resection, all adult
patients presenting for procedure
eligible. Excluded if entirely
laparoscopic operation, needed a
second concomitant procedure,
inoperable at the time of surgery,
unable to consent
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Kapritsou
2017,227 Greece
RCT 63 39.7 60.9 (11.7) [NR] Potential participants
approached the
surgical clinic
Oncology hospital NR Hepatectomy or
pancreatectomy, up to 2 months
after cancer diagnosis, ASA
classification of I–III, aged
> 18 years, normal level of
consciousness and communication.
Excluded if presence of chronic
pain, kidney disease, neuropathy,
systemic or chronic treatment
with analgesics
Richardson
2015,257 UK
UBA 66 56 Median: intervention,
67 (NR) [IQR 54–70];
comparator, 60 (NR)
[IQR 41–70]
Review of
prospectively collected
database
University hospital Diagnoses (%):
Adenocarcinoma,
23 vs. 16; acinar cell
carcinoma, 0 vs. 2,
neuroendocrine
tumour, 23 vs. 11;
metastatic cancer, 5 vs.
5, lymphoma, 0 vs. 2;
intraductal papillary
mucinous neoplasms,
9 vs. 0; mucinous cystic
neoplasm, 36 vs. 41;
pancreatitis, 5 vs. 23
Laparoscopic distal/left
pancreatectomy, considered for
laparoscopic approach. If patients
had preoperative evidence of
tumour invasion to surrounding
organs needing left upper
quadrant clearance with
multivisceral resection considered
for open surgery
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Sutcliffe
2015,263 UK
UBA 130 41 Median: intervention,
67 (NR) [18–83];
comparator, 66 (NR)
[35–83]
NR University hospital Indication for surgery:
Pancreatic ductal
adenocarcinoma, 26 vs.
19; ampullary cancer,
19 vs. 21; duodenal
cancer, 2 vs. 5;
cholangiocarcinoma,
8 vs. 11; neuroendocrine
cancer, 3 vs. 3; other
malignant tumours, 3 vs.
1; benign disease, 4 vs. 5
Pancreaticoduodenectomy
Tanaka 2017,264
Japan
RCT 148 31 67.5 (NR) [29–85] NR Medical college
hospital
NR Gastric cancer surgery,
histologically confirmed
adenocarcinoma of the stomach
for which curative gastrectomy
was planned without
simultaneous resection of other
organs except for the gallbladder,
no involvement of the duodenum
or oesophagus, aged 20–85 years,
sufficient oral intake, ASA score
of < 4, no prior chemotherapy/
radiotherapy. Excluded if factors
that might impede fast recovery,
for example pregnant,
inflammatory bowel disease,
chronic renal disease, severe
cardiopulmonary dysfunction,
complicated diabetes
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TABLE 2 Sample summary table, by broad procedural category (continued )
First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Various procedures
Ellis 2012,207 UK UBA 313 58 73 (6.2) [NR] Assessed for eligibility
at pre-admission
assessment
General hospital NR (‘red flags’ raised as
part of assessment)
Total hip or knee replacement,
other orthopaedic,
transurethral resection of
prostate, transurethral
resection of bladder tumour,
other renal, general (GI)
surgery. Aged > 65 years,
presence of one or more of
following ‘red flags’ identified
during routine pre-assessment:
cognitive problems, mobility
concerns, history of falls,
difficulties with activities of daily
living, concerns regarding home
circumstances
Vascular surgery
Muehling
2008,247 2009246
and 2011,249
Germany
RCT 82; 101;
101c
7.6; 6.1; 6.1 Median: intervention,
67 (NR) [40–81];
comparator, 68 (NR)
[52–84]
All patients admitted
for procedure invited
University hospital NR Open repair of infrarenal aortic
aneurysm. Excluded if withdrawal
of informed consent, clinical signs
of infection on admission,
contraindications for epidural
anaesthesia, neuromuscular
disorder that prevented full
postoperative physiotherapy,
intraoperative suprarenal
clamping; thoracoabdominal or
juxtarenal aneurysms
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First author,
year, country
Study
design
Sample
size (n) Female (%)
Mean age (years)
(SD) [range] Recruitment method
Place
admitted to
Comorbidities
(intervention vs.
comparator) Inclusion/exclusion criteria
Partridge
2017,31 UK
RCT 209 23.9 75.5 (6.5) [NR] Potentially eligible
patients approached
by research nurse or
fellow in the vascular
surgery outpatient
clinic once listed for
surgery
Teaching hospital
with a tertiary
referral practice for
vascular arterial
surgery
Diagnoses made at
preoperative
assessment
j
(%):
Ischaemic heart
disease, 5 vs. 0; cardiac
failure, 5 vs. 0; atrial
fibrillation, 3 vs. 1;
COPD, 14.9 vs. 0;
diabetes, 2 vs. 0; CVD,
1 vs. 0; cancer, 2 vs. 0;
cognitive impairment,
46.5 vs. 1; chronic
kidney disease, 25.7 vs.
0; valve lesion, 8.9 vs.
3; tachyarrhythmia or
bradyarrhythmia, 2 vs.
0; Parkinson’s disease,
1 vs. 0
Vascular surgery (aorta or lower
limb), patients lacking capacity to
consent recruited under Sections
30–34 of the Mental Capacity Act
ASA, American Society of Anaesthesiologists; BMI, body mass index; CABG, coronary artery bypass graft; CAD, coronary artery disease; CCVS, Canadian Cardiovascular Society;
CLASICC, Conventional vs. Laparoscopic-Assisted Surgery in Colorectal Cancer; COPD, chronic obstructive pulmonary disease; COX-2, cyclo-oxygenase; CT, controlled trial; CVD, central
vascular disease; FTP, fast-track protocol; GI, gastrointestinal; HAR, high anterior resection; IQR, interquartile range; LVF, left ventricular function; MI, myocardial infarction; NR, not reported;
NYHA, New York Heart Association; OA, osteoarthritis; PACU, post-anaesthetic care unit; PONV, postoperative nausea and vomiting; PT, personal therapy; RA, rheumatoid arthritis;
RC, radical cystectomy; SWLEOC, South-West London Elective Orthopaedic Centre; THA, total hip arthroplasty; THR, total hip replacement; TKA, total knee arthroplasty; TKR, total knee
replacement; UGI, upper gastrointestinal; UKA, unicompartmental knee arthroplasty; UKR, unicompartmental knee replacement; VATS, video-assisted thoracoscopic segmentectomy.
a Unlikely to be able to mobilise immediately after the operation.
b Within 12 cm above the anal verge measured by a rigid rectoscope.
c Sample size as reported in individual papers.
d BMI of < 20 kg/m2, or weight loss of ≥ 5 kg over past 6 months.
e 526 randomised; 21 who took part in the pilot were excluded before starting intervention.
f 308 reported THA and 299 reported TKA.
g Functionally intact anterior cruciate ligament, a correctable varus deformity, full thickness cartilage in the lateral compartment and < 158 fixed-flexion deformity.
h Sample represents 85% of all lobectomies and segmentectomies performed at institution.
i Abbreviation not defined.
j Intervention group received CGA; comparator group received standard preoperative care.
Bold text denotes the primary reason for inclusion.
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Intervention characteristics: prioritised studies
Interventions are summarised in Table 3; they are described in detail in subsequent sections of the synthesis
and in Report Supplementary Material 3. The key characteristics are summarised here. The most frequently
studied intervention category was ERP (n = 49 studies191,192,194,196,197,199,201,203,206,208,209,211–213,216–218,224–232,234–239,
241–243,245,247,248,250–252,254,256,257,261–265). Thirteen studies193,198,200,204,205,210,214,215,221,222,244,258,269 evaluated prehab;
two studies207,220 evaluated PACPs; four studies202,253,266,267 evaluated rehab; three studies195,255,259 evaluated
specialist wards; and one study223 evaluated a staff mix intervention. The most common comparator was
standard care or pre-intervention pathway (in UBA designs), although study authors used a range of
descriptions (see Table 3).
Primary intervention delivery sites were at hospital, outpatient clinic, rehabilitation centre or the patient’s
home, or a combination of these (see Table 3). The patient usually received the intervention alone, except
in 14 studies31,193,195,200,206,211,216,221,232,234,235,245,254,258 where a family member or carer was actively involved
in the intervention; in two interventions216,267 that included the involvement of friends or a non-specified
support person; in two studies31,245 that involved carers; and in one study31 that involved GPs in the
intervention. Ten studies197,209,241,244,247,248,251,261,266,269 did not report the intervention recipient, in which
case we assumed that this was just the patient.
Quality assessment
Only two studies,193,270 both of which were RCTs, received a global study quality rating of ‘strong’ using
the EPHPP tool.46 Twenty-six studies,194,196,199,202,205,211,213,215,217,220,222,223,225,227,232,234,235,239,242,243,256,258,264,267–269 of
which 24 were RCTs, received a ‘moderate’ quality rating, and the remaining 45 studies191,192,195,197,198,200,201,
203,204,206–210,212,214,216,218,221,224,226,228–231,236–238,241,244,245,247,248,250–255,257,259,261–263,266 (22 RCTs) were rated as ‘weak’.
Quality ratings are displayed in Table 4, with the full breakdown of scores for each item provided in Report
Supplementary Material 4.
The component that contributed most towards the large number of ‘weak’ global ratings was the ‘data
collection methods’ item, on which only nine studies193,194,215,232,255,264,267,269,270 received a ‘strong’ rating and
one study received a ‘moderate’ rating.257 To receive a rating of ‘strong’ for this domain, studies had to
have discussed the reliability and validity of their primary outcome measure, unless this was well known.
In addition, while not contributing towards the global rating of each paper, only 31191–195,197,201,202,206,208–210,
215,217,223–227,232,234,235,237,239,250,252,255,257,259,264,268 of the 73 studies prioritised for synthesis (43.2%) clearly defined
their LOS outcome. Only two studies229,270 achieved a ‘strong’ rating on the selection bias component,
with eight studies205,210,215,221,231,236,238,248 scoring ‘weak’ and the rest scoring ‘moderate’.
Forty-two studies192,193,196,199,200,202,204,205,209–211,213–215,217,220–223,225–227,231,234–236,239,242,243,248,251,254–256,258,261,264,266–270
received a ‘strong’ rating on the study design component, with 31 scoring as ‘weak’.191,194,195,197,198,201,203,
206–208,212,216,218,224,228–230,232,237,238,241,244–247,249,250,252,253,257,259,260,262,263 All of the strongly scoring studies for this
component were RCTs. All UBA studies prioritised for inclusion were rated as ‘weak’, as were the two
controlled trials.224,259 Six RCTs198,217,242,244,247,252 received a ‘weak’ rating because randomisation was not
described. On the component considering the likelihood of possible confounding of results, the majority
of studies were rated as ‘strong’, although one study213 received a rating of ‘moderate’ and 20 were rated
as ‘weak’.192,198,200,201,204,207,212,214,226,230,231,237,241,244,245,251,253–255,261,266,267 Regarding the blinding of outcome
assessors and study participants, four studies194,197,250,262 were rated as ‘strong’ and five studies192,209,251,255,264
received a ‘weak’ rating, with the remaining studies ‘moderate’. Studies scored most highly in terms
of reporting of numbers and reasons for withdrawal and dropouts. All but 11 studies191,192,194,195,208,236,245,252,
257,266,269 were rated as ‘strong’ on this component, including 20 of the 23 UBA studies prioritised for
synthesis.194,195,197,201,203,206,207,212,216,218,228,230,232,237,238,241,250,253,262,263 Two studies194,195 were scored as ‘moderate’
on this item, and 10 studies191,192,208,236,242,245,252,257,266,269 obtained a ‘weak’ rating.
RESULTS
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TABLE 3 Summary of intervention characteristics by broad procedural category
First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
Abdominal surgery
Chen 2017,199
Taiwan
mHELP ERP Reduce incidence of
delirium and LOS
✗ ✗ Hospital Trained mHELP
nurse
Usual care Complications
Cardiac surgery
Arthur 2000,193
Canada
Preoperative
Intervention
Prehab Improve patients’
physical and
psychological readiness
for surgery, reducing
LOS
✗ Hospital, phone,
patient home
Kinesiologists/
exercise specialists
nurses,
psychologist,
family
Usual care Complications,
mental health,
QoL
Fleming 2016,208
UK
ERACS ERP Reduce LOS, improve
perioperative outcomes
✗ ✗ ✗ ✗ Hospital NR Pre-care bundle Complications,
mortality, MoR
Furze 2009,210 UK HeartOp
programme
Prehab Reduce anxiety and
depression, encourage
healthy behaviours
✗ Outpatient
clinic, patient
home
Nurse facilitator Routine nurse
counselling/
education
Costs, QoL,
re-admissions,
UAC, mortality,
complications,
MoR, mental
health
Goodman
2008,215 UK
‘Fit for surgery’
nurse-led
support and
education
programme
Prehab Reduce anxiety,
improve control of
factors related to
postop complications
and CHD progression
✗ Patient home Hospital nurses Standard care Costs
Probst 2014,255
Germany
PACU Specialist
ward
Reduce extubation time
and LOS in ICU post
surgery
✗ ✗ ✗ NR NR Postoperative care
in ICU
Complications,
mortality
Rosenfeldt
2011,258 Australia
Physical
conditioning
and mental
stress reduction
Prehab Evaluate effect on QoL,
rates of postoperative
atrial fibrillation, LOS,
fitness improvements,
stress management
✗ Outpatient
clinics, patient
home
PT, family Usual care QoL, mental
health
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TABLE 3 Summary of intervention characteristics by broad procedural category (continued )
First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
Salhiyyah
2011,259 UK
Fast-track
programme
Specialist
ward
Improve clinical and
economic outcomes,
shorten ICU stay
✗ ✗ Hospital NR ICU for minimum
1 day, transfer to
ward
Costs,
re-admissions
van der Peijl
2004,266
the Netherlands
Exercise therapy Rehab Facilitate recovery after
surgery
✗ Hospital PT Low frequency
exercise programme
1 × day, excluding
weekends
MoR
Colorectal surgery
Anderson
2003,192 UK
Multimodal
optimisation
ERP Optimise pre-op,
perioperative and
post-op management
✗ ✗ ✗ ✗ General hospital MDT Conventional Care MoR,
complications,
readmissions
Carli 2010,198
Canada
Bike/
strengthening
prehabilitation
Prehab Optimise recovery of
functional walking
capacity post surgery
✗ Patient home NR Walking/breathing
group
MoR, mental
health, QoL,
complications
Dronkers
2010,204
the Netherlands
Preoperative
therapeutic
programme
Prehab Improve physical
condition before
surgery and improve
recovery
✗ Outpatient
department,
patient home
NR Home-based
exercise advice
Complications,
QoL, MoR
Forsmo 2016,209
Norway
ERAS ERP Reduce LOS ✗ ✗ ✗ ✗ Hospital MDT Standard care Complications,
mortality,
re-admissions,
MoR
García-Botello
2011,211 Spain
Perioperative
multimodal
rehabilitation
protocol
ERP Improve recovery ✗ ✗ ✗ ✗ Outpatient
clinic, hospital
MDT, family TC Complications,
MoR, costs
re-admissions
Gatt 2005,213 UK Multimodal
optimisation
package
ERP Reduce surgical stress
response, complication,
health costs and LOS.
Accelerate recovery,
without compromising
patient safety
✗ ✗ ✗ ✗ Hospital MDT Conventional care Complications,
MoR, mortality,
re-admissions,
UAC
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First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
Gillis 2014,214
Canada
Prehab Prehab Reduce LOS ✗ Patient home MDT Rehab QoL, MoR,
mental health,
complications,
re-admissions
Khan 2013,229 UK ERAS ERP Improve recovery ✗ ✗ ✗ ✗ Hospital MDT Laparoscopic
surgery with no
ERAS pathway
Re-admissions,
complications
Khoo 2007,231 UK Multimodal
Perioperative
management
protocol
ERP Reduce LOS, improve
independence
✗ ✗ ✗ Hospital MDT Control Complications,
MoR,
re-admissions,
satisfaction,
UAC, mortality
King 2006,232 UK Enhanced
recovery
pathway
ERP Improve clinical
outcomes, QoL and
costs
✗ ✗ ✗ Outpatient
clinic, hospital
MDT, family Conventional care Costs,
complications,
mortality,
re-admissions
Lee 2011,235
South Korea
Rehab
programme
ERP Reduce LOS ✗ ✗ Hospital MDT, family Conventional care Complications,
MoR
Lidder 2013,236
UK
Carbohydrate
and nutritional
supplements
plus ERAS
ERP Improve recovery ✗ ✗ Hospital NR PrO and PO
placebo drinks
Complications,
MoR
Maggiori 2017,239
France
FFT programme ERP Decrease morbidity ✗ ✗ ✗ ✗ Hospital MDT Limited fast-track
programme
Complications,
MoR, mortality
Mari 2014,243
2016, Italy
Fast-track
protocol; ERAS
group
ERP Reduce LOS, improve
care; Improve immune
and nutrition outcomes
✗ ✗ ✗ ✗ Hospital MDT Standard care Complications,
MoR,
re-admissions
Muller 2009,251
Switzerland
Fast-track
protocol
ERP Reduce morbidity and
complications
✗ ✗ ✗ ✗ Hospital MDT Standard care Re-admissions,
complications
Pappalardo
2016,252 Italy
Fast-track
protocol
ERP Reduce LOS, morbidity,
mortality and improve
QoL
✗ ✗ Hospital MDT Traditional care Complications,
mortality, MoR
Dhruva Rao
2015,203 UK
ERP ERP Reduce LOS ✗ ✗ ✗ ✗ Hospital MDT Pre-ERP: non
fast-track
Complications,
mortality
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TABLE 3 Summary of intervention characteristics by broad procedural category (continued )
First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
van Bree 2011265
and Vlug 2011,268
the Netherlands
Fast-track
programme
ERP Reduce LOS ✗ ✗ ✗ ✗ Hospital:
multisite
MDT SC with
laparoscopy or
open surgery
Complications,
MoR, mortality,
re-admissions,
costs
Lower limb arthroplasty
Barlow 2013,195
UK
Ring-fenced
orthopaedic
ward
Specialist
ward
Reduce LOS ✗ Hospital MDT, family Prior to ring-fenced
ward: general
orthopaedic ward
None
Borgwardt
2009,196 Denmark
Accelerated
recovery
programme
ERP Reduce LOS with good
clinical outcomes
✗ ✗ ✗ ✗ ✗ Hospital MDT Conventional care MoR, UAC,
re-admissions
Crowe 2003,200
Canada
Rehab Prehab Improve outcomes and
recovery, reduce LOS
✗ Hospital, clinic,
patient home
MDT, family Usual care MoR,
complications
den Hertog
2012202, Germany
Pathway-
controlled fast
track Rehab
Rehab Improve recovery ✗ Hospital,
rehabilitation
centre
NR Standard PO
rehabilitation
QoL,
complications
Dwyer 2012,206
UK
Enhanced
Recovery
Pathway
ERP Improve recovery ✗ ✗ ✗ ✗ ✗ Assumed
outpatient
clinic, hospital
Surgeons,
nurses, PTs, OTs,
patient as active
participant, family
Conventional care Re-admissions
Gordon 2011,216
UK
Rapid recovery
programme
ERP Reduce LOS ✗ ✗ ✗ ✗ ✗ Hospital,
outpatient clinic
MDT, family,
friend
Pre-rapid recovery
programme
None
Harari 2007,218
UK
POPS ERP Improve access to
elective surgery for
vulnerable older people
✗ ✗ ✗ Hospital, clinic,
patient home
Consultant
geriatrician, nurse
specialist in older
people, OT, PT,
SW
Pre-POPS cohort Mortality,
complications,
re-admissions
Hoogeboom
2010,221
the Netherlands
Preoperative
therapeutic
exercise
Prehab Prevent decline of
functional health status
when waiting for
surgery
✗ Patient home NR Usual PrO/PO care QoL, MoR,
complications
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First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
Huang 2012,222
Taiwan
Home rehab
education
programme
Prehab Improve range of
motion of the knee,
reduce pain, decrease
LOS
✗ Patient home PT Conventional care Complications,
costs, MoR
Huddleston
2004,223 USA
Hospitalist–
orthopaedic
team (co-
management
care)
Staff mix Improve efficiency and
quality of care
✗ ✗ Hospital Hospitalist faculty
(no residents),
consultative
medical specialty
teams (faculty and
resident)
Standard care Complications,
costs
Hunt 2009,224
Salmon 2013,260
UK
Rapid discharge
policy
ERP Reduce LOS, maintain
functional recovery and
QoL
✗ ✗ ✗ ✗ ✗ Hospital,
outpatient clinic
MDT Comparator 1:
usual care in large
regional centre
surgical unit.
Comparator 2:
usual care in
treatment centre
Costs, QoL,
MoR, UAC,
satisfaction
Khan 2014,230 UK Enhanced
recovery
programme
ERP Reduce early mortality
after surgery and LOS.
Reduce perioperative
blood loss, facilitate
earlier mobilisation
✗ ✗ ✗ ✗ ✗ Two hospital
sites
MDT Traditional care Complications,
mortality,
re-admissions
Larsen 2008,234
2008,233 Denmark
Accelerated
perioperative
care and rehab
ERP Reduce LOS ✗ ✗ ✗ ✗ ✗ Hospital MDT, family Usual care Costs, QoL,
re-admissions
Maempel
2015,238 UK
ERP ERP Reduce LOS without
adversely affecting
functional recovery and
ROM at 1 year post
operation
✗ ✗ ✗ Hospital MDT Pre-ERP Complications,
re-admissions,
MoR
Maempel
2016,237 UK
ERP ERP Improve joint function ✗ ✗ ✗ Outpatient
clinic, hospital
MDT Traditional care Re-admissions,
MoR, mortality
Malviya 2011,241
UK
Enhanced
recovery
programme
ERP Reduce LOS and early
complications
✗ ✗ ✗ Hospital,
assumed
outpatients
clinic
MDT Traditional
protocol
Mortality,
complications,
re-admissions
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TABLE 3 Summary of intervention characteristics by broad procedural category (continued )
First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
McGregor
2004,244 UK
Preoperative Hip
Rehab Advice
Prehab Aid patient recovery ✗ NR NR Standard care QoL, MoR,
costs
Mertes 2013,245
UK
Integrated care
pathway
ERP Reduce LOS, improve
surgery re-admission
rate and postoperative
LOS
✗ ✗ ✗ ✗ ✗ Outpatient
clinic, hospital
MDT, family,
carers
Standard PrO
treatment
None
Pengas 2015,253
UK
Weekend
physiotherapy
Rehab Faster rehabilitation
and recovery
✗ Hospital PT assistant Weekday PT only MoR
Pour 2007,254
USA
Group 1:
standard
incision,
enhanced
protocol. Group
2: small incision,
enhanced
protocol
ERP To assess influence
of intervention on
outcomes of total hip
arthroplasty
✗ ✗ ✗ Outpatient
clinic, hospital
MDT, family Group 3: standard
incision, standard
protocol. Group 4:
small incision,
standard protocol
Complications,
QoL, MoR,
mental health
Reilly 2005,256 UK Accelerated
recovery
protocol
ERP Reduce pain to allow
for early mobilisation
✗ ✗ Hospital, patient
home
MDT Standard care MoR
complications,
satisfaction,
costs
Siggeirs dottir
2005,261 Iceland
Preoperative
education and
training
programme/
rehab and
nursing
ERP Reduce LOS ✗ ✗ ✗ Outpatient
clinic, patient
home
PT, OT Conventional care Complications,
MoR
re-admissions
Starks 2014,262
UK
Enhanced
recovery
pathway
ERP Improve patient care,
reduce LOS
✗ ✗ ✗ ✗ ✗ Hospital MDT Pre-ERP Mortality,
re-admissions
Vesterby 2017,267
Denmark
Telemedicine
support
Rehab Reduce LOS ✗ ✗ Outpatient
clinic, patient
home
PT, support
persona
Fast track Re-admissions,
UAC
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First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
Williamson
2007,269 UK
Physiotherapy Prehab Improve condition
before surgery, improve
recovery
✗ NR PT Home exercise QoL, mental
health, MoR
Pelvic surgery
Arumainayagam
2008,194 UK
ERP ERP Reduce LOS ✗ ✗ Hospital MDT Prior to ERP
implementation
Complications,
MoR, mortality,
re-admissions
Gralla 2007;217
Magheli 2001,240
Germany
Fast track
surgery
ERP Allow hospital discharge
3 days after surgery
without additional
complication; improve
outcomes (pain,
mobilisation, recovery of
intestinal function),
reduce LOS
✗ ✗ ✗ ✗ University
hospital;
hospital
MDT Conventional care Complications,
MoR, satisfaction,
re-admissions
Jensen 2015,225
Denmark
Multi-
professional
rehab
programme
ERP Reduce LOS ✗ ✗ Hospital, patient
home
MDT Standard care Complications,
MoR, mortality,
re-admissions
Mukhtar 2013,250
UK
ERP ERP Improve inpatient
hospital stay while
ensuring clinical safety
✗ ✗ ✗ ✗ Hospital MDT Pre-ERP MoR,
complications
Thoracic surgery
Brunelli 2017,197
UK
ERP ERP Improve outcome
benefits
✗ ✗ ✗ ✗ ✗ Hospital MDT Pre-ERP: TM Re-admissions,
mortality,
complications
Gatenby 2015,212
UK
ERAS ERP Reduced total LOS and
stay on CCU
✗ ✗ ✗ ✗ ✗ Teaching
Hospital
MDT Pre-ERP Mortality,
re-admissions
Karran 2016,228
UK
Multimodal
perioperative
pathway
ERP Improve recovery,
reduce LOS, reduce
morbidity/mortality
✗ ✗ ✗ ✗ Outpatient clinic
and hospital
MDT Pre-ERP Re-admissions,
mortality
Muehling
2008,248 Germany
ERP ERP Reduce pulmonary
complications
✗ ✗ ✗ Hospitalb MDT Pre-pathway:
conservative
treatment
Complications
continued
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TABLE 3 Summary of intervention characteristics by broad procedural category (continued )
First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
Surgery to remove tumours (various locations)
Hempenius
2013220 and
2016,219 the
Netherlands
LIFE study PACP Prevent postoperative
delirium
✗ University
medical centre,
teaching
hospital,
community
hospital
Geriatric team Standard care Complications,
QoL, mortality,
re-admissions,
mental health
Upper abdominal surgery
Abu Hilal 2013,191
UK
ERP ERP Assess feasibility and
safety of ERP, reduce
LOS
✗ ✗ ✗ Hospital MDT Traditional
management
MoR, mortality,
complications,
re-admissions
Dasari 2015,201
UK
ERP ERP Reduce LOS ✗ ✗ ✗ ✗ Hospital MDT Pre-pathway/ERP Complications,
MoR,
re-admissions
Dunne 2016,205
UK
Prehabilitation
Exercise
Programme
Prehab Improve fitness to
improve recovery
✗ NR NR Standard care Re-admissions,
QoL mental
health
Jones 2013,226 UK ERP ERP Reduce morbidity and
LOS
✗ ✗ ✗ Hospital MDT Standard care QoL mortality,
MoR,
complications,
re-admissions
Kapritsou
2017,227 Greece
Fast-track
recovery
programme
ERP Improve care, improved
management of stress
and pain
✗ ✗ Oncology
hospital
MDT Conventional care Mental
health, MoR,
complications
Richardson
2015,257 UK
ERP ERP Reduce LOS, maintain
patient safety
✗ ✗ ✗ ✗ Hospital,
outpatient clinic
MDT Traditional
management
Complications,
MoR, mortality,
costs
Sutcliffe 2015,263
UK
ERP ERP Improve clinical
outcomes
✗ ✗ ✗ ✗ Hospital MDT Pre-ERP Complications,
mortality,
re-admissions
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First author,
year, country
Intervention
name in study Category
Stated aims of
intervention
Stages of the care pathway at which intervention elements were
delivered
Site
Who was
involved in
delivery?
Comparator
name in study
Outcomes
reported
(other than
LOS)
Pre
admission Preoperative Perioperative Postoperative
Post
discharge
Tanaka 2017,264
Japan
ERAS ERP Reduce LOS, enhance
recovery
✗ ✗ ✗ Hospital MDT Conventional care Complications,
MoR,
re-admissions,
costs
Various
Ellis 2012,207 UK Preoperative
assessment and
care plan
PACP Identify high-risk
patients and give
appropriate care
✗ Clinic, hospital,
patient home as
appropriate
Nurse, OT Pre-programme:
routine care
Complications,
mental health
Vascular surgery
Muehling
2008,247 2009,246
2011,249 Germany
Fast-track
regime
ERP Reduce morbidity and
mortality after major
surgical procedures
✗ ✗ ✗ Hospital MDT Pre-pathway:
conservative
treatment
Complications,
MoR, mortality,
re-admissions
Partridge
2017,31 UK
Preoperative
assessment and
care plan
PACP Optimise care to
decrease mortality and
morbidity
✗ ✗ Clinic for CGA,
hospital for
delivery of care
plan (assumed)
MDT (geriatrician,
CN specialist, SW,
OT) depending on
patient need,
family, carers, GP
Standard PrO
assessment
Complications,
re-admissions,
MoR
AF, atrial fibrillation; CCU, critical care unit; CHD, coronary heart disease; CN, clinical nurse; ERACS, Enhanced Recovery After Cardiac Surgery; FFT, Full Fast Track; GI, gastrointestinal; ICU, intensive care unit; IV, intravenous;
LIFE, Liaison Intervention in Frail Elderly; MDT, multidisciplinary team; MoR, markers of recovery; NA, not applicable; NR, not reported; OA, older adult; OT, occupational therapist; PA, pre admission; PACU, post-anaesthetic care unit;
PCA, patient-controlled analgesia; PD, post discharge; PO, postoperative; POD, postoperative day; POPS, proactive care of older people undergoing surgery; PrO, preoperative; PrT, pre treatment; PT, physiotherapy; QoL, quality of life;
ROM, range of movement/motion; SW, social worker; UAC, use of additional care.
a Eligibility criteria state need for a ‘support’ person: role not specified.
b Assumed.
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TABLE 4 Quality assessment of prioritised studies
Study (first author
and year)
Component rating (1= strong, 2=moderate, 3=weak)
Global rating of paper (strong, no
weak ratings; moderate, 1 weak
rating; weak, ≥ 2 weak ratings)Selection bias Study design Confounders
Blinding of
assessors and
participants
Data collection
methods
Withdrawals
and dropouts
Is it clear how
LOS is defined
(Y/N)?a
Abdominal surgery
Chen 2017199 2 1 1 2 3 1 N Moderate
Cardiac surgery
Arthur 2000193 2 1 1 2 1 1 Y Strong
Fleming 2016208 2 3 1 2 3 3 Y Weak
Furze 2009210 3 1 1 2 3 1 Y Weak
Goodman 2008215 3 1 1 2 1 1 Y Moderate
Probst 2014255 2 1 3 3 1 1 Y Weak
Rosenfeldt 2011258 2 1 1 2 3 1 N Moderate
Salhiyyah 2011259 2 3 1 2 3 1 Y Weak
van der Peijl 2004266 2 1 3 2 3 3 N Weak
Colorectal surgery
Anderson 2003192 2 1 3 3 3 3 Y Weak
Carli 2010198 2 3 3 2 3 1 N Weak
Dronkers 2010204 2 1 3 2 3 1 N Weak
Forsmo 2016209 2 1 1 3 3 1 Y Weak
García-Botello 2011211 2 1 1 2 3 1 N Moderate
Gatt 2005213 2 1 2 2 3 1 N Moderate
Gillis 2014214 2 1 3 2 3 1 N Weak
Khan 2013229 2 3 1 2 3 1 N Weak
Khoo 2007231 3 1 3 2 3 1 N Weak
King 2006232 2 3 1 2 1 1 Y Moderate
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Study (first author
and year)
Component rating (1= strong, 2=moderate, 3=weak)
Global rating of paper (strong, no
weak ratings; moderate, 1 weak
rating; weak, ≥ 2 weak ratings)Selection bias Study design Confounders
Blinding of
assessors and
participants
Data collection
methods
Withdrawals
and dropouts
Is it clear how
LOS is defined
(Y/N)?a
Lee 2011235 2 1 1 2 3 1 Y Moderate
Lidder 2013236 3 1 1 2 3 3 N Weak
Maggiori 2017239 2 1 1 2 3 1 Y Moderate
Mari 2016242 2 1 1 2 3 1 N Moderate
Mari 2016242 2 1 1 2 3 1 N Moderate
Muller 2009251 2 1 3 3 3 1 N Weak
Pappalardo 2016252 2 3 1 2 3 3 Y Weak
Dhruva Rao 2015203 2 3 1 2 3 1 N Weak
van Bree 2011;265
Vlug 2011268
2 1 1 2 3 1 Y Moderate
Lower limb arthroplasty
Barlow 2013195 2 3 1 2 3 2 Y Weak
Borgwardt 2009196 2 1 1 2 3 1 N Moderate
Crowe 2003200 2 1 3 2 3 1 N Weak
den Hertog 2012202 2 1 1 2 3 1 Y Moderate
Dwyer 2012206 2 3 1 2 3 1 Y Weak
Gordon 2011216 2 3 1 2 3 1 N Weak
Harari 2007218 2 3 1 2 3 1 N Weak
Hoogeboom 2010221 3 1 1 2 3 1 N Weak
Huang 2012222 2 1 1 2 3 1 N Moderate
Huddleston 2004223 2 1 1 2 3 1 Y Moderate
Hunt 2009;224
Salmon 2013260
2 3 1 2 3 1 Y Weak
Khan 2014230 1 3 3 2 3 1 N Weak
continued
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TABLE 4 Quality assessment of prioritised studies (continued )
Study (first author
and year)
Component rating (1= strong, 2=moderate, 3=weak)
Global rating of paper (strong, no
weak ratings; moderate, 1 weak
rating; weak, ≥ 2 weak ratings)Selection bias Study design Confounders
Blinding of
assessors and
participants
Data collection
methods
Withdrawals
and dropouts
Is it clear how
LOS is defined
(Y/N)?a
Larsen 2008234 2 1 1 2 3 1 Y Moderate
Maempel 2015238 2 3 1 2 3 1 N Weak
Maempel 2016237 2 3 3 2 3 1 Y Weak
Malviya 2011241 2 3 3 2 3 1 N Weak
McGregor 2004244 2 3 3 2 3 1 N Weak
Mertes 2013245 2 3 3 2 3 3 N Weak
Pengas 2015253 2 3 3 2 3 1 N Weak
Pour 2007254 2 1 3 2 3 1 N Weak
Reilly 2005256 2 1 1 2 3 1 N Moderate
Siggeirsdottir 2005261 2 1 3 2 3 1 N Weak
Starks 2014262 2 3 1 1 3 1 N Weak
Vesterby 2017267 2 1 3 2 1 1 N Moderate
Williamson 2007269 2 1 1 2 1 3 N Moderate
Pelvic surgery
Arumainayagam 2008194 2 3 1 1 1 2 Y Moderate
Gralla 2007;217
Magheli 2011240
2 1 1 2 3 1 Y Moderate
Jensen 2015225 2 1 1 2 3 1 Y Moderate
Mukhtar 2013250 2 3 1 1 3 1 Y Weak
RESU
LTS
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
60
Study (first author
and year)
Component rating (1= strong, 2=moderate, 3=weak)
Global rating of paper (strong, no
weak ratings; moderate, 1 weak
rating; weak, ≥ 2 weak ratings)Selection bias Study design Confounders
Blinding of
assessors and
participants
Data collection
methods
Withdrawals
and dropouts
Is it clear how
LOS is defined
(Y/N)?a
Thoracic surgery
Brunelli 2017197 2 3 1 1 3 1 Y Weak
Gatenby 2015212 2 3 3 2 3 1 N Weak
Karran 2016228 2 3 1 2 3 1 N Weak
Muehling 2008248 3 1 1 2 3 1 N Weak
Surgery to remove tumours
Hempenius 2013;220
2016219
2 1 1 2 3 1 N Moderate
Upper abdominal surgery
Abu Hilal 2013191 2 3 1 2 3 3 Y Weak
Dasari 2015201 2 3 3 2 3 1 Y Weak
Dunne 2016205 2 1 1 2 3 1 N Moderate
Jones 2013226 2 1 3 2 3 1 Y Weak
Kapritsou 2017227 2 1 1 2 3 1 Y Moderate
Richardson 2015257 2 3 1 2 2 3 Y Weak
Sutcliffe 2015263 2 3 1 2 3 1 N Weak
Tanaka 2017264 2 1 1 3 1 1 Y Moderate
Various surgeries
Ellis 2012207 2 3 3 2 3 1 N Weak
Vascular surgery
Muehling 2008;247
2009;246 2011249
2 3 1 2 3 1 N Weak
Partridge 201731 1 1 1 2 1 1 N Strong
N, no; Y, yes.
a Not included in global rating of paper.
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Synthesis of evidence from randomised controlled trials
Interventions to improve recovery from colorectal surgery: randomised controlled trials
There were 17 RCTs (published in 18 papers) evaluating interventions intended to improve recovery and/or
reduce LOS for older adults following elective colorectal surgery. Of these, 14 studies192,199,209,211,213,231,235,236,
239,242,243,251,252,265,268 evaluated ERP interventions and three198,204,214 trialled prehab. All ERP interventions
were compared with usual or standard care, while prehab interventions were compared with walking
and breathing exercises,198 rehabilitation214 and home-based exercise advice.204 The study by Vlug and
colleagues268 included comparisons of ERP and standard care in both open and laparoscopic surgery as
separate intervention arms.
Four studies were conducted in the UK,192,213,231,236 three were conducted in Italy,242,243,252 two were
conducted in each of the Netherlands204,268 and Canada,198,214 and single studies originated from Spain,211
France,239 Switzerland,251 Norway,209 Taiwan199 and South Korea.235 A total of 3079 people commenced
trials, with sample sizes ranging from 25192 to 427.268 Participants were admitted for hemicolectomy
(left and right), resection of malignant lesions, colonic reconstruction, colorectal resection, rectal resection,
high anterior resection, colonic resection and extraperitoneal rectal surgery. Across the included studies,
the mean proportion of female participants was 44%. Ages within included studies were reported as
either median or mean and can be viewed in Table 2.
The two studies by Mari and colleagues242,243 utilised the same intervention with different samples, the
latter study focusing on patients of ≥ 70 years of age. van Bree and colleagues265 reported on a small
sample of the original 427 participants in the study by Vlug and colleagues268 focusing on recovery
of gastrointestinal transit. In this case, we report outcome data from the original sample in the study
by Vlug and colleagues268 only, except where van Bree and colleagues265 reported additional, unique
outcomes. The study by Chen and colleagues199 included patients undergoing procedures that could be
categorised as both colorectal and upper abdominal surgery; we report the data for patients undergoing
left and right hemicolectomies as distinct groups in this section, with those undergoing gastrectomy or
pancreaticoduodenectomy reported in the upper abdominal section (see Interventions to improve recovery
from upper abdominal surgery: randomised controlled trials).199
Overview: colorectal surgery
Thirteen RCTs evaluated the effectiveness of ERP interventions to improve recovery from colorectal surgery,
and three evaluated prehab interventions. This body of evidence is summarised in Table 5. Full details of
the effectiveness of interventions in this type of surgery are reported in ERP interventions and Prehab
interventions.
Meta-analysis suggests that ERP interventions are associated with a statistically significant, medium-sized
effect on LOS, reducing LOS by a mean of 1.8 days (range 0.0–5.1 days) compared with usual care
(based on data from eight comparisons); however, this effect was weaker when a much older outlier
study with a small sample size was removed from the analysis.192 This change in LOS did not lead to
negative consequences for other clinical outcomes, as meta-analyses indicated no statistically significant
difference overall in the rates of re-admissions (data from seven comparisons) or complications (data
from 15 comparisons). Furthermore, there was evidence from meta-analyses of statistically significant
improvements on patient-reported outcomes following ERP interventions, including return of bowel
function, meeting mobilisation goals earlier and achieving control of pain sooner, although these data
always came from three or four studies and there was usually high statistical heterogeneity.
Three ERP intervention studies199,236,239 reported no significant differences in clinical outcomes compared
with usual care. The interventions and comparators within two of these studies were atypical. The
intervention evaluated by Chen et al.199 mainly involved a series of tailored postoperative care protocols,
added to existing ERP pathways which implemented few ERAS recommendations. For example, mechanical
bowel preparation, overnight fasting, routine use of drains and nasogastric tubes were all implemented,
RESULTS
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TABLE 5 Summary of studies, intervention components and findings for RCTs evaluating interventions to improve recovery from colorectal surgery
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Chen 2017,199
Taiwan
535 ERP FM EON; COMM;
EMOB
Oral and
nutritional
assistance
protocol
◁▷(2/2) ⇦⇨(2/2)
García-Botello
2011,211 Spain
125 ERP AEI PreM; nMBP;
nFAST
ANE; FM;
WARM PONV
EON; EMOB;
nNGT; CATH
▲ ◁▷(4/4) ⇦⇨ x(6/6)
Gatt 2005,213
UK
39 ERP AEI; PBio nMBP; CHL;
nFAST
ANA; DRA;
FM; nNGT;
SURG
EON; EMOB x ⇦⇨ ⇦⇨ ⇦⇨ x ⇦⇨
Lee 2011,235
South Korea
100 ERP FM EON; EMOB;
LAX; CATH
Pre admission:
involvement of
patient and
family
x(2/2) ⇦⇨ ▲(6/10)
▲(1/10)
◁▷(3/10)
Maggiori
2017,239
France
270 ERP AEI CHL; nFAST;
PreM
PONV; ANE;
FM; WARM
EON; EMOB;
ANA
◁▷(2/2) ⇦⇨(2/2) ⇦⇨
Mari 2014,243
Italy
52 ERP CHL; nFAST ANE; FM;
PONV
ANA; EON;
EMOB; nNGT
▲ ⇦⇨ ⇦⇨ ▲(5/5)
Mari 2016,242
Italy
83 ERP CHL; nFAST ANE; FM;
PONV
EON; EMOB;
nNGT; ANA
▲ ⇦⇨ ▲(4/12)
▲(4/12)
◁▷(4/12)
van Bree
2011,265
Vlug 2011,268
Netherlands,
laparoscopic
surgery
93; 427 ERP AIE; EX CHL; nFAST;
PreM
ANA; FM;
PONV
EON; EMOB;
FM; NUT; LAX;
CATH
Guided tour of
surgical ward
△(2/2) ⇦⇨(2/2) ⇦⇨ ⇦⇨ ▲(2/9)
▲(4/9)
△(1/9)
◁▷ (2/9)
van Bree
2011,265
Vlug 2011,268
Netherlands,
open surgery
93; 427 ERP AIE; EX CHL; nFAST;
PreM
ANA; FM;
PONV
EON; EMOB;
FM; NUT; LAX;
CATH
Guided tour of
surgical ward
◁▷(2/2) ⇦⇨(2/2) ⇦⇨ ⇦⇨ ▲(2/9)
▲(3/9)
△(1/9)
◁▷(3/9)
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TABLE 5 Summary of studies, intervention components and findings for RCTs evaluating interventions to improve recovery from colorectal surgery (continued )
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Anderson
2003,192 UK
25 ERP AEI; NUT nMBP; CATH;
CHL; nFAST
ANE; ANA;
nNGT; SURG
EON; EMOB ▲ ⇦⇨ x ▲(1/2)
◁▷(1/2)
Forsmo
2016,209
Norway
324 ERP AEI CHL; PreM ANE; FM LAX; ANA;
CATH; EON;
EMOB
x(2/2) ⇦⇨(3/3) ⇦⇨ ⇦⇨ x(5/5)
Khoo 2007,231
UK
a
81 ERP NUT ANE; FM;
nNGT
EON; EMOB;
ANA; CATH
x(2/2) Ç ⇦⇨ ⇦⇨ x(3/3) ⇦⇨(3/3)
Lidder
2013,236 UK
57 ERP CHL EON; NUT ◁▷ Ç(1/4)
⇦⇨(3/4)
◁▷
Muller
2009,251
Switzerland
156 ERP FM; DRA ANA; EON;
FM; NUT
x Ç(2/3)
⇦⇨(1/3)
⇦⇨
Pappalardo
2016,252 Italy
50 ERP ANE; AP; TP EON; EMOB;
nNGT; ANA
x ⇦⇨(3/3) ⇦⇨ x(4/4)
Carli 2010,198
Canada
133 Prehab EX ◁▷ ⇦⇨ ◁▷(2/2) ◁▷(2/2) ◁▷
Dronkers
2010,204 the
Netherlands
42 Prehab AEI; EX ◁▷ ⇦⇨ ▼(1/4)
◁▷(3/4)
▼(2/7)
◁▷(5/7)
Gillis 2014,214
Canada
89 Prehab AEI; EX;
NUT; PT
Weekly
telephone
contact
◁▷(2/2) ⇦⇨ ⇦⇨(2/2) x ◁▷(3/3) ◁▷(8/8)
AEI, assessment, education, counselling or information; ANA, analgesia protocol; ANE, anaesthesia protocol; AP, antibiotic prophylaxis; CATH, catheter protocol; CHL, carbohydrate loading; COMM, communication protocol; DP, discharge planning;
DRA, drain protocol; EMOB, early mobilisation; EON, early oral nutrition; EX, exercise programme; FM, fluid management protocol; LAX, laxative; nFAST, avoidance of prolonged fasting; nMBP, no mechanical bowel preparation; nNGT, nasogastric
tube protocol; NUT, nutrition supplementation or diet management; OT, occupational therapy; Pbio, probiotic/prebiotic; PONV, active prevention of nausea and vomiting; PreM, pre-medication protocol; PT, physiotherapy; SoW, social worker;
SURG, surgical approach differs between groups; TP, thromboprophylaxis; WARM, intraoperative warming protocol.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d > 0.80);▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50 to 0.79);△, standardised mean difference
indicates significant small beneficial effect size (Cohen’s d 0.20 to 0.49);▼, standardised mean difference indicates significant medium detrimental effect size;◁▷, standardised mean difference indicates no significant difference between groups;
Ç, OR indicates significant beneficial effect; ⇦⇨, OR indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], not reported; (x/y), finding for x of y measures (e.g. where
multiple measures per outcome category).
a Patient satisfaction was reported in the study.
Study quality is indicated by the colour of the study details cell: dark green, ‘moderate’; light blue, ‘weak’.
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in contradiction to ERAS Society guidelines.271 The intervention evaluated by Lidder et al.236 involved adding
preoperative carbohydrate loading and additional postoperative nutrition to the existing ERP provided to
the comparator group. This suggests that these elements alone are not enough to reduce LOS compared
with existing standards of care, although caution is required because the studies were low to moderate
quality, respectively.
The ERP intervention evaluated by Vlug and colleagues268 was effective in reducing LOS when a laparoscopic
surgical technique was used, but not when an open approach was used, indicating the potential influence of
the surgical technique on the effectiveness of an ERP. However, the statistical results for the two studies were
marginally different, and the effects for patient-reported outcomes were similar for patients undergoing both
types of surgery. It is unclear why the intervention was not more effective than usual care in the study by
Maggiori and colleagues,239 except that there were a number of similar pathway elements between the
‘full fast-track’ pathway and the ‘limited fast-track’ pathway that constituted usual care (Table 6).
The evidence for prehab interventions did not indicate a benefit for clinical or patient-reported outcomes,
and it is notable that only three RCTs198,204,214 of ‘weak’ quality were identified. There were no significant
differences in clinical outcomes for any study, and, although all of these studies measured additional
outcomes, only Dronkers and colleagues204 identified a statistically significant difference between groups.
Results from the study indicate an increase in the time taken to rise from a chair, a reduction in physical
work capacity and an increase in fatigue among patients in the intervention group.204 This outcome was
unexpected, as patients in the prehab group appeared to have performed worse on three outcomes.
However, baseline scores for these three measures were similar to post-intervention scores, with near-
statistically significant differences between groups.204 A fairer interpretation of the intervention’s effects
may be that it had little influence on these outcomes, rather than a negative impact. As such, caution
is needed when interpreting this finding, particularly in the light of the fact that confounders were not
controlled for in the study, which received a global quality rating of ‘weak’ overall. With this in mind,
the evidence suggests that prehab interventions alone may not convey beneficial or detrimental effects to
older adults undergoing elective colorectal surgery.
Elements of prehab (exercise, physiotherapy, nutrition all prior to admission) were present in only three of
the ERP interventions,192,213,268 with mixed effectiveness reported. Therefore, little evidence is available to
determine whether or not the addition of prehabilitation to ERP interventions might convey benefits on
patient recovery.
Caution is advised when interpreting the evidence for colorectal surgery. Study effects should be interpreted
alongside detail of the intervention evaluated, as there was considerable heterogeneity in both the content
of interventions, and the evidence of effects, as highlighted in Table 5. Furthermore, comparators were
often poorly described. Study quality was ‘moderate’ or ‘weak’, with no studies globally rated as ‘strong’.
Enhanced recovery protocol interventions
Components of the ERP interventions and comparators are mapped against ERAS Society recommendations
for colonic and rectal/pelvic surgery in Table 6.272 The full details of both ERP and prehab interventions can
be found in Report Supplementary Material 3, Tables 1–4. In summary, the most common ERP components
were the provision of preoperative information, education and counselling (8/13 studies); avoidance of
lengthy preoperative fasting (8/13); a standardised anaesthetic protocol (10/13); laparoscopic surgery used,
where available (10/13); early removal of nasogastric tubes (8/13); thoracic epidural analgesia postoperatively
(10/13); early oral intake postoperatively (12/13); perioperative nutritional care (11/13); and early mobilisation
(11/13). The least common components were preoperative optimisation (3/13 studies); avoidance of
pre-anaesthetic medication (3/13); active prophylaxis against postoperative nausea and vomiting (3/13);
judicious use of vasopressors (2/13); transurethral (0/13) or suprapubic catheter (1/13) use; prevention of
postoperative ileus with chewing gum, oral magnesium or alvimopan (1/13); and postoperative glucose
control (0/13).
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TABLE 6 Components of included ERP interventions and comparators, mapped against ERAS Society guidelines for colonic and pelvic/rectal surgery
ERAS item
Study (first author and year)
aForsmo
2016209
aLidder
2013236
Anderson
2003192
Chen
2017199
García-Botello
2011211
Gatt
2005213
Khoo
2007231
Lee
2011235
Maggiori
2017239
bMari 2014,243
2016242
Muller
2009251
Pappalardo
2016252
van Bree
2011;265
Vlug 2011268
Preoperative information,
education and counselling
E E E E E, C E E, C E
Preoperative optimisation E E E, C
Preoperative mechanical bowel
preparation avoided
E E E E, C
Preoperative fasting: clear fluids
allowed up to 2 hours and solids
up to 6 hours prior to induction
of anaesthesia
E, C E Ec E,c Cc E E E,c Cc E
Preoperative carbohydrate
treatment
E E E E Ec E E
Pre-anaesthetic medication: no
routine long- or short-acting
sedatives (colonic); no
advantages in using long-acting
benzodiazepines, short-acting
should not be given to those
aged > 60 years (R/P)
E E E
Prophylaxis against
thromboembolism
E, C E, C E, C E
Antimicrobial prophylaxis and
skin preparation
E, C E, C E, C E, C E, C E
Standard anaesthetic protocol E E, C E E, C E, C E, C E E, C E E, C
PONV prophylaxis E E E
Laparoscopy and modifications
of surgical access: recommended
for colonic surgery
E,d Cd E,d Cd E, C E,e Ce E,d Cd E, C E, C E, C E, C E, C
Nasogastric intubation:
nasogastric tubes not routinely
used
E, C E, C E E E, C E, C
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ERAS item
Study (first author and year)
aForsmo
2016209
aLidder
2013236
Anderson
2003192
Chen
2017199
García-Botello
2011211
Gatt
2005213
Khoo
2007231
Lee
2011235
Maggiori
2017239
bMari 2014,243
2016242
Muller
2009251
Pappalardo
2016252
van Bree
2011;265
Vlug 2011268
Nasogastric tubes removed
before extubation
E, C E E E E E, C E E, C
Preventing intraoperative
hypothermia
E, C E, C E, C E, C E, C E, C
Perioperative fluid management:
intraoperative fluids guided by
flow measurements to optimise
cardiac output
E, C E, C C E E E
Perioperative fluid management:
judicious use of vasopressors
E E
Perioperative fluid management:
enteral route for fluids
postoperatively should be used
as early as possible, and
intravenous fluids should be
discontinued as soon as is
practicable
E E, C E E E E E E
No drainage of peritoneal cavity
after colonic anastomosis
E,f C E E E E, C
Transurethral catheter (R/P)
Suprapubic catheter (R/P) E
Urinary drainage: routine
transurethral bladder drainage
for 1–2 days is recommendedg
E, C E, C E, C E, C E
Early removal of bladder catheter E E E E E
Prevention of postoperative ileus:
mid-thoracic epidural +
laparoscopic surgery (colonic)
E,d Cd E,d Cd E E, C E
continued
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TABLE 6 Components of included ERP interventions and comparators, mapped against ERAS Society guidelines for colonic and pelvic/rectal surgery (continued )
ERAS item
Study (first author and year)
aForsmo
2016209
aLidder
2013236
Anderson
2003192
Chen
2017199
García-Botello
2011211
Gatt
2005213
Khoo
2007231
Lee
2011235
Maggiori
2017239
bMari 2014,243
2016242
Muller
2009251
Pappalardo
2016252
van Bree
2011;265
Vlug 2011268
Prevention of postoperative ileus:
fluid overload and nasogastric
decompression avoided
E E E E E
Prevention of postoperative ileus:
chewing gum (R/P), oral
magnesium, alvimopan
E
Postoperative laxatives and
prokinetics (R/P)
E E, C E E
Postoperative analgesia. Open
surgery: TEA using low-dose
local anaesthetic and opioids;
laparoscopic: an alternative to
TEA is a carefully administered
spinal analgesia with a low-dose,
long-acting opioid
E, C E E, C E E, C E, C E E E E, C
Early oral intake E E E E E E E E E E E E
Perioperative nutritional care E E E E E E E E E E E
Postoperative glucose control
Early mobilisation E E E E E E E E E E, C E
C, present in comparator arm; E, present in experimental arm; PONV, postoperative nausea and vomiting; R/P, items from guidelines for rectal/pelvic elective surgery; TEA, thoracic
epidural analgesia.
a Interventions were described as ‘ERAS’ by study authors.
b Both studies used the same intervention.
c 3 hours’ fasting for fluids.
d Both laparoscopic and open procedures performed.
e Laparoscopy used on average 47% of patients.
f Rectal resections received pelvic drain.
g Responses relate to mention of bladder catheter or urinary drainage, regardless of site.
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Excluding the item for glucose control (specific to patients with diabetes), interventions adhered to a mean
number of 14.2 (45.7%) ERAS guideline items (range from 3252 to 24268 items), and comparator groups
adhered to a mean number of 4.8 (15.6%) items (range from 0252 to 7211,236,251 items). Interventions branded
as ERAS adhered to a mean of 15.5 (50%) of ERAS guideline items, compared with a mean of 13.9 (44.8%)
of ERP interventions not branded as ERAS.
In the study by Chen and colleagues,199 the intervention (the Modified Hospital Elder Life Program) integrated
relatively few ERAS Society-recommended components, but featured an additional focus on oral and
nutritional assistance, with a postoperative communication protocol to facilitate orientation within the
hospital environment.
Quality assessment
Seven studies211,213,235,239,242,243,268 were rated as ‘moderate’ overall quality; the rest were rated as ‘weak’.
All studies received a rating of ‘weak’ for data collection methods because they failed to describe the reliability
and validity of outcome measures. Only six studies192,209,235,239,252,268 clearly defined how LOS had been calculated.
The study by Anderson and colleagues192 was rated as ‘weak’ on four domains (confounders, blinding, data
collection methods, and withdrawals and dropouts), and five studies198,231,236,251,252 were rated as ‘weak’ on
three domains. Seven studies209,211,235,239,242,243,268 scored ratings of ‘strong’ on three domains; in each case,
these domains were study design, confounders, and withdrawals and dropouts.
Effectiveness of enhanced recovery protocol interventions at improving clinical outcomes Report
Supplementary Material 5, Table 1, displays clinical outcome data from the 14 studies evaluating ERP
interventions in older adults undergoing elective colorectal surgery. After imputation, standardised mean
differences between groups for LOS were available in 10 group comparisons from eight studies.192,199,211,236,
239,242,243,268 A forest plot displaying the results of meta-analysis of these eight studies is displayed in Figure 2a,
showing that ERP interventions are associated with a reduction in LOS when compared with usual care,
associated with a medium effect size (d = –0.51, 95% CI –0.78 to –0.24; p < 0.001). Heterogeneity was large
and statistically significant for this effect (I2 = 78.9%; p < 0.001), reflecting inconsistency in the evidence. The
mean reduction in LOS was 1.8 days (SD 1.5, range 0.0–5.1 days). Examination of Figure 2a suggests that
the effect size from the study by Anderson and colleagues192 may be an outlier. Because the study is 8 years
older than any other in the analysis, and has the smallest sample size (data from 24 participants), a sensitivity
analysis was performed by removing the study from the meta-analysis. The results are shown in the forest
plot in Figure 2b, and indicate that there is still a statistically significant reduction in LOS with ERP interventions;
however, the effect size reduces marginally (d = –0.45, 95% CI –0.71 to –0.19; p < 0.01) and the reduction in
absolute terms decreases slightly to 1.6 days. Sensitivity analysis showing the influence of imputed data on LOS
meta-analysis is available in Appendix 4.
In the studies presenting data that could not be used to calculate standardised mean differences, the
median LOS for patients receiving ERP interventions was lower in all cases.209,213,231,235,251 Pappalardo and
colleagues252 reported that patients receiving ERP had been discharged by postoperative day 6, but around
half of those receiving usual care had not.
Nine studies, evaluating 10 comparisons, reported readmission rates following ERP interventions.
Figure 3 is a forest plot displaying the results of meta-analysis of re-admission data, indicating the odds of
re-admission were similar between ERP and usual care (OR 1.19, 95% CI 0.77 to 1.82). Thirteen studies,
evaluating 15 comparisons, reported incidence of complications following ERP interventions. Meta-analysis
indicates that the odds of experiencing a complication were not statistically significantly different in patients
receiving ERP interventions from those receiving usual care (Figure 4), despite the summary OR indicating a
trend towards a reduction in odds with ERP (OR 0.82, 95% CI 0.65 to 1.03).
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Effectiveness of enhanced recovery protocol interventions at improving patient-reported
outcomes Report Supplementary Material 5, Table 2, displays data for patient-reported outcomes for
RCTs trialling ERP interventions to improve recovery from elective colorectal surgery in older adults. Multiple
outcomes were reported for markers of recovery across the included studies, allowing several meta-analyses
to be performed. In total, five ERP studies192,235,242,243,268 contributed to meta-analyses of the following markers
of recovery from surgery: time to first flatus, time to first stool, time to resumption of diet, time to reach
mobilisation goals and time to reach pain control goals. There was insufficient data for meta-analysis of
mental health or quality-of-life outcomes.
Note: weights are from random-effects analysis
Overall (I 2 = 78.9%; p = 0.000)
Lidder 2013236
Anderson 2003192
Mari 2014243
Mari 2016242
García-Botello 2011211
Maggiori 2017239
Chen 2017199 – LH
Vlug 2011268 – lap
Vlug 2011268 – open
Chen 2017199 – RH
Study ID Cohen’s d (95% CI)
– 0.51 (– 0.78 to – 0.24)
– 0.39 (– 0.92 to 0.13)
– 1.60 (– 2.53 to – 0.66)
– 1.23 (– 1.84 to – 0.62)
– 0.91 (– 1.37 to – 0.46)
– 0.99 (– 1.37 to – 0.61)
– 0.06 (– 0.30 to 0.18)
0.00 (– 0.34 to 0.34)
– 0.29 (– 0.57 to – 0.02)
– 0.20 (– 0.49 to 0.08)
– 0.32 (– 0.82 to 0.17)
Shorter with ERP  Shorter with usual care 
– 4 – 3 – 2 – 1 0 0.5
(a)
Note: weights are from random-effects analysis
Overall (I 2 = 77.6%; p = 0.000)
Vlug 2011268 – lap
Mari 2016242
Study ID
Chen 2017199 – LH
Lidder 2013236
Vlug 2011268 – open
García-Botello 2011211
Chen 2017199 – RH
Maggiori 2017239
Mari 2014243
Cohen’s d (95% CI)
– 0.45 (– 0.71 to – 0.19)
– 0.29 (– 0.57 to – 0.02)
– 0.91 (– 1.37 to – 0.46)
0.00 (– 0.34 to 0.34)
– 0.39 (– 0.92 to 0.13)
– 0.20 (– 0.49 to 0.08)
– 0.99 (– 1.37 to – 0.61)
– 0.32 (– 0.82 to 0.17)
– 0.06 (– 0.30 to 0.18)
– 1.23 (– 1.84 to – 0.62)
Shorter with ERP  Shorter with usual care 
– 4 – 3 – 2 – 1 0 0.5
(b)
FIGURE 2 (a) Forest plot showing the results of meta-analysis of the effect of ERP vs. usual treatment on LOS
following colorectal surgery; (b) forest plot of analysis with Anderson et al.192 removed. Lap, laparoscopic surgery
group; LH, left hemicolectomy/high anterior resection; open, open surgery group; RH, right hemicolectomy.
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Figure 5a is a forest plot of the effect of ERP interventions on the time to resumption of diet after colorectal
surgery, when compared with usual care. Across five group comparisons from four studies,235,242,243,268 there
was a statistically significant reduction in time to resumption of diet, with a large effect size (d = –2.07,
95% CI –3.11 to –1.03; p < 0.001). In absolute terms, the mean reduction in time to resumption of diet
after surgery was 1.7 days (SD 0.7, range 0.7–2.0 days). In Figure 5b, meta-analysis indicates that there
was a medium-sized effect indicating earlier passage of first flatus in participants undergoing
Overall (I 2 = 0.0%; p = 0.823)
Vlug 2011268 – lap
Muller 2009251
Gatt 2005213
Khoo 2007231
Vlug 2011268 – open
García-Botello 2011211
Forsmo 2016209
Study ID
1.19 (0.77 to 1.82)
0.93 (0.30 to 2.88)
1.50 (0.24 to 9.24)
OR (95% CI)
0.22 (0.02 to 2.20)
0.94 (0.18 to 5.01)
1.06 (0.36 to 3.16)
1.45 (0.23 to 9.00)
1.46 (0.79 to 2.69)
Lower odds with ERP Lower odds with usual care 
0.2 0.5 1 2 5
FIGURE 3 Forest plot showing the results of meta-analysis of the effect of ERP vs. usual treatment on the odds of
re-admission following colorectal surgery. Lap, laparoscopic surgery group; open, open surgery group.
Overall (I 2 = 35.7%; p = 0.084)
Study ID
Khoo 2007231 (total number of complications)
García-Botello 2011211 (total complications)
Lidder 2013236 (patients with complications at 30 days)
Anderson 2003192 (patients with complications)
Pappalardo 2016252 (total complications)
Lee 2011235 (total complications)
Mari 2016242 (total complications)
Chen 2017199 (RH) (delirium incidence)
Gatt 2005213 (total complications)
Maggiori 2017239 (patients with complications)
Forsmo 2016209 (patients with major complications)
Vlug 2011268 – open (patients with major complications)
Chen 2017199 (LH, LAR or AR) (delirium incidence)
Muller 2009251 (patients with a complication)
Vlug 2011268 – lap (patients with major complications)
0.82 (0.65 to 1.03)
0.33 (0.12 to 0.89)
0.96 (0.47 to 1.98)
0.59 (0.20 to 1.70)
0.48 (0.09 to 2.52)
0.60 (0.15 to 2.47)
0.44 (0.15 to 1.26)
1.48 (0.31 to 7.07)
0.48 (0.04 to 5.55)
0.30 (0.08 to 1.16)
1.37 (0.81 to 2.30)
OR (95% CI)
1.46 (0.67 to 3.17)
0.94 (0.47 to 1.89)
0.56 (0.19 to 1.65)
0.35 (0.16 to 0.74)
1.43 (0.63 to 3.22)
Lower odds with ERP Lower odds with usual care 
0.2 0.5 1 2 5
FIGURE 4 Forest plot showing the results of meta-analysis of the effect of ERP vs. usual treatment on odds of
complications following colorectal surgery. AR, anterior resection; lap, laparoscopic surgery group; LAR, lower
anterior resection; LH, left hemicolectomy/high anterior resection; open, open surgery group; RH, right
hemicolectomy.
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Study ID Cohen’s d (95% CI)
(a)
Note: weights are from random-effects analysis
Overall (I 2 = 96.5%; p = 0.000)
Mari 2016242 (solid-meal tolerance)
Vlug 2011268 – lap (tolerate solid food)
Vlug 2011268 – open (tolerate solid food)
Mari 2014243 (solid-diet tolerance)
Lee 2011235 (tolerable diet for 24 hours)
– 2.07 (– 3.11 to – 1.03)
– 2.85 (– 3.47 to – 2.24)
– 0.56 (– 0.83 to – 0.28)
– 0.86 (– 1.16 to – 0.56)
– 3.46 (– 4.35 to – 2.57)
– 2.88 (– 3.45 to – 2.32)
Earlier with ERP Earlier with comparator 
– 5 – 4 – 3 – 2 – 1 0 1
Study ID Cohen’s d (95% CI)
(b)
Note: weights are from random-effects analysis
Overall (I 2 = 82.7%; p = 0.000)
Lee 2011235
Vlug 2011268 – lap
Mari 2014243
Vlug 2011268 – open
Mari 2016242
– 0.64 (– 1.05 to – 0.24)
– 0.13 (– 0.52 to 0.27)
– 0.56 (– 0.83 to – 0.28)
– 1.39 (– 2.01 to – 0.77)
– 0.22 (– 0.50 to 0.07)
– 1.17 (– 1.64 to – 0.70)
Earlier with ERP Earlier with comparator 
– 3 – 2 – 1 0 1
FIGURE 5 Forest plots displaying meta-analyses of patient-reported outcomes following colorectal surgery.
(a) Time to resumption of diet; (b) time to passage of first flatus; (c) time to passage of first stool; (d) time to
reach ambulation goals; and (e) time to reach pain reduction of control goals. Lap, laparoscopic surgery group;
open, open surgery group. (continued )
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Study ID Cohen’s d (95% CI)
(c)
Note: weights are from random-effects analysis
Overall (I 2 = 92.9%; p = 0.000)
Vlug 2011268 – open (passage of first stool)
Mari 2014243 (time to first bowel movement)
Vlug 2011268 – lap (passage of first stool)
Lee 2011235 [time to first defecation (hours)]
Mari 2014243 (passage of first stool)
Earlier with ERP Earlier with comparator 
0– 5 – 4 – 3 – 2 – 1 1 2
– 1.12 (– 1.81 to – 0.43)
– 0.69 (– 0.98 to – 0.40)
– 2.50 (– 3.25 to – 1.76)
– 0.35 (– 0.63 to – 0.08)
– 0.12 (– 0.52 to 0.27)
– 2.36 (– 3.09 to – 1.63)
Note: weights are from random-effects analysis
Overall (I 2 = 91.1%; p = 0.000)
Anderson 2003192 (able to walk to the toilet unaided)
Lee 2011235 (safe ambulation)
Vlug 2011268 – open (mobilisation as preoperative)
Vlug 2011268 – lap (mobilisation as preoperative)
Mari 2016242 (walking 100 m)
Mari 2014243 (walk at least 60 m)
– 1.02 (– 1.62 to – 0.42)
0.75 (– 0.07 to 1.57)
– 0.71 (– 1.11 to – 0.30)
– 0.63 (– 0.92 to – 0.34)
– 0.89 (– 1.17 to – 0.60)
– 1.52 (– 2.01 to – 1.03)
– 3.35 (– 4.22 to – 2.48)
Earlier with ERP Earlier with comparator 
– 5 – 4 – 3 – 2 – 1 0 1 2
Study ID Cohen’s d (95% CI)
(d)
FIGURE 5 Forest plots displaying meta-analyses of patient-reported outcomes following colorectal surgery.
(a) Time to resumption of diet; (b) time to passage of first flatus; (c) time to passage of first stool; (d) time to
reach ambulation goals; and (e) time to reach pain reduction of control goals. Lap, laparoscopic surgery group;
open, open surgery group. (continued )
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ERP (d = –0.64, 95% CI –1.05 to –0.24; p < 0.001), with a mean absolute difference of –0.7 days (SD 0.4,
range –0.15 to –1.2 days). The evidence for passage of first stool was similar, occurring 1.4 days earlier
with ERP (SD 1.2 days, range 0.3–1.4 days) with Figure 5c indicating a large pooled effect size (d = –1.12,
95% CI –1.81 to –0.43; p < 0.001).
Figure 5d is a forest plot of the effect of ERP interventions on the time to reach ambulation goals following
surgery. Goals included walking a target distance, walking safely or independently and reaching preoperative
levels of mobilisation. Patients receiving ERP met goals 2.0 days earlier (SD 1.8 days, range 1.3–3.4 days),
with a large effect size (d = –1.02, 95% CI –1.62 to –0.42; p < 0.001). Figure 5e shows that there was a
small effect size indicating that patients randomised to ERP achieved pain control/goals earlier than those
receiving usual care (d = –0.47, 95% CI –0.65 to –0.30; p < 0.001). Pain goals were achieved a mean of
0.8 days earlier (SD 0.2 days, range 0.7–1.0 days).
In studies not reporting analysable data, Forsmo and colleagues209 reported that the median time to passage
of first stool and pain control with oral medication occurred earlier in patients receiving ERP, but it took
longer to tolerate food without nausea; García-Botello and colleagues211 reported favourable median scores
for all outcomes, except for pain scores on postoperative days 2 and 3, which were similar for both groups;
Khoo and colleagues231 reported that only 9% of patients randomised to the ERP group felt that they would
benefit from a longer inpatient stay, compared with 69% in the usual care group; and Pappalardo and
colleagues252 reported similar quality-of-life scores between groups.
Heterogeneity
There was often high and statistically significant statistical heterogeneity in meta-analyses of the effects of ERP
on LOS and markers of recovery in patients undergoing elective colorectal surgery, indicating inconsistency
between studies. Although heterogeneity was not statistically significant for the meta-analysis of achievement
of pain control outcomes (see Figure 5e), it was for other analyses, with I2 values ranging from 77.6% (LOS)
to 96.5% (time to resumption of diet), indicating lack of consistency between outcome data. Furthermore,
95% CIs were wide in all cases, suggesting that any underlying true effect of interventions was uncertain.
Meta-analyses of complications and re-admissions were associated with low and non-statistically
significant heterogeneity.
Note: weights are from random-effects analysis
Overall (I 2 = 0.0%; p = 0.511)
Study ID
Vlug 2011268 – open (controlled with oral medication)
Lee 2011235 (analgesic-free)
Vlug 2011268 – lap (controlled with oral medication)
Cohen’s d (95% CI)
– 0.47 (– 0.65 to – 0.30)
– 0.34 (– 0.63 to – 0.06)
– 0.56 (– 0.96 to – 0.16)
– 0.56 (– 0.83 to – 0.28)
Earlier with ERP Earlier with comparator 
– 2 – 1.5 – 1 – 0.5 0 0.5
(e)
FIGURE 5 Forest plots displaying meta-analyses of patient-reported outcomes following colorectal surgery.
(a) Time to resumption of diet; (b) time to passage of first flatus; (c) time to passage of first stool; (d) time to
reach ambulation goals; and (e) time to reach pain reduction of control goals. Lap, laparoscopic surgery group;
open, open surgery group.
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Prehab interventions
Two204,214 of the three prehab interventions began with dedicated pre-intervention information and
education, with Gillis and colleagues214 also including assessments and a booklet to facilitate adherence.
All three prehab interventions incorporated a programme of physiotherapy that included multiple weekly
sessions and a range of aerobic and strength training exercises. Gillis and colleagues214 supplemented
these activities with a review of patient nutrition and subsequent optimisation, visits with a psychologist
that included motivation and training to reduce anxiety, and regular telephone support. Participants in the
study by Carli and colleagues198 also received weekly telephone support and a home visit. Perioperative
care was described only by Gillis and colleagues,214 with all participants receiving the same ERAS protocol.
Comparators in the three studies were a walking and breathing exercise group,198 home-based exercise
advice204 and postoperative rehabilitation,214 precluding meta-analysis.
Effectiveness of prehab interventions at improving clinical outcomes
Report Supplementary Material 5, Table 3, displays clinical outcome data reported in all studies. There
were no statistically significant differences in LOS or complications across the three studies. Only Gillis and
colleagues214 reported re-admissions, which were similar between groups. Meta-analysis was not performed
because the three studies had different comparators.
Effectiveness of prehab interventions at improving patient-reported outcomes
Report Supplementary Material 5, Table 4, displays data for patient-reported outcomes from the studies
trialling prehab interventions to improve recovery following colorectal surgery. A number of outcomes
were related to markers of physical recovery, quality of life and mental health. Participants in the prehab
group in the study by Dronkers and colleagues204 took 5.4 seconds longer to perform the chair rise test
than comparators, associated with a large effect size but wide CIs, leading to uncertainty about the true
effect (d = 0.88, 95% CI 0.22 to 1.54; p < 0.01). Participants in the prehab group also had lower physical
work capacity (d = –0.79, 95% CI –1.44 to –0.14; p < 0.05) and reported greater fatigue (d = 0.70,
95% CI 0.06 to 1.35; p < 0.05) than their comparators; these differences also had large but uncertain
effect sizes. There were no differences between groups on any other outcome across the included studies.
Interventions to improve recovery from lower limb arthroplasty: randomised
controlled trials
Thirteen RCTs trialled interventions intended to improve recovery and/or reduce LOS following lower limb
arthroplasty. Of these, five studies196,234,254,256,261 compared ERP interventions with usual care; five200,221,222,244,269
trialled prehab versus either usual care200,221,222,244 or home exercise;269 two202,267 compared rehab programmes
with usual care and one223 trialled a staff mix intervention versus usual care.
Three studies were conducted in the UK,244,256,269 three were conducted in Denmark,196,234,267 two were
conducted in the USA,223,254 and one was conducted in each of Canada,200 Germany,202 the Netherlands,221
Taiwan222 and Iceland.261
A total of 1686 people commenced trials, with sample sizes ranging from 21221 to 505.223 Procedures
included primary or revision unilateral or total hip or knee arthroplasty. Across the included studies, 58.5%
of participants were female.
Overview: lower limb arthroplasty
This body of evidence is summarised below and in Table 7. Full details of the effectiveness of interventions
in this type of surgery are reported in Enhanced recovery protocol interventions, Prehab interventions,
Rehab interventions and Staff mix interventions.
Evidence was generally of low quality, and not all studies reported data that could contribute to analyses
of effectiveness. Meta-analysis of two studies suggests that ERP interventions were associated with a
reduction in LOS of over 3 days compared with usual care, with neither study reporting evidence of
detriment to patient recovery or well-being. Similarly, meta-analysis of two studies evaluating prehab
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TABLE 7 Summary of studies, intervention components and findings for RCTs evaluating interventions to improve recovery from lower limb arthroplasty
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Borgwardt
2009,196
Denmark
a
50 ERP AEI; OT ANE ANA TEL x ⇦⇨ x(5/5) ⇦⇨(2/2)
Larsen 2008, 234
2008, 2008,233
Denmark
90 ERP AEI; EX;
GOAL; NUT;
OT; SW
AEI PONV EMOB; GOAL;
LAX; OT; ANA;
EON
PT ▲ ⇦⇨ ▲
Reilly 2005,256
UK
41 ERP ANA; EMOB;
EON
AEI; TEL x ⇦⇨(2/2) ▲(1/5)
◁▷(4/5)
Pour 2007,254
USA
100 ERP AEI; PT; OT ANA ANE ANA; DRA;
EMOB; PT
x ⇦⇨ x(9/9) x x(5/5)
Siggeirsdottir
2005,261 Iceland
50 ERP AEI; EX TP EX; PT; OT ▲ Ç ◁▷ ▲(1/2)
x(1/2)
Huang 2012,222
Taiwan
243 Prehab AEI; EX ▲ ⇦⇨(4/4) ◁▷(2/3)
x(1/3)
Williamson
2007,269 UK
181 Prehab EX; PT ◁▷ ◁▷(3/3) ▼(1/2)
◁▷(1/2)
◁▷
Crowe 2003,200
Canada
133 Prehab AEI; OT; PT;
SoW
Pre-hospital
day therapy
△ Ç ▲(2/7)
△(2/7)
◁▷(3/7)
Hoogeboom
2010,221 the
Netherlands
21 Prehab EX Spouse/family
involved in
exercises
x ⇦⇨ ◁▷(6/6) ◁▷
McGregor
2004,244 UK
39 Prehab AEI x ◁▷(2/2) ◁▷(4/4)
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Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
den Hertog
2012,202
Germany
160 Rehab EMOB; MT; PT;
SW
x ⇦⇨ ▲
Vesterby
2017,267
Denmark
73 Rehab PT Tele-medicine
support
x ⇦⇨ ⇦⇨(2/2)
Huddleston
2004,223 USA
505
b
Staff mix SM SM SM x Ç(2/4)
⇦⇨(2/4)
AEI, assessment, education, counselling or information; ANA, analgesia protocol; ANE, anaesthesia protocol; CATH, catheter protocol; CHL, carbohydrate loading; DP, discharge planning; DRA, drain protocol; EMOB, early mobilisation; EON, early
oral nutrition; EX, exercise programme; GOAL, goal-setting; LAX, laxative; MT, motivational talks; NUT, nutrition supplementation or diet management; OT, occupational therapy; PONV, active prevention of nausea and vomiting; PT, physiotherapy;
SM, staff mix; SoW, social worker; TP, thromboprophylaxis.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d > 0.80);▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50 to 0.79);△, standardised mean difference
indicates significant small beneficial effect size (Cohen’s d 0.20 to 0.49);▼, standardised mean difference indicates significant medium detrimental effect size;◁▷, standardised mean difference indicates no significant difference between groups;
Ç, OR indicates significant beneficial effect; ⇦⇨, OR indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], not reported; (x/y), finding for x of y measures (e.g. where
multiple measures per outcome category).
a Patient satisfaction was reported in the study.
b 526 were randomised; 21 from pilot were excluded before starting intervention.
Intervention components are listed when they only appear in the experimental arm of the study. Study quality is indicated by the colour of the border of the study details cell: dark green, ‘moderate’; light blue, ‘weak’.
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suggests that LOS may be reduced by around 2.5 days compared with usual care. There was, however,
insufficient evidence to draw further comparisons between interventions in either category.
Complications were reported in eight studies, with evidence of improvement with interventions in
three.200,223,261
There was not enough evidence to allow the evaluation of the effectiveness of rehab or staff mix
interventions. In general, lack of useable data for clinical outcomes in eight studies precludes a balanced
and critical overview of the evidence.
The prehab intervention evaluated by Crowe and colleagues200 represents the most multidisciplinary
intervention, with patients receiving assessment by an occupational therapist, a physiotherapist, a dietitian
and a social worker, and with nurse input, within a day-therapy programme. This programme contains
both education and physiotherapy components, which is similar to the intervention evaluated by Huang
and colleagues,222 although the latter programme was delivered primarily by a physiotherapist. The
interventions evaluated by Hoogeboom and colleagues221 and Williamson and colleagues269 constituted a
home exercise and a physiotherapy programme, respectively. In the intervention evaluated by McGregor
and colleagues,244 although patients were given the opportunity to practise the exercises they were to
complete postoperatively, there was no separate physiotherapy or exercise training programme. The
effectiveness of prehab in this study may in part be because the comparator group in this study received
only minimal information prior to admission, whereas patients in the comparator groups of other studies
received more comprehensive education packages.221,269 A tentative interpretation based on the limited
data available may be that an intervention requires both an educational and a physiotherapy component
to be effective in reducing LOS. However, the quality of the studies this interpretation is based on was
rated as ‘moderate’222,269 and ‘weak’.200
The four studies199,200,234,261 that provided statistically significant evidence of reduced LOS had different
interventions. Intervention components common to these four interventions were preoperative assessment,
education or information of differing degrees of intensities; and a pre-admission physical component,
either an exercise programme or physiotherapy. However, these components were also present in other
interventions that were ineffective at improving outcomes, suggesting that further evidence is required
before it is possible to examine components that determine improvements in patient recovery following
lower limb arthroplasty.
Enhanced recovery protocol interventions
Components of the ERP interventions and comparators are mapped in Table 8. We used an ERAS-style
intervention component mapping approach, despite absence of ERAS Society guidelines for lower limb
arthroplasties. The following items were present in at least three of the five studies: pre-admission assessment,
education and counselling; preoperative exercises; preoperative assessment by an occupational therapist or
a social worker to identify postoperative needs and/or provision of equipment; minimally invasive surgical
technique; avoidance of patient-controlled analgesia; avoidance of routine opiate analgesia; early mobilisation
protocol; and follow-up support.
Quality assessment
Five studies were rated globally as ‘weak’ and eight were rated globally as ‘moderate’. No study was rated
as ‘strong’ overall. The study by McGregor and colleagues244 was the only one to be rated as ‘weak’ on
three domains: study design, confounders and data collection methods. Only three studies202,223,234 provided
a clear definition of their LOS outcomes.
Effectiveness of enhanced recovery protocol interventions at improving clinical outcomes Report
Supplementary Material 5, Table 5, displays clinical outcome data for each study trialling an ERP intervention
to improve recovery from lower limb arthroplasty. Two studies234,261 provided data from which standardised
mean differences could be calculated. Meta-analysis indicates a reduction in LOS of 3.3 days (SD 0.5 days,
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TABLE 8 Map of components found in interventions and comparators for ERP interventions aiming to improve
recovery from lower limb arthroplasty
Intervention component
Study (first author and year)
Borgwardt
2009196
Larsen
2008234
Pour
2007254
Reilly
2005256
Siggeirsdottir
2005261
Assessment/education/counselling E E E, C E
Avoidance of preoperative fasting
Preoperative carbohydrate treatment
Preoperative exercise E E E
Optimisation of physical condition prior to surgery E E
Discharge planning: prior to admission
Discharge planning after hospital admission
Preoperative OT/SW assessment of PO needs and/or
equipment provision
E E E
Admission on day of surgery E
Pre- or postoperative antibiotic prophylaxis E, C
Anaesthesia protocol: routine use of spinal or epidural
anaesthesia
E, C E, C
Anaesthesia protocol: short-acting, opiate avoidance E E, C
Minimally invasive surgical technique E, C Ea E, C
Wound management protocol E, C
Avoidance of routine urinary catheter E, C
No routine drains E
Avoidance of PCA E, C E E
Avoidance of routine opiate analgesia E E, C E
Early mobilisation protocol E, C E E E
Dedicated post-surgery physiotherapy exercises,
supported by PT
E, C E
Early resumption of oral intake (fluids, nutrition) E E
PONV prophylaxis E
Laxative use E
Thromboembolic prophylaxis E, C E
Goal-setting with patient E
Patient encouraged to be active participant in own care/
disown sick role
E
Provision of equipment/medication on discharge E, C
Follow-up support: contact telephone number, telephone
call, home visit
E E E
Post-discharge exercise regimen and/or PT support E E E
Follow-up outpatient/community clinic visit/referrals E, C
C, comparator group; E, experimental group; OT, occupational therapist; PCA, patient-controlled analgesia; PO, postoperative;
PONV, postoperative nausea and vomiting; PT, physiotherapist; SW, social worker.
a Experimental group divided into those who received small incisions of 7–10 cm and those who received standard
incisions of 11–19 cm.
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range 2.9–3.6 days), with a large effect size (d = –1.26, 95% CI –1.62 to –0.89; p < 0.001) (Figure 6).
In the three studies196,254,256 reporting LOS variance as range data, thereby precluding secondary analysis,
LOS was always shorter in the ERP group. Sensitivity analysis showing the influence of imputed data on LOS
meta-analysis is available in Appendix 4.
Rates of re-admissions and use of additional support were similar between ERP and usual care, where
reported. The odds of experiencing a complication were statistically significantly lower in patients receiving
ERP in the study by Siggeirsdottir and colleagues261 (OR 0.25, 95% CI 0.07 to 0.88). The odds of experiencing
a complication were similar between groups in the study by Reilly and colleagues.256 No other studies
reported complications.
Effectiveness of enhanced recovery protocol interventions at improving patient-reported
outcomes Report Supplementary Material 5, Table 6, displays patient-reported outcome data for each RCT
trialling an ERP intervention to improve recovery from lower limb arthroplasty. Assessments of joint function
before discharge were performed in three studies,196,254,256 although standardised mean differences could not
be calculated for two of these.196,254 Reilly and colleagues256 reported that patients receiving ERP had improved
knee flexion range of motion, with an increase of around 5°. Although this change was associated with a
medium effect size, wide CIs indicate uncertainty about the true effect (d = 0.79, 95% CI 0.16 to 1.43;
p < 0.05). There were no differences between groups for other assessments of knee function in this study.256
Longer-term (up to 6-month follow-up after surgery) assessments of hip and knee function were undertaken
using standardised outcomes such as the Harris Hip Score, Oxford Hip Score, Oxford Knee Score, American
Knee Society Score, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Figure 7
is a forest plot showing standardised mean differences for these outcomes, as presented in the three studies
providing analysable data.234,256,261
Improvements were seen on two measures following ERP interventions, the EuroQol-5 Dimensions (EQ-5D)
quality-of-life measure234 and the Oxford Hip Score,261 both of which were associated with medium effect
sizes but wide CIs (EQ-5D: d = 0.50, 95% CI 0.07 to 0.93, p < 0.05; Oxford Hip Score: d = –0.66, 95% CI
–1.24 to –0.07, p < 0.05). The change in Oxford Hip Scores observed by Siggeirsdottir and colleagues261
was five points, which could be enough to change the classification of hip arthritis severity.
For outcomes with no variance data, there were reports of a benefit with ERP interventions for the number
of patients with lower limb weakness, the number of patients who were well at 3 months and the walking
status of patients at discharge. There was little difference in the ratings of confidence or satisfaction with
care at the end of the study by Borgwardt and colleagues,196 despite median scores for all other outcomes
Note: weights are from random-effects analysis
Overall (I 2 = 0.0%; p = 0.868)
Siggeirsdottir 2005261
Study ID
Larsen 2008234
– 1.26 (– 1.63 to – 0.89)
– 1.22 (– 1.83 to – 0.61)
– 1.28 (– 1.75 to – 0.82)
Cohen’s d (95% CI)
Shorter with ERP Longer with ERP 
– 2 – 1 0
FIGURE 6 Forest plot showing the results of meta-analysis of the effect of ERP vs. usual treatment on LOS
following lower limb arthroplasty.
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appearing favourable for ERP patients. Pour and colleagues254 reported favourable mean scores on a
number of outcomes in ERP patients, including quality of life and markers of recovery; however,
presentation of only range data precluded further analysis.
Prehab interventions
Five RCTs trialled prehab intervention in patients undergoing lower limb arthroplasty (knee,222,269 hip,221,244
and hip or knee200). Pre-admission education was delivered in two studies.222,244 Huang and colleagues222
delivered this in the form of an educational group programme 2–4 weeks prior to admission, supplemented
with an educational booklet. McGregor and colleagues244 delivered a class in which they provided
information about the procedure and rehabilitation process, ensuring that exercises could be performed.
They also made provisions for adapting the home environment if required. In the study by Crowe and
colleagues,200 participants were assessed by an occupational therapist, a physiotherapist or a nurse, and
were assigned tailored strengthening exercises. They also received a home visit to plan environmental
changes, were supported financially or loaned equipment to make adaptations if required, received
dietary/nutrition support and counselling, and were provided with a telephone number for support.
Pre-admission exercise programmes featured in four of the interventions.200,221,222,269 Hoogeboom and
colleagues221 delivered a 3- to 6-week programme of strength and endurance exercises at their physiotherapy
outpatient department, as well as using pedometry to increase general activity and including family in
the programme. Similarly, the patients randomised to the intervention group in the study by Williamson
and colleagues269 underwent a 6-week programme of lower limb strength and balance training. In the
intervention delivered by Huang and colleagues,222 lower limb strength exercises were performed at home,
and a telephone call was made to patients 1 week before surgery to discuss the home exercise programme
and answer any questions. Participants in the study by Crowe and colleagues200 received their individualised
programme of strength and endurance training either in an outpatient physiotherapy clinic or from a
physiotherapist at home. Any patients in the study by Crowe and colleagues200 who required multidisciplinary
prehab, as determined by baseline assessment, attended a day-care hospital. Full details of these interventions
can be found in Report Supplementary Material 3, Table 7.
Two of the studies were rated globally as being of ‘moderate’ quality,222,269 and three were rated as
‘weak’.200,221,244 Only the study by McGregor and colleagues244 was rated as ‘weak’ in three domains
(study design, confounders and data collection methods). None of the studies described clearly how LOS
was defined.
Larsen 2008234 (EQ-5D)
Reilly 2005256 (Oxford Knee Assessment)
Reilly 2005256 (AKSS objective)
Reilly 2005256 (AKSS functional)
Siggeirsdottir 2005261 (Oxford Hip Score)
Study ID
0.45 (0.03 to 0.88)
0.27 (– 0.35 to 0.88)
– 0.07 (– 0.68 to 0.54)
0.07 (– 0.54 to 0.68)
– 0.66 (– 1.24 to – 0.07)
Cohen’s d (95% CI)
Lesser value with ERP Greater value with ERP 
– 2 – 1 0 1 2
FIGURE 7 Forest plot (without pooled effects) displaying standardised mean differences for quality-of-life
outcomes related to lower limb arthroplasty. AKSS, American Knee Society Score; EQ-5D, EuroQol-5 Dimensions.
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Effectiveness of prehab interventions at improving clinical outcomes
The results for clinical outcomes are shown in Report Supplementary Material 5, Table 7. Meta-analysis
of two studies in which effect sizes were calculable200,222 indicates that LOS was around 2.5 days shorter
with prehab, associated with a medium effect size (d = –0.55, 95% CI –0.77 to –0.28; p < 0.001; Figure 8).
Median LOS was 6 days in both groups in the study by Hoogeboom and colleagues221 and mean LOS
was 3 days shorter in the prehab group in the study by McGregor and colleagues,244 although it was not
possible to calculate effect sizes for these two studies. In the study by Williamson and colleagues,269 LOS
was similar for both groups of patients. Sensitivity analysis showing the influence of imputed data on LOS
meta-analysis is available in Appendix 4.
No data were provided for use of additional care, morbidity, mortality or re-admissions. The odds of
experiencing complications was statistically significantly lower in the study by Crowe and colleagues,200
with odds 75% lower in the prehab group (OR 0.25, 95% CI 0.10 to 0.64). Complications were also
reported in the studies by Hoogeboom and colleagues221 and Huang and colleagues,222 but did not differ
statistically between groups. Williamson and colleagues269 reported three complications but did not identify
the study group in which these occurred.
Effectiveness of prehab interventions at improving patient-reported outcomes
Report Supplementary Material 5, Table 8, displays results for patient-reported outcomes from RCTs
evaluating prehab interventions to improve recovery from lower limb arthroplasty. Crowe and colleagues200
reported that patients randomised to prehab achieved the following discharge criteria sooner than
controls: able to get out of bed independently (d = –0.36, 95% CI –0.71 to –0.02; p < 0.05); getting all
equipment ready for discharge (d = –0.85, 95% CI –1.20 to –0.49; p < 0.001); having meals planned for
discharge (d = –1.32, 95% CI –1.69 to –0.94; p < 0.001); and having all discharge criteria met (d = –0.43,
95% CI –0.77 to –0.08; p < 0.05).
Anxiety was significantly greater in the prehab group in the study by Williamson and colleagues;269 this
change was associated with a medium effect size (d = 0.52, 95% CI 0.21 to 0.94; p < 0.01), although
scores for both groups were in the ‘normal’ range.273 Figure 9 is a forest plot displaying standardised mean
differences (Cohen’s d) after prehab for a variety of outcomes relating to functional recovery after surgery,
quality of life, pain and mental health across included studies.
Rehab interventions
Two studies202,267 were RCTs of rehab interventions in patients undergoing lower limb arthroplasty. In the
study by den Hertog and colleagues,202 patients in the rehab arm received specialist care in a three-bed
care unit, where they were given motivational messages and urged to ‘compete’ with others to meet
Note: weights are from random-effects analysis
Overall (I 2 = 24.4%; p = 0.250)
Study ID
Crowe 2003200 (total LOS)
Huang 2012222 (LOS)
– 0.53 (– 0.77 to – 0.28)
Cohen’s d (95% CI)
– 0.37 (– 0.72 to – 0.03)
– 0.63 (– 0.88 to – 0.37)
Shorter with prehab Shorter with usual care 
– 1 – 0.5 0
FIGURE 8 Forest plot showing the results of meta-analysis of the effect of prehab interventions vs. usual treatment
on LOS following lower limb arthroplasty.
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recovery goals. There was a target discharge day of postoperative day 6. Daily mobilisation goals were set,
and 2 hours of physiotherapy were delivered each day in a living room environment. The participants in the
intervention arm of the study by Vesterby and colleagues267 received a home visit from a physiotherapist
3 days after their operation, with a video conference 2 and 6 days after the operation. The main component
of the intervention was a telemedicine rehabilitation programme, working through a box connected to a
television, with interactive comprehensive information about osteoarthritis and guidance on completing
exercises and using supplementary aids. Full details of interventions can be found in Report Supplementary
Material 3, Table 8.
Effectiveness of rehab interventions
Report Supplementary Material 5, Table 9, displays the results for all outcomes reported in the two rehab
intervention studies. Standardised mean differences were not calculable because of the absence of variance
data or imputable variance data. However, mean LOS was reported to be 6.5 days shorter in patients
receiving rehab intervention in the study by den Hertog and colleagues,202 whereas median LOS was 1 day
shorter in the experimental group in the study by Vesterby and colleagues.267 The number of procedure-
related complications was similar in both groups in the study by den Hertog and colleagues.202
Note: weights are from random-effects analysis.
Function
Crowe 2003200 (independently get out of bed)
Crowe 2003200 (joint flexion)
Crowe 2003200 (walk 30 m)
Crowe 2003200 (climb stairs)
Hoogeboom 2010221 (6MWT)
Hoogeboom 2010221 (Timed Up and Go Test)
Hoogeboom 2010221 (chair rise time)
Hoogeboom 2010221 (PWC-170 ergometer test)
Hoogeboom 2010221 (HGS raw score)
Hoogeboom 2010221 (HGS 2s mean score)
Huang 2012222 (knee range of motion)
Williamson 2007269 (time to walk 50 m)
Quality of life
Hoogeboom 2010221 (LAPAQ)
McGregor 2004244 (WOMAC pain)
McGregor 2004244 (WOMAC stiffness)
McGregor 2004244 (WOMAC function)
McGregor 2004244 (Harris Hip Score)
McGregor 2004244 (Barthel ADL)
Williamson 2007269 (Oxford Knee Score)
Williamson 2007269 (WOMAC)
Pain
Huang 2012222 (knee pain VAS)
McGregor 2004244 (pain VAS)
Williamson 2007269 (pain VAS)
Mental health
Williamson 2007269 (HADS anxiety)
Williamson 2007269 (HADS depression)
Study ID
– 0.36 (– 0.71 to – 0.02)
– 0.31 (– 0.65 to 0.03)
– 0.22 (– 0.56 to 0.12)
– 0.12 (– 0.46 to 0.23)
0.16 (– 0.72 to 1.03)
– 0.45 (– 1.34 to 0.43)
– 0.41 (– 1.30 to 0.48)
– 0.25 (– 1.13 to 0.63)
– 0.29 (– 1.18 to 0.59)
– 0.45 (– 1.34 to 0.44)
0.00 (– 0.25 to 0.25)
0.27 (– 0.09 to 0.62)
0.00 (– 0.88 to 0.88)
– 0.03 (– 0.66 to 0.60)
0.13 (– 0.50 to 0.76)
– 0.47 (– 1.11 to 0.17)
0.16 (– 0.47 to 0.78)
0.15 (– 0.48 to 0.78)
0.18 (– 0.17 to 0.54)
0.08 (– 0.28 to 0.44)
0.08 (– 0.17 to 0.33)
0.11 (– 0.52 to 0.74)
– 0.04 (– 0.39 to 0.32)
0.58 (0.21 to 0.94)
– 0.11 (– 0.47 to 0.25)
Cohen’s d (95% CI)
Score reduced with prehab Score increased with prehab 
– 2 – 1 0 1 2
FIGURE 9 Forest plot (without pooled effects) displaying effect sizes (Cohen’s d) and 95% CIs for function,
quality of life, pain and mental health outcomes from studies trialling prehab outcomes. 6MWT, Six-Minute Walk
Test; ADL, Activities of Daily Living; HADS, Hospital Anxiety and Depression Scale; HGS, hand grip strength;
LAPAQ, Longitudinal Ageing Study Amsterdam Physical Activity Questionnaire; PWC, physical work capacity;
VAS, visual analogue scale.
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Den Hertog and colleagues202 reported lower scores on the WOMAC measure, with a large effect size
(d = –1.52 95% CI –1.89 to –1.14; p < 0.001 – per-protocol analysis). Numbers of unplanned patient
telephone calls, hospital visits and re-admissions were similar in both groups in the study by Vesterby and
colleagues.267 Meta-analysis was not possible.
Staff-mix interventions
One study223 trialled a staff mix intervention. The intervention was a hospitalist-orthopaedic team using
co-management care. The team comprised hospitalist faculty (no residents) and consultative medical
specialty teams (faculty and resident) with a mean length of postgraduate clinical experience of > 6 years.
Hospitalists provided postoperative medical care after the surgical team completed initial postoperative
orders. In the control group, these duties were undertaken by the regular orthopaedic team. The study
was of ‘moderate’ quality overall, offering a clear definition of LOS and rated as ‘weak’ only for data
collection methods.223
Huddleston and colleagues223 collected data on LOS and complications in 469 patients; however, no
estimates of variance were reported, precluding the calculation of standardised mean differences. Data are
reported in Report Supplementary Material 5, Table 10. LOS was similar between trial arms. The odds of
patients experiencing complications was 38% lower in patients in the staff mix intervention (OR 0.62,
95% CI 0.43 to 0.89; p < 0.05). This difference can be largely attributed to the 46% lower odds of minor
complications in the intervention group (OR 0.54, 95% CI 0.37 to 0.8; p < 0.01).
Interventions to improve recovery from cardiac surgery: randomised controlled trials
Six RCTs trialled interventions to improve recovery following cardiac surgery. Four compared prehab
interventions with usual care193,210,215,258 and there were single studies examining the effectiveness of a
specialist ward255 and rehab.266 The evidence came from the UK,210,215 Canada,193 Germany,255 Australia258
and the Netherlands.266
A total of 1267 people commenced trials, with sample sizes ranging from 117258 to 309.266 In all studies,
patients were scheduled for coronary artery bypass graft (CABG) surgery, plus in two studies valve surgery
or combined CABG and valve surgery was also undertaken.255,258 Across the included studies, the sample
was 21.6% female and 63.7 years old (where mean age was reported).
Quality assessment
One study achieved a global rating of ‘strong’,193 with no ‘weak’ domains. Two further studies were rated
as ‘moderate’,215,258 with one weak domain. Goodman and colleagues215 retained < 60% of the recruited
participants, and Rosenfeldt and colleagues258 did not report validity or reliability of their primary outcome
measure. Of the studies rated as ‘weak’ overall, two were ‘weak’ for two domains (selection bias and data
collection methods;210 confounders and blinding255) and one was weak in three.266 The study by van der Peijl
and colleagues266 did not adjust for confounding variables, did not comment on the validity or reliability of
their primary outcome, and did not clearly report withdrawals and dropouts. Two of the six studies also
failed to clearly define their LOS outcome.258,266
Overview: cardiac surgery
This body of evidence is summarised below and in Table 9. Full details of the effectiveness of interventions
are described in Prehab interventions and Specialist ward and rehabilitation interventions.
The six RCTs of interventions to improve recovery after elective cardiac surgery in older adults failed to
provide conclusive evidence of benefit. Meta-analysis of the four RCTs trialling prehab interventions
indicated a small reduction in LOS, compared with usual care; however, two of the three studies included
showed no benefit. There were only single studies for rehab and specialist ward interventions. Although
there were statistically significant changes on individual measures of quality of life and risk of complications
in two studies, more evidence is required to determine whether or not multimodal interventions can convey
any benefit in this population.
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TABLE 9 Summary of studies, intervention components and findings for RCTs evaluating interventions to improve recovery from cardiac surgery
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre
hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Arthur
2000,193
Canada
249 Prehab AEI; EX;
REF; TEL
▲(2/2) ◁▷ △
Goodman
2008,215 UK
188 Prehab AEI; MT ◁▷
Rosenfeldt
2011,258
Australia
117 Prehab AEI; EX;
REF; OT;
PSYC
x ◁▷ ◁▷
Furze 2009,210
UK
204 Prehab AEI; EX;
GOAL; REF;
TEL; PSYC
◁▷ ⇦⇨ ⇦⇨ ⇦⇨ x x ⇦⇨
Probst
2014,255
Germany
200 SW PreM ANE; ANA;
WARM
ANA; SW ◁▷ Ç ⇦⇨
van der Peijl
2004,266 the
Netherlands
309 Rehab PT; EX Programme
frequency:
2 × day
x ◁▷(4/4)
AEI, assessment, education, counselling or information; ANA, analgesia protocol; ANE, anaesthesia protocol; EX, exercise programme; GOAL, goal-setting; MT, motivational talks; OT, occupational therapy; PreM, pre-medication protocol;
PSYC, psychological support; PT, physiotherapy; REF, referrals; SW, specialist ward; TEL, telephone support; WARM, intraoperative warming protocol.
▲, standardised mean difference indicates significant medium beneficial effect size;△, standardised mean difference indicates significant small beneficial effect size;◁▷, standardised mean difference indicates no significant difference between
groups; Ç, OR indicates significant beneficial effect; ⇦⇨, OR indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], Not reported; (x/y), finding for x of y measures
(e.g. where multiple measures per outcome category).
Intervention components are listed where they appear in only the experimental arm of the study. Study quality is indicated by the colour of the border of the study details cell: light green, ‘strong’; dark green, ‘moderate’; light blue, ‘weak’.
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The only study to indicate a statistically significant reduction in LOS with prehab was conducted by Arthur and
colleagues.193 This Canadian RCT was of ‘strong’ quality with a fairly large sample size (n = 249), and, as such,
is the most robust study in the group, although also the oldest. The authors also observed a statistically
significant improvement in physical quality of life.193 The three other prehab programmes210,215,258 had no
statistically significant impact on LOS, but did not result in any adverse effects on rates of readmission, use of
additional care210 or quality of life.258
The intervention evaluated by Arthur and colleagues193 was the only one of the four prehab studies to
include both an education component and supervised outpatient exercise training as part of its intervention.
It was also the only intervention to involve spouses and family members, by informing them of what to
expect when they saw the patient after surgery.
Goal-setting with the aim of increasing activity level was incorporated within the education delivered as
part of the ‘HeartOp Programme’ evaluated by Furze and colleagues.210 The studies by both Arthur and
colleagues193 and Furze and colleagues210 incorporated telephone follow-up by nurses at regular intervals
prior to surgery, which may also have contributed towards improved outcomes.
Perhaps the combination of individual supervision, regular telephone calls and involvement of family members
helped motivate patients to engage with the prehab programme in the study by Arthur and colleagues.193
The other study to integrate face-to-face education and regular patient contact (via motivational interviewing
delivered monthly) did not reduce LOS.215 The absence of ongoing support and/or supervision within this
intervention may limit its effectiveness, or motivational interviewing may not be as effective as being
motivated by family members.
Prehab interventions
The interventions trialled in the studies by Arthur and colleagues193 and Furze and colleagues210 included
extensive preoperative information, education and counselling. Arthur and colleagues193 followed this
with individual exercise prescriptions for supervised 90-minute sessions, twice per week in the lead-up to
surgery. In the study by Furze and colleagues,210 participants in the prehab arm also received relaxation
therapy to reduce stress and advice on postoperative self-management. In the study by Rosenfeldt and
colleagues,258 participants in the intervention group received aerobic exercise physiotherapy, aiming to
reach four 30-minute sessions per week. Participants also received relaxation therapy from an occupational
therapist. The intervention in the study by Goodman and colleagues215 was a series of monthly visits from a
cardiac home-care nurse in order to reduce cardiac risks, establish lifestyle changes, provide education and
answer questions.
Effectiveness of prehab interventions at improving clinical outcomes
Report Supplementary Material 5, Table 10, displays data for clinical outcomes for each study trialling a
prehab intervention. Meta-analysis of the effects of prehab on LOS yielded evidence of a small reduction in
LOS with prehab interventions (d = –0.35, 95% CI –0.68 to –0.02; p < 0.05) (Figure 10). In absolute terms,
LOS was reduced by a mean of 0.7 days (SD 0.3 days, range 0.5–1 days); however, CIs for the pooled
effect approach zero, indicating inconsistency across outcomes. Prehab was associated with a reduction
in LOS in the study by Arthur and colleagues193 (d = –0.67, 95% CI –0.92 to –0.41; p < 0.001), but not
in any of the other studies. The main influence on LOS in this study came from the time spent in hospital
after surgery, which was an average of 1 day shorter in the prehab group. Sensitivity analysis showing the
influence of imputed data on LOS meta-analysis is available in Appendix 4.
Furze and colleagues210 provided information about the use of additional GP and NHS hospital visits in
the eight weeks after discharge, with results being similar between groups. Rosenfeldt and colleagues258
reported that median LOS was the same (6 days) in both groups. Only Furze and colleagues210 reported
complications or mortality, both of which were similar in both groups.
RESULTS
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Effectiveness of prehab interventions at improving patient-reported outcomes
Report Supplementary Material 5, Table 11, displays data for patient-reported outcomes for each study
trialling a prehab intervention. The Short Form questionnaire-36 items (SF-36) was utilised by Arthur and
colleagues193 and Rosenfeldt and colleagues.258 Arthur and colleagues193 presented change scores from
baseline on various subscales of the SF-36, with significantly greater changes (indicating improvement)
in the prehab group than in the usual care group on the physical functioning subscale and the physical
composite summary scales; both changes were associated with small effect sizes. There was no statistically
significant difference in the change from baseline between groups for any other subscale of the SF-36.
In the study by Rosenfeldt and colleagues,258 participants in both groups scored similarly on both physical
and mental composite scores. Furze and colleagues210 calculated QALYs as a measure of health-related
quality of life and mortality, but, as they evaluated these prior to surgery, we have not reported them here.
Goodman and colleagues215 collected data for mental health outcomes but did not report numerical data.
The effects for quality-of-life outcomes are displayed in Figure 11.
Specialist ward and rehabilitation interventions
Specialist ward and rehabilitation interventions were trialled in one RCT each. The specialist ward in the
study by Probst and colleagues255 was a three-bed post-anaesthetic care unit, a patient-to-staff ratio of
1 : 3, limited opening times, strict analgesia regime with pain monitoring, extubation as soon as ready and
discharge into a step-down unit. This was compared with the larger conventional unit with 21 beds, where
the physician to patient ratio was 12 : 1, staff were less specialised, opening hours were longer, analgesia
was liberal, and extubation and discharge were typically delayed.
Note: weights are from random-effects analysis
Overall (I 2 = 76.6%; p = 0.014)
Study ID
Arthur 2000193
Goodman 2008215
Furze 2009210
– 0.35 (– 0.68 to – 0.02)
– 0.67 (– 0.92 to – 0.41)
– 0.21 (– 0.50 to 0.08)
Cohen’s d (95% CI)
– 0.16 (– 0.43 to 0.12)
Shorter with prehab Shorter with usual care 
– 1 – 0.5 0 0.5
FIGURE 10 Forest plot showing the results of meta-analysis of the effect of prehab interventions vs. usual
treatment on LOS following cardiac surgery.
Arthur 2000193 (SF-36 physical composite score)
Arthur 2000193 (SF-36 mental composite score)
Rosenfeldt 2011258 (SF-36 physical composite score)
Rosenfeldt 2011258 (SF-36 mental composite score)
Study ID
0.39 (0.13 to 0.66)
– 0.14 (– 0.41 to 0.12)
0.13 (– 0.23 to 0.49)
0.23 (– 0.13 to 0.60)
Cohen’s d (95% CI)
Shorter with ERP Longer with ERP 
– 0.5 0 0.5 1
FIGURE 11 Forest plot (without pooled effects) displaying the effects of prehab on quality-of-life outcomes in
patients receiving cardiac surgery.
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In the study by van der Peijl and colleagues,266 patients were randomised to high- or low-frequency
rehabilitation. In the high-frequency intervention, patients began a progressive exercise programme
targeting flexibility, strength, co-ordination, walking and stair climbing. Exercises began the day after
surgery and continued at weekends. In the comparator group, exercises were not supervised and were
interrupted by the weekend.
The results of these two studies are displayed in Report Supplementary Material 5, Table 12. Despite
reduced time in the treatment unit and intermediate care in the intervention group, total LOS was similar
in both groups in the study by Probst and colleagues.255 However, the odds of incurring a complication
were statistically significantly lower, by 79%, in the patients randomised to the specialist ward (OR 0.21,
95% CI 0.10 to 0.41).
Median LOS was the same in both groups in the rehabilitation trial by van der Peijl and colleagues,266 and all
outcomes related to physical activity and functional independence after surgery were similar between groups.
Interventions to improve recovery from upper abdominal surgery: randomised
controlled trials
There were five RCTs199,205,226,227,264 of interventions to improve recovery and/or reduce LOS following upper
abdominal surgery. Procedures in these studies were liver resection,205,226 hepatectomy or pancreatectomy,227
pancreaticoduodenectomy199 and gastric cancer surgery.199,264 Two studies were conducted in the UK,205,226
one was conducted in Taiwan,199 one was conducted in Japan264 and one was conducted in Greece.227
Four of the studies199,226,227,264 evaluated ERP interventions and one205 evaluated prehab. In all cases, the
comparator was standard care. Across the five studies, there were 485 participants, of whom approximately
42% were female. In the study by Chen and colleagues,199 participants were undergoing different abdominal
surgeries. The results for those receiving gastrectomy and pancreaticoduodenectomy were treated as separate
analyses, both compared with groups of patients receiving usual care for the same procure.
Quality assessment
Three of the studies were rated as ‘moderate’ overall199,227,264 and two were rated as ‘weak’.205,226 The
studies rated as ‘weak’ overall scored the lowest rating across two domains. The study by Dunne and
colleagues205 was rated as ‘weak’ for data collection methods and selection bias. Selection bias was rated
as ‘weak’ owing to the large number of dropouts.226 Jones and colleagues226 did not control for important
between-group differences. Three studies226,227,264 provided a clear definition of LOS.
Overview: upper abdominal surgery
The evidence for upper abdominal surgery is summarised here and in Table 10. Full details of the effectiveness
of interventions can be found in Enhanced recovery protocol interventions and Prehab interventions.
Meta-analysis of the four RCTs trialling ERP interventions aiming to improve recovery after upper abdominal
surgery suggests that LOS can be reduced by around 5 days with ERP compared with usual care. Furthermore,
meta-analysis of these four studies199,226,227,264 indicated that the odds of sustaining complications were lower
with ERP interventions. Individual studies reported markers of recovery that either improved or remained
similar with ERP. There was one trial of a prehab intervention, which led to improvements in some markers
of physical fitness, but not in LOS. The successful interventions were heterogeneous, combining multiple
components, and, as such, it is difficult to further explore reasons for their success.
Enhanced recovery protocol interventions
Components of the ERP interventions and comparators are mapped against ERAS Society guidelines for
liver surgery,274 pancreaticoduodenectomy275 and gastrointestinal surgery253,276–278 in Table 11. The most
commonly occurring items were preoperative counselling (2/4 studies); minimal fasting and carbohydrate
loading preoperatively (2/4); avoidance of long-acting pre-anaesthetic medication (3/4); early oral intake
postoperatively (3/4); early mobilisation (4/4) audit; and feedback (2/4). Usual care in the comparator
arms was identical with respect to bowel preparation, pre-anaesthetic medication, antithrombotic and
RESULTS
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TABLE 10 Summary of studies, intervention components and findings for RCTs evaluating interventions to improve recovery from upper abdominal surgery
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre
hospital
admission Preoperative Perioperative Postoperative Post discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Dunne
2016,205 UK
38 Prehab AEI; EX ◁▷ ⇦⇨ ⇦⇨ ◁▷ ⇦⇨(5/5)
Chen 2017,199
Taiwan
535 ERP FM EON; COMM;
EMOB
Oral and
nutritional
assistance
protocol
▲(2/4) Ç(1/2)
⇦⇨(1/2)
Kapritsou
2017,227
Greece
63 ERP nNGT EMOB ▲ Ç ◁▷(5/5) ◁▷(3/3)
Tanaka
2017,264
Japan
148 ERP CHL; nFAST DRA EON; ANA ▲(2/2) Ç(1/2)
⇦⇨(1/2)
⇦⇨ ▲(1/6)
△(3/6)
◁▷(2/6)
Jones 2013,226
UK
104 ERP AEI; NUT DRA; FM DRA; CATH;
EON; FM; NUT;
ANA
▲ Ç(2/4)
⇦⇨(2/4)
⇦⇨ ⇦⇨ ▲ x
AEI, assessment, education, counselling or information; ANA, analgesia protocol; CATH, catheter protocol; CHL, carbohydrate loading; DRA, drain protocol; EMOB, early mobilisation; EON, early oral nutrition; EX, exercise programme;
NUT, nutrition supplementation or diet management.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d > 0.80);▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50 to 0.79);△, standardised mean difference
indicates significant small beneficial effect size;◁▷, standardised mean difference indicates no significant difference between groups; Ç, OR indicates significant beneficial effect; ⇦⇨, OR indicates no significant difference between groups;
x, data but standardised mean difference or OR could not be calculated; [blank], not reported; (x/y), finding for x of y measures (e.g. where multiple measures per outcome category).
Intervention components are listed where they only appear in the experimental arm of the study. Study quality is indicated by the colour of the border of the study details cell: dark green, ‘moderate’; light blue, ‘weak’.
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TABLE 11 The ERAS components included in ERP (E) and comparator (C) arms in trials examining the effectiveness
of ERP for upper abdominal surgery. Items derive from guidance for liver surgery unless indicated
ERAS item and description
Study (first author and year)
Chen
2017199
Jones
2013226
Kapritsou
2017227
Tanaka
2017264
Preoperative counselling: patients should receive routine dedicated
preoperative counselling and education before liver surgery
E E, C
Preoperative endoscopic biliary drainage should not be undertaken
routinely in patients (PD)
Preoperative smoking and alcohol consumption: abstinence should be
attempted for 1 month prior to surgery (PD)
Preoperative nutrition: routine use not warranted, but significantly
malnourished patients should be optimised (PD)
Perioperative nutrition: patients at risk should receive oral nutritional
supplements for 7 days prior to surgery
Ea
Perioperative oral immunonutrition: limited evidence for use
(immunonutrition for 5–7 days perioperatively should be considered – PD)
Preoperative fasting and preoperative carbohydrates load: preoperative
fasting does not need to exceed 6 hours for solids and 2 hours for liquids.
Carbohydrate loading the evening before surgery and 2 hours before the
induction of anaesthesia
E E
No oral mechanical bowel preparation E, C E, C
Pre-aesthetic medication: long-acting anxiolytic drugs should be avoided.
Short-acting anxiolytics may be used to perform regional analgesia prior to
the induction of anaesthesia
E, C E, C E, C
Antithrombotic prophylaxis E, C
Perioperative steroids administration: steroids (methylprednisolone) may be
used before hepatectomy in normal liver parenchyma
Antimicrobial prophylaxis and skin preparation E, C
Incision: the choice of incision is at the surgeon’s discretion E, C
Minimally invasive approach: laparoscopic liver resections can be performed
by hepatobiliary surgeons experienced in laparoscopic surgery
E,b Cb E, Cc
Avoidance of prophylactic nasogastric intubation E
Nasogastric tubes removed prior to extubation (PD)
Prophylactic abdominal drainage: no recommendation E, Cd
Preventing intraoperative hypothermia E, C
Early oral intake: eat normal food on POD1. Enteral or parenteral feeding
reserved for malnourished patients or those with prolonged fasting due to
complications
E,e C E
Normal diet after surgery without restrictions, beginning carefully and
increasing intake according to tolerance over 3–4 days (PD)
E
Postoperative glycaemic control (diabetic patients)
Avoidance of perianastomotic drains (G) E, C
Urinary drainage: suprapubic catheterisation is superior to transurethral
catheterisation if used for > 4 days (PD)
Prevention of delayed gastric emptying
Stimulation of bowel movement: not indicated E, C
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antimicrobial prophylaxis, and the choice of incision. The intervention in the study by Tanaka and colleagues264
was described as an ERAS intervention by the authors. In the study by Chen and colleagues,199 the intervention
(the Modified Hospital Elder Life Program) integrated relatively few ERAS Society-recommended components,
but featured an additional focus on oral and nutritional assistance, with a postoperative communication
protocol to facilitate orientation.
The two studies evaluating ERP pathways with patients undergoing liver surgery226,227 adhered to a mean
of 10.5 (45.7%) of the 23 relevant ERAS guidelines, while the comparator groups in these studies adhered
to a mean of seven (30.4%) items.
The intervention in the study by Kapritsou and colleagues,227 conducted with patients undergoing
hepatectomy or pancreatectomy, adhered to three (9.7%) of the 31 ERAS guideline items relevant to
individuals undergoing pancreaticoduodenectomy, as did the comparator group.
TABLE 11 The ERAS components included in ERP (E) and comparator (C) arms in trials examining the effectiveness
of ERP for upper abdominal surgery. Items derive from guidance for liver surgery unless indicated (continued )
ERAS item and description
Study (first author and year)
Chen
2017199
Jones
2013226
Kapritsou
2017227
Tanaka
2017264
Stimulation of bowel movement: a multimodal approach with epidural and
near-zero fluid balance is recommended, including oral laxatives and
chewing gum given postoperatively (PD)
Early mobilisation E E, Cf E E, C
Analgesia: routine TEA not recommended in open liver surgery. Wound
infusion catheter or intrathecal opiates can be good alternatives combined
with multimodal analgesia
Pain management: opioid-sparing analgesic strategies, including regional
analgesia techniques, should be implemented in context of a multimodal
analgesic regimen (G)
E
Epidural analgesia: mid-thoracic epidurals are recommended, compared
with intravenous opioids (PD)
Intravenous analgesia: some evidence supports the use of PCA or
intravenous lidocaine analgesic methods (PD)
Multimodal approach to PONV should be used. Patients should receive
PONV prophylaxis with two antiemetic drugs
E, C
g
Fluid management: maintenance of low central venous pressure with close
monitoring. Balanced crystalloid preferred over saline or colloids
E
Fluid management: perioperative haemodynamic management: maintain
fluid homeostasis avoiding fluid excess and organ hypo perfusion (G)
E, C
Audit: systematic audit E E, C
C, present in comparator arm; E, present in experimental arm; G, item from gastric surgery guidelines; PD, item from
pancreaticoduodenectomy guidelines; POD, postoperative day; PONV, postoperative nausea and vomiting; TEA, thoracic
epidural analgesia.
a Consumed for 3 days prior to surgery.
b Laparoscopy used on average 47% of patients.
c Patients from both experimental and control groups had either laparoscopic or open gastrectomy.
d Generally avoided and placed if only deemed necessary by operating surgeon.
e Patients in experimental group received additional supplements.
f Experimental, twice per day; control, once per day.
g Only one antiemetic provided.
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The two studies evaluating ERP pathways with patients undergoing gastrointestinal surgery adhered to a
mean of six (23%) of the 23 ERAS guideline items, with their comparator groups adhering to a mean of
3.5 items (15.2%).199,264
The intervention evaluated in the study by Chen and colleagues,199 conducted with patients undergoing a
mix of pancreaticoduodenectomy and gastric procedures, adhered to five (17.9%) of the 28 relevant ERAS
guideline items. The comparator group adhered to two (7.1%) of the relevant items.199
Effectiveness of enhanced recovery protocol interventions at improving
clinical outcomes
Report Supplementary Material 5, Table 13, displays clinical outcome data for RCTs evaluating ERP
interventions to improve recovery from upper abdominal surgery. Meta-analysis of all trials indicated that
LOS was a mean of 5.1 days shorter in ERP groups (SD 3.2 days, range 1.2–9.5 days), with a large effect
size (d = –1.04, 95% CI –1.55 to –0.53; p < 0.001) (Figure 12). Heterogeneity was high and statistically
significant, with wide CIs reflecting uncertainty in the true effect (I2 = 82.8%; p < 0.001).
Complications were reported in five groups across four studies,199,226,227,264 with meta-analysis finding that
the odds of sustaining complications were 61% lower in patients receiving ERP (OR 0.39, 95% CI 0.24 to
0.64; Figure 13). Although heterogeneity was low and not statistically significant for this effect (I2 = 37.4;
p = 0.17), there was a mix of positive and null findings across the included studies. Re-admission rates
were similar in the two studies that reported this outcome.226,264
Effectiveness of enhanced recovery protocol interventions at improving
patient-reported outcomes
Report Supplementary Material 5, Table 14, displays data for patient-reported outcomes from the studies
trialling an ERP intervention to improve recovery from upper abdominal surgery. The study by Jones and
colleagues226 found that patients in the ERP arm were medically fit for discharge around 4 days sooner
than those receiving standard care, with a very large effect size reported (d = –5.23, 95% CI –6.1 to –4.35;
p < 0.001). A range of markers of recovery was reported by Kapritsou and colleagues,227 including pain,
sadness, optimism and various stress outcomes, but these did not differ between groups. Tanaka and
colleagues264 reported earlier passage of first stool in participants in the ERP group (1 day earlier, d = –0.52,
95% CI –0.85 to –0.18; p < 0.01) but not first flatus. Patients in this study also had greater serum
concentration of protein and transthyretin on day 7 following surgery, and experienced less weight loss
Note: weights are from random-effects analysis
Overall (I 2 = 82.8%; p = 0.000)
Kapritsou 2017227
Chen 2017199 (PD)
Chen 2017199 (gastrectomy)
Jones 2013226
Tanaka 2017264
Study ID
– 1.04 (– 1.55 to – 0.53)
– 1.36 (– 1.91 to – 0.81)
– 0.63 (– 1.22 to – 0.03)
Cohen’s d (95% CI)
– 0.62 (– 1.06 to – 0.19)
– 1.96 (– 2.46 to – 1.46)
– 0.68 (– 1.02 to – 0.34)
Shorter with ERP Shorter with comparator 
– 4 – 2 0
FIGURE 12 Forest plot showing the results of meta-analysis of the effect of ERP vs. usual treatment on LOS
following upper abdominal surgery. PD, pancreaticoduodenectomy.
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than patients in the comparator arm at 1 week (0.9% less, d = 0.58, 95% CI 0.24 to 0.92; p < 0.01) and
1 month (1.6% less, d = 0.51, 95% CI 0.17 to 0.84; p < 0.01) after surgery. There was no opportunity to
perform meta-analysis as outcomes were not similar between studies.
Prehab interventions
One RCT205 trialled a prehab intervention to improve recovery from upper abdominal surgery, with 35
patients included in the study. Patients in the experimental group performed 4 weeks of exercise sessions
tailored to their physical capacity. Outcomes are presented in Report Supplementary Material 5, Table 15.
There was no difference in LOS, complications or re-admissions between the groups. The authors
evaluated markers of physical conditioning for all participants, also performing a subgroup analysis of
‘high-risk’ patients, as evaluated on study entry. Improvements were seen in a number of these outcomes,
associated with large effect sizes, with some benefits also observed in high-risk patients.
Interventions to improve recovery from pelvic surgery, vascular surgery, thoracic
surgery and surgery to remove tumours: randomised controlled trials
Several procedure categories featured in only one or two RCTs. These were interventions to improve recovery
from pelvic,217,225 vascular31,247 and thoracic surgeries,248 as well as a range of surgeries to remove tumours.220
Evidence from these studies is summarised below and in Table 12, with full details of intervention effectiveness
described in Pelvic surgery, Vascular surgery, Thoracic surgery and Surgery to remove a tumour.
Overview: interventions to improve recovery from pelvic surgery, vascular surgery,
thoracic surgery and surgery to remove tumours
Pelvic surgery
The two RCTs trialling interventions to improve recovery after pelvic surgery investigated the effect of
ERPs. Evidence from the two trials was inconclusive regarding the effects of ERP on any of the outcomes
presented. The study by Gralla and colleagues217 demonstrated a statistically significant reduction of LOS
within the intervention group. There were also statistically significant improvements for complications and
markers of recovery in this study. However, the study by Jensen and colleagues,225 which was of higher
quality than the German study, did not report any statistically significant differences between groups for
any outcomes.217 One apparent difference between these studies is that the intervention by Gralla and
colleagues217 contained 12 active components, compared with the five in the intervention in the study by
Jensen and colleagues.225 However, with only two studies available, the RCT evidence for ERP to improve
recovery from pelvic surgery is both limited and inconclusive.
Overall (I 2 = 37.4%; p = 0.172)
Tanaka 2017264 (patients with C–D grade C2 or C3 complications)
Chen 2017,199 PD (delirium incidence)
Kapritsou 2017227 (total complications)
Jones 2013226 (patients with liver complications)
Chen 2017,199 gastrectomy (delirium incidence)
Study ID
0.39 (0.24 to 0.64)
OR (95% CI)
0.35 (0.17 to 0.72)
0.22 (0.04 to 1.22)
0.32 (0.11 to 0.94)
1.43 (0.41 to 4.91)
0.10 (0.01 to 0.87)
Lower odds with ERP Lower odds with usual care 
0.2 0.5 1 2 5
FIGURE 13 Forest plot showing the results of meta-analysis of the effect of ERP interventions vs. usual treatment
on odds of complications following upper abdominal surgery. C-D, Clavien–Dindo; PD, pancreaticoduodenectomy.
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TABLE 12 Summary of studies, intervention components and findings for RCTs evaluating interventions to improve recovery from pelvic surgery, vascular surgery, thoracic
surgery and surgery to remove various tumours
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre
hospital
admission Preoperative Perioperative Postoperative Post discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Pelvic surgery
Jensen
2015,225
Denmark
129* ERP AEI; PT; EX EMOB; EX x ⇦⇨ ⇦⇨ ⇦⇨ x(4/4)
Gralla 2007;217
Magheli
2001,240
Germany^
50 ERP nMBP; nFAST ANE; WARM;
PONV
ANA; DRA;
EON; EMOB;
FM; LAX
AEI ▲ Ç ⇦⇨ ▲
Vascular surgery
Partridge
2017,31 UK
209 PACP AEI FAPP Pre-surgery:
medications
changed and
level of care
required advised.
Post discharge:
longer-term
GP follow-up
x Ç(3/8)
⇦⇨(5/8)
⇦⇨ ⇦⇨(2/2)
Muehling
2008,247
2009,246
2011,49
Germany
82; 101;
101
ERP nMBP; nFAST CATH CATH; EON;
EMOB; ANA
x Ç(2/3)
⇦⇨(1/3)
⇦⇨ ⇦⇨ x(3/3)
Thoracic surgery
Muehling
2008,248
Germany
62 ERP nFAST SURG EON; EMOB;
ANA
x ⇦⇨
Surgery to remove tumours
Hempenius
2013,220
2016,219 the
Netherlands
297; 260
a
PACP AEI Screened for
delirium 3×day
x ⇦⇨(2/2) ⇦⇨ ⇦⇨ ⇦⇨(2/2) È(1/13)
⇦⇨(4/13)
x(9/13)
AEI, assessment, education, counselling or information; ANA, analgesia protocol; ANE, anaesthesia protocol; CATH, catheter protocol; CHL, carbohydrate loading; DRA, drain protocol; EMOB, early mobilisation; EON, early oral nutrition; EX, exercise
programme; LAX, laxative; nFAST, avoidance of prolonged fasting; nMBP, avoidance of mechanical bowel preparation; PACP, preoperative assessment with care plan; PONV, active prevention of nausea and vomiting; PT, physiotherapy;
SURG, surgical approach differs between groups.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d > 0.80);▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50 to 0.79); Ç, OR indicates significant
beneficial effect; ⇦⇨, OR indicates no significant difference between groups; È, OR indicates significant negative effect; x, data but standardised mean difference or OR could not be calculated; [blank], not reported; (x/y), finding for x of y
measures (e.g. where multiple measures per outcome category).
a Sample size reported in individual paper from same study.
*107 received allocated regime. Intervention components are listed where they only appear in the experimental arm.
^Patient satisfaction also reported.
Study quality indicated by the colour of the study details cell: light green, ‘strong’; dark green, ‘moderate’; light blue, ‘weak’.
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Vascular surgery
Two studies evaluated interventions to improve recovery from vascular surgery. In the study by Muehling
and colleagues,247 patients receiving ERP were less likely to experience complications, and there were no
re-admissions or deaths in the study. The study was rated as ‘weak’ and the data presented for LOS
precluded secondary analysis.
Partridge and colleagues31 evaluated a preoperative assessment that informed a care plan. Although the
study was of ‘strong’ quality, and LOS was reported as 2.3 days shorter in the experimental group, a lack
of variance data precluded calculations of effect size or statistical difference. The identification of 58 more
new comorbidities in the experimental group than in the usual care group may have contributed to the
reduced odds of complications and, ultimately, LOS. However, few conclusions about interventions to
improve recovery from vascular surgery can be drawn.
Thoracic surgery
Muehling and colleagues248 evaluated an ERP intervention to improve recovery in patients undergoing
thoracic surgery. The study was of ‘weak’ quality and outcomes either could not be analysed or did not
differ between groups.
Surgery to remove a tumour
One study220 evaluated an intervention to provide supportive care and prevent delirium in patients undergoing
various surgeries to remove a tumour. The study was of ‘moderate’ quality and reported on a wide range of
outcomes other than LOS. Fewer patients could return to their previous living arrangements, which was an
undesirable outcome. No other differences were observed in the study, and LOS could not be analysed.
Interventions to improve recovery from pelvic surgery: randomised controlled trials
There were two RCTs217,225 of ERP interventions to improve recovery following pelvic surgery, reported across
three journal articles. One of the studies took place in Germany217 and one took place in Denmark.225 The
study by Gralla and colleagues217 was reported across two papers, with the publication by Magheli and
colleagues240 focusing on aspects of recovery, while the core paper focused on LOS and complications.217
Patients (n = 179) were admitted for radical cystectomy225 or radical prostatectomy;217 they had a mean age
of 67.8 years and 81% were male.
The study by Jensen and colleagues225 was rated as ‘moderate’ quality overall, scoring as ‘weak’ only for data
collection methods. Across the two papers reporting on the study by Gralla and colleagues,217,240 all domains
were rated as ‘strong’ or ‘moderate’ except for data collection methods. LOS was clearly defined in both studies.
Enhanced recovery protocol interventions
Components of the ERP interventions and comparators are mapped against ERAS Society guidelines for
pelvic surgery272 and radical cystectomy279 in Table 13. Usual care in the study by Jensen and colleagues225
already included a number of fast-track items; the experimental group underwent additional prehabilitation,
rehabilitation and discharge planning in addition to the existing fast-track protocol. In the study by Gralla
and colleagues,217 few ERAS items had been implemented into standard care.
The intervention evaluated by Jensen and colleagues225 adhered to 14 (53.8%) items, the same number as the
comparator group, but with additional exercise components. After excluding the two ERAS items exclusive to
radical cystectomy, the intervention evaluated by Gralla and colleagues217 adhered to 12 out of the 24 (50%)
ERAS items listed in Table 13, and the comparator group adhered to a mean of five (20.8%) items.
Effectiveness of enhanced recovery protocol interventions at improving clinical outcomes
Table 12 displays outcome data for LOS, re-admissions, additional care, mortality, morbidity and complication
where reported in both studies. LOS was reduced by 3.1 days in the study by Gralla and colleagues,217 with
a large effect size (d = –2.90, 95% CI –3.73 to –2.12; p < .001). In the study by Jensen and colleagues,225
median LOS was the same in both groups.
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TABLE 13 Components of included ERP interventions and comparators, mapped against ERAS guidelines for rectal/
pelvic surgery and radical cystectomy
ERAS item
Study (first author and year)
Gralla 2007,217
Magheli 2011240 Jensen 2015225
Preoperative information, education and counselling E, C
Preoperative optimisation E,a C
Preoperative mechanical bowel preparation avoided Eb E,b Cb
Preoperative fasting: clear fluids allowed up to 2 hours and solids
up to 6 hours prior to induction of anaesthesia
Preoperative carbohydrate treatment for patients without diabetes E, C
Pre-anaesthetic medication: avoidance of long-acting sedatives
Prophylaxis against thromboembolism E, C
Antimicrobial prophylaxis and skin preparation E, C E, C
Standard anaesthetic protocol E, C E, C
Epidural analgesia: TEA is superior to systemic opioids. It should be
continued for 72 hours
E E, C
PONV prophylaxis E E, C
Laparoscopic resection recommended for benign disease and rectal
cancer (R/P). Minimally invasive approach not recommended
outside trial setting (RC)
E, C E,c Cc
Nasogastric intubation: nasogastric tubes not routinely used E, C
Nasogastric tubes removed before extubation
Preventing intraoperative hypothermia E, C
Perioperative fluid management: intraoperative fluids guided by
flow measurements to optimise cardiac output (RC)
Perioperative fluid management: judicious use of vasopressors (RC)
Transurethral catheter (R/P) E
Suprapubic catheter (R/P)
Urinary drainage: transurethral catheter removal on POD1 in low
risk patients
Early removal of bladder catheter E, C
Prevention of postoperative ileus: chewing gum (R/P), oral
magnesium, alvimopan
Postoperative laxatives and prokinetics (R/P) E
Early oral intake 4 hours after surgery E E, C
Early mobilisation E E,a C
Audit: all patients should be audited for protocol compliance and
outcomes
E, C
C, present in comparator arm; E, present in experimental arm; POD, postoperative day; PONV, postoperative nausea and
vomiting; RC, radical cystectomy; R/P, items from guidelines for rectal/pelvic elective surgery; TEA, thoracic epidural analgesia.
a Additional exercise programme.
b Enema only.
c Mini-laparotomy or robot-assisted.
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The odds of experiencing a complication was significantly lower in patients receiving ERP in the study by
Gralla and colleagues217 (OR 0.25, 95% CI 0.07 to 0.83), with patients 75% less likely to experience
complications. However, the wide CI indicated that this reduction in odds may have been as low as 17%
or as high as 93%. ERP and usual care patients experienced similar rates of complications in the study by
Jensen and colleagues.225 Re-admission rates were similar between groups in both studies, and 90-day
mortality was similar in the study by Jensen and colleagues.225
Effectiveness of enhanced recovery protocol interventions at improving
patient-reported outcomes
Report Supplementary Material 5, Table 17, displays outcome data for patient-reported outcomes where
these were reported. It was possible to calculate standardised mean difference for only one outcome,
which was time to first deflation/defecation in the study by Gralla and colleagues.217 This occurred 0.4 days
earlier after ERP than with usual care, associated with a medium effect size (d = –0.61, 95% CI –1.18 to
–0.05; p < 0.05).
Descriptive statistics for patient satisfaction were presented by Gralla and colleagues.217 There were similar
distributions of scores for both groups for satisfaction with the LOS, while slightly more patients thought
that the perioperative course was better than expected in the ERP group than in the usual care group
(17 vs. 13 patients).217 Jensen and colleagues225 reported postoperative pain scores, suggesting that
patients in the ERP group were in more pain than the patients receiving usual care (16% reporting pain
as 4 or above vs. 7%). After 90 days, the distribution of scores on the Clavien–Dindo scale was broadly
similar between the groups.225
Interventions to improve recovery from vascular surgery: randomised controlled trials
There were two RCTs31,247 of interventions to improve recovery and/or reduce LOS following vascular
surgery. In the German study by Muehling and colleagues,247 82 patients underwent open repair of an
infrarenal aortic aneurysm. We report data from the 2009 paper,246 when full recruitment of 101 patients
had been completed, and the 2011 paper,249 which contains additional outcomes (incidence of organ
failure and development of systemic inflammatory response syndrome). Patients randomised to the
experimental arm received an ERP, primarily consisting of no bowel preparation, reduced preoperative
fasting, patient-controlled epidural analgesia, enhanced postoperative nutrition and early mobilisation.
ERP was compared with usual care.
In the study from the UK by Partridge and colleagues,31 patients were admitted for endovascular/open
aortic aneurysm repair or lower limb arterial bypass surgery. Two hundred and nine participants were
randomised either to a preoperative CGA leading to an optimised care plan or to standard preoperative
assessment. Full details of the interventions trialled in the two vascular surgery studies can be found in
Report Supplementary Material 3, Tables 17 and 18.
The study by Partridge and colleagues31 was rated as ‘strong’ overall, with only one rating of ‘moderate’,
for blinding of assessors and participants. However, a clear definition of LOS was not provided. The study
by Muehling and colleagues,246,247,249 which was reported across three journal articles, achieved a global
rating of ‘weak’. LOS was not clearly defined in any of the three papers reporting on the study.
Effectiveness of interventions
Report Supplementary Material 5, Table 18, displays data for all effectiveness outcomes reported in the
two studies trialling interventions to improve recovery from vascular surgery. In the study by Muehling and
colleagues,246,249 patients receiving ERP were at lower odds of requiring postoperative ventilation (OR 0.11,
95% CI 0.02 to 0.55), experiencing organ failure (OR 0.34, 95% CI 0.13 to 0.88) or developing systemic
inflammatory response syndrome (OR 0.39, 95% CI 0.17 to 0.9). There were no re-admissions or deaths
in the study. For LOS and markers of recovery, the authors presented only medians and ranges, precluding
secondary analysis.
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In the study by Partridge and colleagues,31 LOS was reported as 2.3 days shorter in the experimental group;
however, lack of variance data precluded calculations of effect size or statistical difference. The CGA
identified 58 more new comorbidities than were diagnosed in the group receiving regular preoperative
assessment. Postoperatively, odds of delirium (OR 0.39, 95% CI 0.17 to 0.9), cardiac complications
(OR 0.24, 95% CI 0.02 to 0.58), and bowel and bladder complications (OR 0.4, 95% CI 0.22 to 0.74) were
significantly lower in the experimental group. There were no statistically significant differences in any
other outcomes.
Interventions to improve recovery from thoracic surgery: randomised controlled trials
There was one RCT of an intervention aiming to improve recovery following thoracic surgery.248 The study
compared ERP with traditional care among 59 patients undergoing lung resection. Both the ERP and standard
care pathways featured preoperative information, education and counselling, preoperative warming and
prevention of fluid overload. In addition, patients in the ERP arm received minimal preoperative fasting,
a standardised anaesthetic protocol, early oral intake and early mobilisation. Full details of the intervention
can be found in Report Supplementary Material 3, Table 19.
Publication bias: randomised controlled trials
Figure 14 is a funnel plot of the data for LOS from 30 comparisons from the 26 RCTs that provided data
from which standardised mean differences could be calculated.192,193,198–200,204,205,210,211,214,215,217,222,226,227,234,236,
239,242,243,255,261,264,266,268,269 As the intercept was below zero, this indicates a tendency towards publication of
studies showing beneficial effects of the interventions being evaluated. Studies with more robust data were
clustered more symmetrically than those with less robust estimates (small sample sizes), which may indicate
that there is bias whereby smaller trials with null or negative outcomes are not included in the data.
Although publication bias may be suspected in the first instance, it should be noted that interventions
were often the implementation of evidence-based protocols to improve recovery from surgery and usually
involved additional changes to existing ‘best care’. This may make it unlikely that such interventions would
have an adverse effect on LOS, and a negative intercept value could therefore be expected. However, it
might be expected that, although interventions ought to lead to reductions in LOS, the influence of such
an outcome on risk of complications is less predictable. Therefore, we produced Figure 15, a funnel plot of
the data for 36 summary complications outcomes from the 28 RCTs providing such data.192,198,200,204,205,209,
211,213,214,220,222,223,226,227,231,235,236,239,242,246,247,251,252,255,256,261,264,268 Inspection of this funnel plot indicates a
symmetrical distribution of studies about the intercept, although this is again in favour of a beneficial
effect (lower odds of complications in experimental groups).
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FIGURE 14 Funnel plot to assess publication bias in reporting of LOS across all RCTs. Dotted lines indicate
pseudo-95% CIs. SMD, standardised mean difference (effect size) for each study; SE of SMD, the standard error
of that effect.
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In summary, although there is a possibility of publication bias in the evidence from RCTs evaluating
interventions to reduce LOS in older adults undergoing elective procedures, the context of the evidence
should alleviate concerns that possible unpublished trials with negative results could threaten the
robustness of the evidence.
Synthesis of evidence from the UK
Interventions to improve recovery from colorectal surgery: evidence from the UK
Seven studies192,203,213,230–232,236 trialled interventions intended to improve recovery and/or reduce LOS
following colorectal surgery in the UK, all of which evaluated ERP interventions compared with usual care.
Among these were four RCTs,192,213,231,236 one controlled trial230 and two UBA designs.203,232 A total of
912 people commenced trials, with sample sizes ranging from 25192 to 506.203 Only the UBA studies by
Dhruva Rao and colleagues203 and King and colleagues232 had sample sizes > 100. Participants were
admitted for hemicolectomy (left and right)192 or colorectal resection.203,213,230,231,236 Across the included
studies, approximately half of the participants were female. Sample ages were reported as both medians
and means and these can be seen in Table 2.
Overview: colorectal surgery
The evidence from the UK relating to colorectal surgery is summarised here and in Table 14. Full details of
the effectiveness of interventions can be found in Enhanced recovery protocol interventions.
Seven studies based in the UK evaluated interventions to improve recovery and/or reduce LOS following
colorectal surgery, and all evaluated ERP interventions. The evidence from these studies suggests that ERP
interventions may be associated with shorter LOS, with a mean reduction of 2.4 days across three studies
reporting data conducive to secondary analysis.192,230,236 This occurred alongside a trend for the odds of
experiencing a complication to be lower. Re-admission rates were similar between groups of patients
receiving ERP and usual care, and, although there was a trend for markers of recovery to improve with ERP
interventions, such outcomes were not widely reported.
When reported data precluded calculation of standardised mean differences, studies reported favourable
effects with ERP. As such, the heterogeneity of interventions (i.e. multiple combinations of multiple
components) and homogeneity in results (indicating effectiveness for LOS and little effect on other
outcomes) leads to the conclusion that ERP interventions of the nature described in this section may
reduce LOS without detrimental effect to other outcomes. However, the causative factors bringing about
such an effect are not readily identifiable.
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FIGURE 15 Funnel plot to assess publication bias in reporting of complications across all RCTs. Dotted lines indicate
pseudo-95% CIs. Log(OR), the log of the OR for each study; SE of log(OR), the standard error of that OR.
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TABLE 14 Summary of studies, intervention components and findings for RCTs evaluating interventions to improve recovery from colorectal surgery
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre
hospital
admission Preoperative Perioperative Postoperative Post discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Gatt 2005,213
RCT
39 ERP AEI; PBio nMBP; CHL;
nFAST
ANA; DRA; FM;
nNGT; SURG
EON; EMOB x ⇦⇨ ⇦⇨ ⇦⇨ x ⇦⇨
King 2006,232
UK, UBA
146 ERP NUT SURG; FM;
nNGT; DRA
DP; EON;
EMOB; LAX;
ANA; CATH
x(5/5) ⇦⇨ ⇦⇨ ⇦⇨
Anderson
2003,192 RCT
25 ERP AEI; NUT nMBP; CATH;
CHL; nFAST
ANE; ANA;
nNGT; SURG
EON; EMOB ▲ ⇦⇨ ⇦⇨ x ▲(1/2)
◁▷(1/2)
Dhruva Rao
2015,203
UK, UBA
506 ERP NUT CHL; DP; nFAST ANE; FM; PONV EON; EMOB;
ANA
Pre-
admission
optimisation
x ◁▷(2/2) ◁▷
Khan 2013,229
UK, CT
83 ERP AEI CHL; nFAST ANE; FM; DRA;
SURG
EON; EMOB;
ANA; CATH;
LAX
▲ ⇦⇨ ⇦⇨
Khoo 2007,231
RCT
81 ERP nFAST FM; nNGT EON; EMOB;
ANA; CATH
x(2/2) Ç ⇦⇨ ⇦⇨ x(3/3) ⇦⇨(3/3)
Lidder 2013,236
RCT
57 ERP CHL EON; NUT ◁▷ Ç(1/4)
⇦⇨(3/4)
◁▷
AEI, assessment, education, counselling or information; ANAl, analgesia protocol; ANEl, anaesthesia protocol; AP, antibiotic prophylaxis; CATH, catheter protocol; CHLl, carbohydrate loading; CT, controlled trial; DRA, drain protocol; DP, discharge
planning; EMOB, early mobilisation; EON, early oral nutrition; EX, exercise programme; FM, fluid management protocol; LAX, laxative; nFAST, avoidance of prolonged fasting; nMBP, no mechanical bowel preparation; nNGT, nasogastric tube
protocol; NUT, nutrition supplementation or diet management; Pbio, probiotic/prebiotic; PONV, active prevention of nausea and vomiting; SURG, surgical approach differs between groups.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d > 0.80);▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50 to 0.79);◁▷, standardised mean difference
indicates no significant difference between groups; Ç, OR indicates significant beneficial effect; ⇦⇨, OR indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], not
reported; (x/y), finding for x of y measures (e.g. where multiple measures per outcome category).
Study quality is indicated by the colour of the study details cell: dark green, ‘moderate’; light blue, ‘weak’.
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Enhanced recovery protocol interventions
Components of the ERP interventions and comparators are mapped against ERAS Society
recommendations for colorectal271 and rectal/pelvic surgery272 in Table 15. The full details of both ERP
and prehab interventions can be found in Report Supplementary Material 3, Tables 1–4. In summary, the
most common ERP components were the provision of preoperative information, education and counselling
(5/7 studies); avoidance of lengthy preoperative fasting (5/7); preoperative carbohydrate treatments (6/7);
a standardised anaesthetic protocol (7/7); laparoscopic surgery used where available (5/7); nasogastric
tubes not routinely used (5/7); enteral route for fluids and early discontinuation of intravenous fluids
postoperatively (5/7); thoracic epidural analgesia postoperatively (7/7); early oral intake postoperatively
(7/7); perioperative nutritional care (6/7); and early mobilisation (6/7). The least common components
were avoidance of pre-anaesthetic medication (0/7 studies); prophylaxis against thromboembolism (0/7);
antimicrobial prophylaxis and skin preparation (1/7); prevention of intraoperative hypothermia (1/7);
judicious use of vasopressors (0/7); transurethral (0/7) or suprapubic catheter (0/7) use; prevention of
postoperative ileus with chewing gum, oral magnesium or alvimopan (0/7); and postoperative glucose
control (0/7) (although this item was a specific allowance for diabetic patients, and no such patients were
explicitly reported within the included samples).
TABLE 15 Components of included ERP interventions and comparators, mapped against ERAS Society guidelines
for colonic and pelvic/rectal surgery
ERAS item
Study (first author and year)
Khan
2013229a
Lidder
2013236a
Anderson
2003192
Gatt
2005213
Khoo
2007231
King
2006232
Dhruva
Rao 2015203
Preoperative information, education and
counselling
E E E E, C E, C
Preoperative optimisation E E E
Preoperative mechanical bowel
preparation avoided
E E
Preoperative fasting: clear fluids allowed
up to 2 hours and solids up to 6 hours
prior to induction of anaesthesia
E,b C E Eb E,b Cb E
Preoperative carbohydrate treatment E E E E Ec E
Pre-anaesthetic medication: no routine
long- or short-acting sedatives (colonic);
no advantages to using long-acting
benzodiazepines, short-acting should not
be given to those aged > 60 years (R/P)
Prophylaxis against thromboembolism
Antimicrobial prophylaxis and skin
preparation
E, C
Standard anaesthetic protocol E E, C E E, C E, C E, C E
PONV prophylaxis E E
Laparoscopy and modifications of
surgical access: recommended for
colonic surgery
E, C E,d Cd E, C E,d Cd E,d Cd
Nasogastric intubation: nasogastric tubes
not routinely used
E, C E, C E E E
Nasogastric tubes removed before
extubation
E E E C
Preventing intraoperative hypothermia E, C
continued
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TABLE 15 Components of included ERP interventions and comparators, mapped against ERAS Society guidelines
for colonic and pelvic/rectal surgery (continued )
ERAS item
Study (first author and year)
Khan
2013229a
Lidder
2013236a
Anderson
2003192
Gatt
2005213
Khoo
2007231
King
2006232
Dhruva
Rao 2015203
Perioperative fluid management:
intraoperative fluids guided by flow
measurements to optimise cardiac
output
E, C C E E
Perioperative fluid management:
judicious use of vasopressors
Perioperative fluid management: enteral
route for fluids postoperatively should be
used as early as possible, and intravenous
fluids should be discontinued as soon as
is practicable
E E, C E E E
No drainage of peritoneal cavity after
colonic anastomosis
E E E E
Transurethral catheter (R/P)
Suprapubic catheter (R/P)
Urinary drainage: routine transurethral
bladder drainage for 1–2 days is
recommendede
E E, C E, C
Early removal of bladder catheter E E E
Prevention of postoperative ileus:
mid-thoracic epidural plus laparoscopic
surgery (colonic)
E E,d Cd E Ed
Prevention of postoperative ileus: fluid
overload and nasogastric decompression
avoided
E E E
Prevention of postoperative ileus:
chewing gum (R/P), oral magnesium,
alvimopan
Postoperative laxatives and prokinetics
(R/P)
E E
Postoperative analgesia. Open surgery:
TEA using low-dose local anaesthetic
and opioids; laparoscopic: an alternative
to TEA is a carefully administered spinal
analgesia with a low-dose, long-acting
opioid
E E, C E E E, C E E
Early oral intake E, C E E E E E E
Perioperative nutritional care E E E E E E
Postoperative glucose control
Early mobilisation E E E E E E
C, present in comparator arm; E, present in experimental arm; R/P, items from guidelines for rectal/pelvic elective surgery;
TEA, thoracic epidural analgesia.
a Interventions were described as ‘ERAS’ by study authors.
b 3 hours’ fasting for fluids.
c High-protein/high-calorie drinks.
d Both laparoscopic and open procedures performed.
e Responses relate to mention of bladder catheter or urinary drainage, regardless of site.
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Excluding the item for glucose control, ERP intervention groups adhered to a mean of just below 14 (45.6%)
of the 30 ERAS Society guideline items (range from 11231 to 17232), whereas comparator groups adhered to
just over four items (14.9%, range 1213 to 8236). Interventions ‘branded’ by study authors as ERAS adhered
to a mean of 10 (33.3%) of ERAS Society guideline items, compared with a mean of 13.8 (45.8%) of ERP
interventions not branded as ERAS.
Quality assessment
Studies were rated as either ‘weak’ or ‘moderate’ quality globally. Typically, studies were rated as ‘strong’ for
study design if they were RCTs192,213,231,236 and ‘weak’ if they were not.203,229,232 Studies were commonly rated
as ‘moderate’ for selection bias and blinding and ‘weak’ for data collection. Only two studies192,232 clearly
described how LOS was defined. Three studies192,231,236 were rated as ‘weak’ on three or more domains.
Effectiveness of ERP interventions at improving clinical outcomes Report Supplementary Material 6,
Table 1, displays data for clinical outcomes for each study trialling ERP interventions to improve recovery
from colorectal surgery in the UK. Where it was possible to calculate standardised mean differences for LOS,
LOS was significantly shorter in the studies by Anderson and colleagues192 (d = –1.60, 95% CI –2.54 to
–0.66; p < 0.001) and Khan and colleagues229 (d = –0.65, 95% CI –1.09 to –0.20; p < 0.01) but not in the
study by Lidder and colleagues.236 The mean reduction in LOS across those three studies was 2.4 days
(SD 0.6 days, range 1.9–3.0 days).
In the remaining studies, median LOS was reported as lower with ERP than usual care.203,213,231,232 Re-admissions
were reported in five studies,192,213,229,231,232 and were similar between groups in all.
Complications were reported in seven studies, with results plotted in Figure 16. Although only one study
reported a statistically significant reduction in the odds of complications, the point estimates of all seven
studies were indicative of a trend in favour of ERP.231
Effectiveness of ERP interventions at improving patient-reported outcomes Report Supplementary
Material 6, Table 2, displays data for patient reported outcomes for the studies trialling ERP interventions
to improve recovery from colorectal surgery in the UK. Gastrointestinal function returned statistically
significantly earlier in the ERP group in the study by Anderson and colleagues (d = –1.53, 95% CI –2.43 to
–0.66; p < 0.001), but there was no difference in the time until patients could walk to the toilet unaided,
despite a medium effect size (d = –0.65, 95% CI –1.46 to 0.16; p = 0.08).192 Lidder and colleagues236 found
no difference in the time taken for patients to be medically fit for discharge.
Anderson 2003192 (patients with complications)
Dhruva Rao 2015203 (major complications)
Gatt 2005213 (total complications)
Khan 2013229 (postoperative complications)
Khoo 2007231 (total number of complications)
King 2006232 (number of major complications )
Lidder 2013236 (patients with complications at 30 days)
Study ID
0.48 (0.09 to 2.52)
0.66 (0.29 to 1.50)
0.30 (0.08 to 1.16)
0.71 (0.15 to 3.40)
0.33 (0.12 to 0.89)
0.58 (0.26 to 1.30)
0.59 (0.20 to 1.70)
OR (95% CI)
Lower odds with ERP Lower odds with usual care 
0.2 0.5 1 2 5
FIGURE 16 Forest plot (without pooled effects) showing the results of meta-analysis of the effect of ERP in odds of
complications in patients undergoing elective colorectal surgery in the UK.
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For other outcomes, where between-group statistics could not be calculated, patients in the ERP group
spent longer out of bed on postoperative day 1 in the study by Gatt and colleagues;213 Khoo and
colleagues231 reported earlier median time to tolerating solid diet, achieving independent mobility and
passage of first stool. In the same study, only 3 out of 35 patients in the ERP group felt that they would
have benefited from a longer stay, whereas 24 out of 35 patients receiving usual care would have
preferred a longer stay.
Interventions to improve recovery from lower limb arthroplasty:
evidence from the UK
There were 15 studies reporting across 16 papers evaluating interventions to improve recovery following
lower limb arthroplasty in the UK. Of these, 11 studies206,216,218,224,230,237,238,241,245,256,260,262 compared ERP
interventions with usual care; two trialled prehab versus usual care244 or home exercise;269 one trialled a
7-day rehab programme compared with weekday-only rehab253 and one evaluated a specialist ward versus
previous usual care.195
There were three RCTs,244,256,269 two controlled trials224,253 and 10 UBA studies.195,206,216,218,230,237,238,241,245,262
In the study reported in two papers,224,260 the authors compared outcomes between centres with differing
LOS in Belfast, Liverpool and London. The paper by Hunt and colleagues224 reports most outcomes from
the study, with the paper by Salmon and colleagues260 focusing on patient satisfaction.
A total of 17,023 participants were included, with sample sizes ranging from 39244 to 5319.230 Four studies
had samples of 100–200 patients,206,218,238,269 five had samples of 400 to 1000216,224,245,253,195 and four had
samples of > 1000.230,237,241,262 Procedures were primary or revision unilateral or total hip or knee arthroplasty.
The full details of all interventions can be found in Report Supplementary Material 3, Tables 5–9.
Overview: lower limb arthroplasty
The evidence regarding interventions to improve recovery from lower limb arthroplasty in older adults in
the UK is summarised below and in Table 16. Full details of the effectiveness of interventions are available
in Enhanced recovery protocol interventions, Prehab interventions, Rehab interventions and Specialist ward.
Of the 11 UK studies evaluating the effectiveness of an ERP intervention in older adults undergoing
lower limb arthroplasty, five216,218,237,245,262 provided variance data that allowed for secondary analysis,
all demonstrating reduced LOS with the intervention group on at least one outcome measure. These five
studies indicated that ERP interventions was associated with a reduction in LOS of between 2.4 and 4.3 days
compared with usual care. This change was achieved without detriment to patient recovery or well-being,
as demonstrated by eight studies measuring additional outcomes.206,218,224,230,237,241,256,262 Six studies did not
provide variance data to allow for secondary analysis.206,224,230,238,241,256
There was variation in the magnitude of effect in the two studies by Maempel and colleagues, performed
with patients undergoing knee238 and hip237 replacements. Discharge planning before admission was added
to the intervention in hip replacement patients, although the greater reduction in LOS may be due to the
differences in knee and hip replacement surgeries and their different recovery times.
Evidence for prehab was equivocal, ultimately leading to the conclusion that there was no overall benefit
for either LOS or patient recovery beyond that conveyed by usual care. There were just single studies about
rehab253 and specialist ward195 interventions, preventing conclusions about their effectiveness.
Enhanced recovery protocol interventions
Components of the ERP interventions and comparators are mapped in Table 17. We used an ERAS-style
mapping approach, despite the absence of ERAS Society guidelines for lower limb arthroplasty. The following
items were the most common: pre-admission assessment, education and counselling (10/11 studies);
preoperative assessment by an occupational therapist or a social worker to identify postoperative needs
RESULTS
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TABLE 16 Summary of studies, intervention components and findings for studies evaluating interventions to improve recovery from lower limb arthroplasty in UK hospitals
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Reilly
2005,256 RCT
41 ERP ANA; EMOB;
EON
AEI; TEL x ⇦⇨(2/2) ▲(1/5)
◁▷(4/5)
Dwyer
2012,206 UBA
127 ERP AEI; DP; NUT;
EX; OT; PT
CHL; nFAST;
nPreM
ANE; CATH;
PONV; TP
ANA; DP;
EON; EMOB;
EX; PT; NUT;
GOAL
TEL; FAPP Pre-hospital
admission:
involvement
of a family
member
x ⇦⇨
Gordon
2011,216 UBA
847 ERP AEI; DP; EX;
OT
SW AIE; EMOB;
ANA; SW;
GOAL
TEL; EX △
Gordon
2011,216 UBA
847 ERP AEI; DP; EX;
OT
SW AIE; EMOB;
ANA; SW;
GOAL
TEL; EX Joint
replacement
school. Family
member as
‘coach’. Audio
devices in
theatre. Senior
nurses have
discharge
authority.
Pre-prepared
analgesia
packs at
discharge
△
Harari
2007,218 UBA
108 ERP AEI; DP; OT;
PT; SoW
EMOB; EON;
GOAL
FAPP; REF;
TEL
Geriatrician/
nurse reviewed
patients in
wards plus
provided staff
education
△ Ç(5/6)
⇦⇨(1/6)
⇦⇨ ⇦⇨
Hunt
2009,224
Salmon
2013,260 CT
a
579;
560
ERP OT; PT DA ANA; ANE;
SURG
ANA; EMOB;
PT; SW
TEL Discharge
planned for
POD2. Belfast
site vs.
Liverpool site
x ▲ ◁▷(7/7)
continued
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TABLE 16 Summary of studies, intervention components and findings for studies evaluating interventions to improve recovery from lower limb arthroplasty in UK hospitals
(continued )
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Hunt
2009,224
Salmon
2013,260 CT
a
579;
560
b
ERP OT; PT DA ANA; ANE;
SURG
ANA; EMOB;
PT; SW
TEL Discharge
planned for
POD2. Belfast
site vs. London
site
x △ △(1/7)
◁▷(6/7)
Ç(2/2)
Khan
2014,230 UBA
6000 ERP AEI ANA ANE
FM
CATH T
EMOB
FM
ANA
DP
EX
LAX
TEL x Ç(2/7)
⇦⇨(5/7)
⇦⇨(2/2) ⇦⇨
Maempel
2015,238 UBA
165 ERP AEI; OT AP ANA x ⇦⇨(3/3) ⇦⇨ ⇦⇨(2/2)
x(1/3)
Maempel
2016,237 UBA
1161 ERP AEI; DP; OT AP EMOB; ANA ▲ ⇦⇨ ⇦⇨ ⇦⇨
Malviya
2011,241 UBA
4500 ERP AEI; PreM ANE; FM;
CATH
AEI; EMOB;
MT; ANA
TEL x Ç(1/1) Ç(2/2) ⇦⇨
Mertes
2013,245 UBA
607
c
ERP AEI; DP; PT;
OT
AEI; nFAST;
TP
AP AEI; CATH;
DRA; DP; EON;
EMOB; OT;
REF
FAPP Family
involvement in
education
programme
▲(1/4)
△(1/4)
◁▷(2/4)
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Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Starks
2014,262 UBA
2128 ERP AEI; DP nFAST ANA; ANE;
AP; WARM
EMOB; PT;
ANA
TEL Medical
optimisation
before
admission.
Promotion of
independence
and wellness
postoperatively
Ç(2/4)
x(2/4)
⇦⇨(2/2) ⇦⇨(2/2)
Williamson
2007,269 RCT
181 Prehab EX; PT ◁▷ ◁▷(3/3) ▼(1/2)
◁▷(1/2)
◁▷
McGregor
2004,244 RCT
39 Prehab AEI x ◁▷(2/2) ◁▷(4/4)
Pengas
2015,253 UBA
791 Rehab PT Weekends
included in
programme
◁▷(2/2) △(2/5)
x(3/5)
Barlow
2013,195 UBA
410 SW SW ▲(2/2)
AEI, assessment, education, counselling or information; ANA, analgesia protocol; ANE, anaesthesia protocol; AP, antibiotic prophylaxis; CATH, catheter protocol; CHL, carbohydrate loading; CT, controlled trial; DP, discharge planning; DRA, drain
protocol; EMOB, early mobilisation; EON, early oral nutrition; EX, exercise programme; FAPP, follow-up appointment; GOAL, goal-setting; LAX, laxative; MT, motivational talks; nFAST, avoidance of prolonged fasting; NUT, nutrition supplementation
or diet management; OT, occupational therapy; PONV, active prevention of nausea and vomiting; PreM. pre-medication protocol; PT, physiotherapy; SoW, social worker; SW, specialist ward; TEL, telephone support; TP, thromboprophylaxis;
WARM, avoidance of intraoperative hypothermia.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d > 0.80);▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50–0.79);△, standardised mean difference
indicates significant small beneficial effect size (Cohen’s d 0.20–0.49);▼, standardised mean difference indicates significant medium detrimental effect size;◁▷, standardised mean difference indicates no significant difference between groups;
Ç, OR indicates significant beneficial effect; ⇦⇨, OR indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], not reported; (x/y), finding for x of y measures (e.g. where
multiple measures per outcome category).
a Patient satisfaction was reported in the study.
b Sample size as reported in separate papers.
c 308 reported THA and 299 reported TKA.
Intervention components are listed where they only appear in the experimental arm of the study. Study quality is indicated by the colour of the study details cell: dark green, ‘moderate’; light blue, ‘weak’.
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TABLE 17 Map of components found in interventions and comparators for ERP interventions aiming to improve recovery from lower limb arthroplasty in UK hospitals
Intervention component
Study (first author and year)
Dwyer
2012206
aGordon
2011216
Harari
2007218
Hunt 2009;224
Salmon 2013260
Khan
2014230
Maempel
2015238
Maempel
2016237
Malviya
2011241
Mertes
2013245
Reilly
2005256
Starks
2014262
Assessment/education/counselling E E E E, Cb E E E E E E
Avoidance of preoperative fasting E E E
Preoperative carbohydrate treatment E
Preoperative exercise Ec E E C2d
Optimisation of physical condition prior to surgery E E E
Discharge planning: prior to admission E E E E E
Discharge planning after hospital admission E E
Pre-treatment OT/SW assessment of PO needs and/or
equipment provision
E E E C E E E
Admission on day of surgery E C1, C2 E,C E E E
Pre- or postoperative antibiotic prophylaxis E E E E
Anaesthesia protocol: routine use of spinal or epidural
anaesthesia
E, C E, C E, C2 E E, C E, C E E
Anaesthesia protocol: short-acting, opiate avoidance E E, C E E E, C
Minimally invasive surgical technique E, C
Wound management protocol E E, C E
Avoidance of routine urinary catheter E E
Perioperative fluid management: intraoperative fluids
guided by flow measurements to optimise cardiac output
E, C
Perioperative fluid management: judicious use of
vasopressors
E E
No routine drains E E, C
Maintenance of normothermia E
Avoidance of PCA E C2 E E E E E E E
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Intervention component
Study (first author and year)
Dwyer
2012206
aGordon
2011216
Harari
2007218
Hunt 2009;224
Salmon 2013260
Khan
2014230
Maempel
2015238
Maempel
2016237
Malviya
2011241
Mertes
2013245
Reilly
2005256
Starks
2014262
Avoidance of routine opiate analgesia E E E E E
Early mobilisation protocol E E E E, C1, C2 E E, C E E E E
Dedicated post-surgery physiotherapy exercises,
supported by PT
E E, C1, C2 E E E, C E E
Early resumption of oral intake (fluids, nutrition) E E E E
PONV prophylaxis E
Laxative use E
Thromboembolic prophylaxis E E, C1, C2 E E, C E, C
Goal-setting with patient E E E
Patient encouraged to be active participant in own care/
disown sick role
E E E E E
Provision of equipment/medication on discharge E E E E, C
Follow-up support: contact telephone number, telephone
call, home visit
E E E E, C2 E E E E
Post-discharge exercise regimen and/or PT support E E
Follow-up outpatient/community clinic visit/referrals E E E, C1, C2 E E
C, comparator group; C1, comparator group 1; C2, comparator group 2; E, experimental group; OT, occupational therapist; PCA, patient-controlled analgesia; PONV, postoperative nausea
and vomiting; PT, physiotherapist; SW, social worker.
a Detail provided for full protocol and joint replacement school.
b Assessment only.
c Patients attended preoperative class led by physiotherapist and OT.
d Routine home visit by physiotherapist prior to hospital admission.
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and/or provision of equipment (7/11); routine use of spinal or epidural anaesthesia (8/11); avoidance of
patient-controlled analgesia (9/11); early mobilisation protocol (10/11); dedicated post-surgery physiotherapy,
supported by a physiotherapist (PT) (7/11); and follow-up support (8/11).
In the study by Gordon and colleagues,216 two experimental groups were compared with a historical cohort
receiving standard care. One experimental group received an ERP and one group received this ERP as well as
attending ‘joint recovery school’, where patients received multimodal education about all aspects of care
and recovery.
Quality assessment
Two studies256,269 achieved a global rating of ‘moderate’ and the rest were rated as ‘weak’. The studies
rated as ‘moderate’ achieved ‘strong’ ratings for study design and confounders. In addition, the study by
Reilly and colleagues256 scored ‘strong’ for reporting of withdrawals and dropouts, and the study by
Williamson and colleagues269 was rated as ‘strong’ for data collection methods.
All of the ‘weak’ studies were given domain ratings of ‘weak’ for study design and data collection
methods. Six studies were rated as ‘weak’ for confounders.230,237,241,245,253 Only four studies195,206,224,237
offered a clear definition of LOS.
Effectiveness of enhanced recovery protocol interventions at improving clinical outcomes Report
Supplementary Material 6, Table 3, displays data for clinical outcomes for each study trialling an ERP
intervention to improve recovery from lower limb arthroplasty in a UK hospital. The forest plot in Figure 17
shows standardised mean differences in LOS between ERP and usual care in studies from which these data
could be calculated.216,218,237,245,256 In the seven groups from these five studies, LOS was reduced with ERP
by a mean of 2.4 days (SD 1.2 days, range 0.8–4.3 days). Effect sizes were small in five groups,216,218,245
and large in two (–1.35 and –3.0).237,256 Re-admissions were recorded in six studies,206,218,230,241,256,262 with
no statistically significant difference in the odds of re-admission with ERP or usual care for any of the
individual studies (Figure 18).
In the study by Gordon and colleagues,216 attendance at the joint replacement school, in addition to ERP,
seemed to have greater benefit in hip replacement patients than in knee replacement patients. LOS was
reduced by an additional 2.3 days in these knee replacement patients, compared with those who received
ERP only.
Gordon 2011216 (ERP)
Gordon 2011216 (ERP + JRS)
Harari 2007218
Maempel 2016237
Mertes 2013245 (THA)
Mertes 2013245 (TKA)
Study ID
– 0.32 (– 0.49 to – 0.15)
– 0.47 (– 0.64 to – 0.31)
– 0.43 (– 0.81 to – 0.05)
– 1.35 (– 1.47 to – 1.22)
– 0.44 (– 0.67 to – 0.21)
– 0.30 (– 0.53 to – 0.07)
Cohen’s d (95% CI)
– 2 – 1 0 1
Shorter with ERP Shorter with comparator 
FIGURE 17 Forest plot (without pooled effects) showing standardised mean differences in LOS between ERP and
usual care in patients undergoing lower limb arthroplasty in UK hospitals. JRS, joint replacement school; THA, total
hip arthroplasty; TKA, total knee arthroplasty.
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In the study by Harari and colleagues,218 who evaluated the ‘POPS’ intervention (Proactive care of older
people undergoing surgery), LOS was 4.3 days shorter and delayed discharge was 87% less likely in the
intervention group (95% CI 0.06 to 0.31). Medical complications (24% fewer in ERP) and delays while
waiting for occupational therapists and/or equipment (16.7% fewer in ERP) accounted for the majority
of the delays in discharge in the usual care group, with differences between groups being statistically
significant for these reasons for delay.
In the studies where standardised mean differences could not be calculated, LOS was always reported as
shorter with ERP.206,224,230,238,241,262 Dwyer and colleagues206 reported that LOS was a mean of 3 days shorter
with ERP, with comparable numbers of re-admissions in both groups. Patient data were also stratified by
preoperative haemoglobin levels, American Society of Anesthetists scores and body mass index, with
similar reductions in LOS for ERP patients regardless of stratum.
In the large UBA study by Khan and colleagues,230 median LOS was 3 days shorter and there were 0.5%
fewer myocardial infarctions with ERP, but there were no statistically significant differences in any other
outcome compared with the pre-ERP group. Maempel and colleagues conducted separate studies with
knee238 and hip237 replacement patients receiving slightly different ERP packages. The study conducted
with hip replacement patients237 was considerably larger (n = 1161) than the one conducted with knee
replacement patients238 (n = 165). Median LOS was 1 day shorter in the ERP group with knee replacement
patients.238 Rates of dislocation and death in the year following surgery did not differ between groups in
the same study.238 In the 2016 study with hip replacement patients, LOS was 2 days shorter in ERP
patients, associated with a large effect size (d = –1.35, 95% CI –1.47 to –1.22; p < 0.001), with no
differences between groups for other outcomes.237
In the large study by Malviya and colleagues,241 mean LOS was 3.7 days shorter in the ERP group, and
re-admission rates were similar between groups. Odds of death within both 30 and 90 days of surgery were
statistically significantly lower in the ERP group (30 days: OR 0.13, 95% CI 0.02 to 1.01; 90 days: OR 0.24,
95% CI 0.07 to 0.79). However, wide CIs indicate that the odds of death within 30 days was between
98% lower and 1% greater in the ERP group, indicating great uncertainty about the true outcome.241
Starks and colleagues262 reported mean LOS without variance data, with shorter LOS with ERP in both
hip and knee procedures, as well as when considering a subgroup analysis of patients aged > 85 years.
The odds of patients experiencing a ‘long LOS’ [defined as those who stayed beyond the national upper
Dwyer 2012206
Harari 2007218
Khan 2014230
Malviya 2011241
Reilly 2005256
Starks 2014262
Starks 2014262 (> 85 years subgroup)
Study ID
0.77 (0.20 to 3.02)
1.00 (0.14 to 7.38)
0.98 (0.76 to 1.26)
1.03 (0.77 to 1.38)
0.95 (0.06 to 16.29)
0.85 (0.64 to 1.12)
0.86 (0.29 to 2.55)
OR (95% CI)
Lower odds with ERP Lower odds with usual care 
0.2 0.5 1 2 5
FIGURE 18 Forest plot (without pooled effects) showing the relative odds of being re-admitted for patients
receiving ERP or usual care groups when undergoing lower limb arthroplasty in UK hospitals.
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quartile LOS for their strata of procedure (8 days for 2007 data and 7 days for 2008 and 2009 data)] was
reduced with ERP in all patients (OR 0.18, 95% CI 0.15 to 0.23), and within the subgroup analysis of
patients aged > 85 years (OR 0.13, 95% CI 0.07 to 0.25).
Effectiveness of enhanced recovery protocol interventions at improving patient-reported
outcomes Report Supplementary Material 6, Table 4, displays outcome data for patient-reported
outcomes from studies evaluating ERP interventions to improve recovery from lower limb arthroplasty
in UK hospitals. Assessments of physical recovery, quality of life and patient satisfaction were across
the included studies. Where standardised mean differences were calculated, there were no statistically
significant differences between outcomes, except an improvement on the Oxford Hip Score in the study by
Hunt and colleagues224 for patients in the Belfast centre compared with both control sites. These differences
were a mean of 5.1 and 3.3 points on a scale of 12–48, with each category separated by 9 points. There
was also a slightly better score on the WOMAC function scale for patients in Belfast than for those in
south-west London (d = 0.23, 95% CI 0.02 to 0.44; p < 0.05). In the study by Reilly and colleagues,256
patients in the ERP group demonstrated improved knee function, with 4.9 degrees’ greater knee flexion
range of motion than patients receiving usual care. This difference was associated with a medium effect
size, although wide CIs indicate the true effect may have ranged from negligible to very large (d = 0.79,
95% CI 0.16 to 1.43; p < 0.05).
Salmon and colleagues260 reported patient satisfaction outcomes from the core study by Hunt and
colleagues.224 More patients in the Belfast centre reported no problems with care than did those in
Liverpool (18.8% more) and south-west London (26.5% more). The number reporting no problems with
recovery was similar in all three centres.
Prehab interventions
Two RCTs evaluated prehab in patients undergoing knee269 and hip arthroplasty.244 Between the two
studies, there were 220 patients with a mean age of 70.9 ± 8.9 years, of whom 54% were female.
The intervention delivered by McGregor and colleagues244 included a pre-admission class at which staff
provided information about the procedure and rehabilitation process and ensured that exercises could be
performed effectively by patients. They also made provisions to adapt the home environment, if required.
The intervention in the study by Williamson and colleagues269 was a 6-week programme of lower limb
strength and balance training. Full descriptions of the interventions are available in Report Supplementary
Material 3, Table 7.
Effectiveness of prehab interventions
Data from all outcomes in the two prehab studies are presented in Report Supplementary Material 6,
Table 5. There was no difference in LOS between prehab and home exercise in the study by Williamson
and colleagues.269 It was not possible to calculate the effect on LOS in the study by McGregor and
colleagues,244 who reported that patients undergoing prehab spent 3 days fewer in hospital than those
receiving usual care.
Measures of mental health, quality of life and markers of recovery were assessed. Anxiety was statistically
significantly greater in the prehab group in the study by Williamson and colleagues,269 associated with a
medium effect size (d = 0.58, 95% CI 0.21 to 0.94; p < 0.001) and a change of 1.8 points on the Hospital
Anxiety and Depression Scale anxiety scale (95% CI 0.65 to 3.03). However, anxiety scores in both groups
were low and well within the normal range (‘normal’ range being 0–7 points273). There were no
differences between groups on any other outcome.
Rehab interventions
One controlled trial evaluated a rehab intervention.253 The intervention was specifically the incorporation of
weekends into the programme, meaning that rehabilitation was uninterrupted and patients could begin without
delay. One hundred patients were recruited, with a mean age of 60.8 years, and 47% of them were female.
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The study was of low quality, assessed as ‘weak’ on all domains except items relating to selection bias and
blinding, for which it received ‘moderate’ scores.
Results are presented in Report Supplementary Material 6, Table 6, with data presented separately for hip
and knee patients. LOS was not significantly different between trial arms. Data for patients undergoing
knee replacement approached statistical significance but with only a small effect size indicated and
a mean difference of less than half a day (d = –0.25, 95% CI –0.51 to 0.0; p = 0.054). In both knee and
hip replacement patients, the time to mobilising with two walking sticks was reduced with weekend
physiotherapy, by a mean of half a day, associated with small effect sizes. Group numbers were not
clearly reported for knee and hip functional assessments and therefore no analysis was performed.253
Specialist ward
We identified one UBA study195 evaluating a specialist ward intervention in which a ring-fenced
orthopaedic ward was introduced into the hospital. The ward had stringent access restrictions and
extensive measures to prevent infection or contamination (full details are given in Report Supplementary
Material 3, Table 9). Data from patients admitted to this ward were compared with data from patients
previously treated on a general orthopaedic ward.
The study achieved a ‘strong’ quality assessment rating for confounders and provided a clear definition of
LOS. It was assessed as ‘weak’ for study design and data collection methods and ‘moderate’ for all other
items. It was rated as ‘weak’ overall.
Effectiveness data are reported in Report Supplementary Material 6, Table 7. Patients undergoing total
hip replacements with recovery in the specialist ward stayed a mean of 1.6 days fewer than those in
the standard orthopaedic ward, with a large effect size (d = –1.03, 95% CI –1.32 to –0.74; p < 0.001).
Similarly, those patients undergoing total knee replacements with recovery in the specialist ward stayed a
mean of 2.2 days fewer than those in the standard orthopaedic ward, with a large effect size (d = –1.02,
95% CI –1.31 to –0.73; p < 0.001).
Although this study indicates that LOS may be reduced with a specialist ward, no outcomes were reported
on the wider impact of a shorter stay, for example on complications, recovery or satisfaction with care.
Interventions to improve recovery from cardiac surgery: evidence from the UK
From the UK, we identified two RCTs,210,215 one controlled trial259 and one UBA study208 that evaluated
interventions intended to improve recovery following cardiac surgery. Both of the RCTs compared prehab
interventions with usual care, 210,215 the controlled trial evaluated the effectiveness of a specialist ward
versus usual care259 and the UBA study compared a newly implemented ERP with previous usual care.208
A total of 633 people commenced trials, with sample sizes ranging from 105208 to 204.210 In all studies,
patients were scheduled for at least CABG surgery, with some patients scheduled for valve surgery or
combined CABG and valve surgery. Across the sample, 20.3% of participants were female, and the mean
age was 64.8 ± 6.6 years.
Overview: cardiac surgery
Evidence for interventions to improve recovery after cardiac surgery in the UK is summarised here and
in Table 18. Full details of the effectiveness of interventions are available in Prehab interventions and
Other interventions.
Only four UK-based studies evaluated interventions to improve recovery from cardiac surgery, distributed
across three intervention types. There was no conclusive evidence that any intervention was associated
with reduced LOS, despite some findings approaching statistical significance, including meta-analysis of
two prehab interventions. Few outcomes were reported with regard to markers of recovery, quality of life
or other outcomes not directly related to LOS.
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TABLE 18 Summary of studies, intervention components and findings for studies evaluating interventions to improve recovery from cardiac surgery in the UK
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Goodman
2008,215 RCT
188 Prehab AEI ◁▷
Furze 2009,210
RCT
204 Prehab AEI; EX;
GOAL; REF;
TEL
◁▷ ⇦⇨ ⇦⇨ ⇦⇨ x ▲ ⇦⇨
Salhiyyah
2011,259 CT
136 SW FM SW Extubation
criteria,
cardiovascular
support
available.
Mechanical
ventilation
not provided
◁▷ ⇦⇨
Fleming
2016,208 UBA
105 ERP AEI CHL; nFAST FM; ANA EMOB; LAX ◁▷ Ç(1/7)
x(6/7)
⇦⇨ ▲(3/12)
x(9/12)
AEI, assessment, education, counselling or information; ANA, analgesia protocol; CHL, carbohydrate loading; CT, controlled trial; EMOB, early mobilisation; EX, exercise programme; FM, fluid management protocol; GOAL, goal-setting;
LAX, laxative; nFAST, avoidance of prolonged fasting; REF, referrals; SW, specialist ward; TEL, telephone support.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d > 0.80);▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50 to 0.79);◁▷, standardised mean difference
indicates no significant difference between groups; Ç, OR indicates significant beneficial effect; ⇦⇨, OR indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], not
reported; (x/y), finding for x of y measures (e.g. where multiple measures per outcome category).
Intervention components are listed where they only appear in the experimental arm of the study. Study quality is indicated by the colour of the study details cell: dark green, ‘moderate’; light blue, ‘weak’.
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Prehab interventions
The interventions trialled in the RCTs by Furze and colleagues210 included extensive preoperative information,
education and counselling. Participants in the prehab arm also received relaxation therapy to reduce stress
and advice on postoperative self-management. The intervention in Goodman and colleagues215 was a series
of monthly visits from a cardiac home-care nurse to reduce cardiac risks, establish lifestyle changes, provide
education and answer questions. The full details of each intervention can be found in Report Supplementary
Material 3, Table 10.
Quality assessment
Both studies were allocated ‘strong’ scores regarding study design, confounders, reporting of withdrawals
and dropouts, and both reported clearly how LOS was defined. The study by Furze and colleagues210 was
‘weak’ for blinding and data collection tools, and the study by Goodman and colleagues215 was rated as
‘weak’ for study selection but ‘strong’ for data collection tools. All other domains were rated as ‘moderate’
in both studies.
Effectiveness of prehab interventions Report Supplementary Material 6, Table 8, displays data for all
effectiveness outcomes reported in the two studies trialling a prehab intervention to improve recovery from
cardiac surgery in UK hospitals. Meta-analysis of the influence of prehab on LOS yielded evidence of no
overall effect, although this result approached statistical significance (Figure 19). Furze and colleagues210
described the use of additional GP and NHS hospital visits in the 8 weeks after discharge, as well as non-fatal
cardiac events and deaths; however, there were no statistically significant differences between groups for
any of these variables. Goodman and colleagues215 collected data for mental health outcomes but did not
report numerical data.
Other interventions
Specialist ward intervention
The specialist ward in the controlled trial by Salhiyyah and colleagues259 was called the theatre recovery
unit. The theatre recovery unit had two beds with one-on-one nursing provision, operating between 08.00
and 18.30 on weekdays. Patients were transferred to the theatre recovery unit immediately after surgery
and then to the high-dependency progressive care unit on the same day, and then to the general ward.
Patients allocated to the comparator arm were transferred to the cardiac intensive care unit immediately
after surgery, where they remained for at least 1 day, before moving to the general ward. Full details of
the intervention can be found in Report Supplementary Material 3, Table 11.
Note: weights are from random-effects analysis
Overall (I 2 = 0.0%; p = 0.788)
Study ID
Goodman 2008215
Furze 2009210
– 0.18 (– 0.38 to 0.02)
Cohen’s d (95% CI)
– 0.21 (– 0.50 to 0.08)
– 0.16 (– 0.43 to 0.12)
Shorter with prehab Longer with prehab 
– 1 0 0.5
FIGURE 19 Forest plot showing the results of meta-analysis of the effect of prehab interventions vs. usual
treatment on LOS in UK hospitals following cardiac surgery.
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The study was rated ‘strong’ for confounders and reporting of withdrawals and dropouts. The definition of
LOS was reported clearly; however, the study was rated ‘weak’ in terms of study design and data collection
tools and therefore ‘weak’ overall.
The effectiveness of the intervention was assessed in terms of overall LOS, time spent in different wards
during recovery and complications. Outcomes are presented in Report Supplementary Material 6, Table 9.
There was no change in LOS, despite patients in the specialist ward spending significantly less time in the
cardiac intensive care unit and intensive care. These patients spent a mean of 5.8 hours in the theatre
recovery unit (vs. 0 hours in the usual care group) and 15.4 hours longer in the progressive care unit.
Rates of complications were similar in both groups. No indicators of recovery were assessed.
Enhanced recovery protocol intervention
The ERP intervention introduced in the UBA study by Fleming and colleagues208 included the following key
components not present in the previous model of care: pre-admission assessment clinic and information;
carbohydrate treatment and absence of fasting beyond 2 hours; active prevention of postoperative nausea
and vomiting; avoidance of long-acting opioids; early discontinuation of opioid infusion postoperatively;
regular oral analgesia after extubation; regular laxatives; early mobilisation; and early enteral nutrition.
Full details of the intervention can be found in Report Supplementary Material 3, Table 12.
The study received a global quality rating of ‘weak’, thanks to ‘weak’ ratings for study design, data collection
and reporting of withdrawals and dropouts. However, the authors did provide a clear definition of LOS.
Effectiveness of the ERP intervention was assessed in terms of LOS, complications and markers of early
physical recovery. Outcomes are presented in Report Supplementary Material 6, Table 9. LOS was not
statistically different between the ERP and usual care groups, although there was a small effect size
approaching statistical significance (d = –0.37, 95% CI –0.76 to –0.02; p = 0.06). The odds of experiencing
a complication were 77% lower in the ERP group, (OR 0.23, 95% CI 0.01 to 0.35). Pain scores on days 1,
2 and 3 after surgery were significantly lower in the ERP cohort, associated with a mean reduction of half
a point (on a scale of 1–3) and medium effect sizes (mean effect size –0.63).
Interventions to improve recovery from upper abdominal surgery: evidence from the UK
Six studies investigated the effectiveness of interventions to improve recovery following upper abdominal
surgery in the UK, of which two were RCTs205,226 and four were UBA designs.191,201,257,263 Five studies trialled ERP
interventions, 191,201,226,257,263 with one prehab intervention.205 All interventions were compared with usual care.
Patients in these studies visited hospital for liver resection,201,205,226 pancreatectomy257 or
pancreaticoduodenectomy.191,263 There were 593 participants, with sample sizes ranging from
38205 to 211.201 Participants were 43.5% female and there was a variety of median and mean ages,
as presented in Table 2.
Overview: upper abdominal surgery
Evidence in this area is summarised here and in Table 19. Full details about the effectiveness of
interventions can be found in Enhanced recovery protocol interventions and Prehab interventions.
The study was rated ‘weak’ quality overall. The selection bias domain was rated ‘weak’ owing to lack of
clarity in the reporting of participant recruitment. Data collection methods were also rated ‘weak’. It was
not clear how LOS was defined.248
Effectiveness of intervention
Report Supplementary Material 5, Table 19, displays data for all outcomes reported in the study by
Muehling and colleagues,248 which trialled an ERP intervention to improve recovery from thoracic surgery.
There was no difference in the requirement for patients to undergo postoperative ventilation, and the
reporting of medians with ranges precluded a statistical comparison of LOS.
RESULTS
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TABLE 19 Summary of studies, intervention components and findings for studies evaluating interventions to improve recovery from upper abdominal surgery in the UK
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment) Sample size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Dunne 2016,205
RCT
38 Prehab AEI ◁▷ ⇦⇨ ◁▷ ⇦⇨(5/5)
Abu Hilal,191
2013 UBA
44 ERP nMBP; nFAST CATH; DRA EON; EMOB;
FM; nNGT; DP
▲(2/2) ⇦⇨ ⇦⇨ ⇦⇨ ▲(3/5)
▲(1/5)
x(1/5)
Dasari 2015,201
UBA
211 ERP AEI; EX nFAST; CHL PONV EMOB; ANA ◁▷ ⇦⇨ ⇦⇨ ◁▷
Jones 2013,226
RCT
104 ERP AEI; NUT DRA; FM DRA; CATH;
EON; FM; NUT;
ANA
▲ Ç(2/4)
⇦⇨(2/4)
⇦⇨ ⇦⇨ ▲ x
Richardson
2015,257 UBA
66 ERP AEI CHL; TP PONV; FM CATH; DRA;
DP; EON;
EMOB; NGT;
ANA
TEL; FAPP ▲ ⇦⇨(2/2) ⇦⇨ ⇦⇨ ▲(2/6)
◁▷(2/6)
x(3/6)
Sutcliffe
2015,263 UBA
130 ERP CHL DRA CATH; EON;
EMOB
x ⇦⇨(2/2) ⇦⇨
AEI, assessment, education, counselling or information; ANA, analgesia protocol; CHL, carbohydrate loading; DP, discharge planning; DRA, drain protocol; EMOB, early mobilisation; EON, early oral nutrition; EX, exercise programme; FAPP, follow-
up appointment; FM, fluid management protocol; nFAST, avoidance of prolonged fasting; nMBP, no mechanical bowel preparation; nNGT, nasogastric tube protocol; NUT, nutrition supplementation or diet management; PONV, active prevention of
nausea and vomiting; PreM, pre-Medication Protocol; TEL, telephone support; TP, thromboprophylaxis.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d> 0.80);▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50 to 0.79);◁▷, standardised mean difference
indicates no significant difference between groups; Ç, OR indicates significant beneficial effect; ⇦⇨, OR indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], not
reported; (x/y), finding for x of y measures (e.g. where multiple measures per outcome category).
Intervention components are listed where they only appear in the experimental arm of the study. Study quality is indicated by the colour of the study details cell: dark green, ‘moderate’; light blue, ‘weak’.
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Interventions to improve recovery from tumour removal surgery: randomised controlled
trials One RCT, by Hempenius and colleagues,220 investigated the effectiveness of an intervention to
improve recovery in patients undergoing various tumour removal surgeries. Data were obtained for
297 patients in the Netherlands, of whom 64% were female, with a mean age of 77.5. Patients were
admitted for solid tumour removal at various hospital sites.
The intervention focused on supportive care and the prevention of postoperative delirium. A preoperative
assessment was performed by a specialist geriatric care team, and patients were regularly assessed during
the hospital stay, using a checklist to ensure well-being and identify needs. Care plans were formulated
as required, with subsequent daily checking to ensure adherence. The intervention was compared with
usual care, in which additional geriatric care was provided only at the request of the treating physician.
A related paper by the same authors, published in 2016, focused on long-term outcomes in the study
sample, and reported on re-admissions.219
The study was rated as being ‘moderate’ quality. Study design, confounders and reporting of withdrawals
and dropouts achieved scores of ‘strong’ but data collection methods were rated ‘weak’. It was not clear
how LOS was defined.219
Effectiveness of intervention
Report Supplementary Material 5, Table 20, displays data for all outcomes reported in the study by
Hempenius and colleagues.220 Fewer patients in the experimental group were able to return to their
preoperative living situation (11.8% fewer). There were no significant differences between groups for any
other outcome.
Evidence for ERP interventions came from five studies; four used UBA designs and one was a RCT.
The evidence suggests that ERP interventions are associated with a reduction in LOS of around 3 days,
although results from individual studies ranged from almost no difference with ERP, to a 5-day reduction.
The reduction in LOS was also associated with favourable or non-detrimental effects for other outcomes,
including complications and markers of recovery. There was one RCT of a prehab intervention, which led
to improvements in some markers of physical fitness, but not in LOS.
Within the ERP interventions evaluated, large beneficial effect sizes for LOS and some markers of recovery
were observed in three studies.191,226,257 Compared with the two studies with less-effective interventions,201,263
these protocols included more additional components than usual care. However, all experimental components
were implemented in both highly effective and less effective studies, except discharge planning, which was
used in two of the most effective interventions.191,257 The two studies showing more null effects were the
largest two trials, although all five were rated as ‘weak’ overall. Given the heterogeneity of the evidence, it is
not possible to make causative associations between intervention components and outcome effectiveness.
Enhanced recovery protocol interventions
Components of the ERP interventions and comparators are mapped against ERAS Society guidelines for liver
surgery,274 pancreaticoduodenectomy275 and gastrointestinal surgery276 in Table 20. The most commonly
occurring items were: preoperative counselling (4/5 studies); antithrombotic prophylaxis (3/5); antimicrobial
prophylaxis and skin preparation (3/5); preventing intraoperative hypothermia (3/5); multimodal approach to
postoperative nausea and vomiting (4/5); early oral intake postoperatively (4/5); and early mobilisation (5/5).
Usual care in the comparator arms was identical with respect to pre-anaesthetic medication, antithrombotic
and antimicrobial prophylaxis, choice of incision, preventing intraoperative hypothermia and use of
thoracic epidural analgesia. The full description of each intervention can be found in Report Supplementary
Material 3, Table 14.
RESULTS
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TABLE 20 The ERAS components included in ERP (E) and comparator (C) arms in trials examining the effectiveness
of ERP for upper abdominal surgery. Items derive from guidance for liver surgery unless indicated
ERAS item and description
Study (first author and year)
Abu Hilal
2013191
(PDE)
Dasari
2015201
(liver)
Jones
2013226
(liver)
Richardson
2015257 (PE)
Sutcliffe
2015263
(PDE)
Patients should receive dedicated preoperative counselling
routinely
E E E, C E, C
Preoperative endoscopic biliary drainage should not be
undertaken routinely in patients (PD)
Preoperative smoking and alcohol consumption: abstinence
should be attempted for 1 month before surgery (PD)
Patients at risk should receive oral nutritional supplements
for 7 days prior to surgery [not warranted unless significantly
malnourished (PD)]
Ea
Perioperative oral immunonutrition: limited evidence for use
(immunonutrition for 5–7 days perioperatively should be
considered – PD)
Preoperative fasting does not need to exceed 6 hours for
solids and 2 hours for liquids. Carbohydrate loading the
evening before surgery and 2 hours before the induction of
anaesthesia
E E
Preoperative treatment with carbohydrates should be given
to patients without diabetes (PD)
E E
No oral mechanical bowel preparation Eb E, C Eb
Pre-aesthetic medication: long-acting anxiolytic drugs should
be avoided. Short-acting anxiolytics may be used to perform
regional analgesia prior to the induction of anaesthesia
E, C E, C
Antithrombotic prophylaxis E, Cc E, C E, C
Perioperative steroids administration: steroids
(methylprednisolone) may be used before hepatectomy in
normal liver parenchyma
Antimicrobial prophylaxis and skin preparation E, C E, C E, C
Incision: the choice of incision is at the surgeon’s discretion E, C E, C E, C
Minimally invasive approach: laparoscopic liver resections can
be performed by hepatobiliary surgeons experienced in
laparoscopic surgery
E, C
Avoidance of prophylactic nasogastric intubation E, C
Nasogastric intubation: nasogastric tubes removed early (PD) E
Prophylactic abdominal drainage: no recommendation E, Cd
Preventing intraoperative hypothermia E, C E, C E, C
Analgesia: routine TEA is not recommended in open liver
surgery. Wound infusion catheter or intrathecal opiates can
be good alternatives combined with multimodal analgesia
E, C E, C
Epidural analgesia: mid-thoracic epidurals are recommended,
compared with intravenous opioids (PD)
C E, C
Pain management: opioid-sparing analgesic strategies,
including regional analgesia techniques, should be
implemented in the context of a multimodal analgesic
regimen (G)
continued
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Interventions in studies with patients undergoing liver surgery201,226 adhered to a mean of 13.5 (58.7%) of
the 23 relevant ERAS guideline items, and comparator groups adhered to a mean of nine (39.1%) items.
Interventions with patients undergoing pancreaticoduodenectomy or pancreatectomy191,257,263 adhered to
a mean of nine (34.6%) of the relevant 26 ERAS items (range seven263 to 12257), and the comparator group
adhered to a mean of four (15.4%) items (range three263 to five191).
Quality assessment
All studies were rated as ‘weak’ globally, having received ratings of ‘weak’ in two or more individual
domains. The studies by Abu Hilal and colleagues191 and Dasari and colleagues201 both received three
ratings of ‘weak’. Only Jones and colleagues’226 paper avoided a rating of ‘weak’ for study design, and
TABLE 20 The ERAS components included in ERP (E) and comparator (C) arms in trials examining the effectiveness
of ERP for upper abdominal surgery. Items derive from guidance for liver surgery unless indicated (continued )
ERAS item and description
Study (first author and year)
Abu Hilal
2013191
(PDE)
Dasari
2015201
(liver)
Jones
2013226
(liver)
Richardson
2015257 (PE)
Sutcliffe
2015263
(PDE)
Multimodal approach to PONV should be used. Patients
should receive PONV prophylaxis with two antiemetic drugs
E, C Ee E,e Ce E
Fluid balance: near-zero fluid balance, avoiding overload of
salt and water, results in improved outcomes (PD)
E
Fluid management: maintenance of low central venous
pressure with close monitoring. Balanced crystalloid preferred
over saline or colloids
E, C E
Fluid management: perioperative haemodynamic
management – maintain fluid homeostasis, avoiding fluid
excess and organ hypoperfusion (G)
Early oral intake: eat normal food on POD1. Enteral or
parenteral feeding is reserved for malnourished patients or
those with prolonged fasting as a result of complications
E E,f C E E
Postoperative glycaemic control (diabetic patients)
Avoidance of perianastomotic drains (G) Eg E
Suprapubic catheterisation is superior to transurethral
catheterisation if used for > 4 days. Transurethral catheters
can be removed safely on POD1 or POD2 unless otherwise
indicated (PD)
E, C
Prevention of delayed gastric emptying
Stimulation of bowel movement: not indicated
Early mobilisation E E E, Ch E E
Audit: systematic audit E E, C
G, item derived from guidance for gastric surgery; PD, item derived from guidance for pancreaticoduodenectomy;
PDE, pancreaticoduodenectomy; PE, pancreatectomy; POD, postoperative day; PONV, postoperative nausea and vomiting;
TEA, thoracic epidural analgesia.
a Given for 3 days.
b Phosphate enema for experimental group and some of comparator group.
c Not postoperatively in comparator.
d Generally avoided and placed only if deemed necessary by operating surgeon.
e Only one antiemetic provided.
f Patients in Experimental group received additional supplements.
g Drain removal after 48 hours if possible.
h Experimental, twice per day; control, once per day.
RESULTS
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only the study by Richardson and colleagues257 received a ‘moderate’ rating for data collection methods,
the rest were ‘weak’. The paper by Sutcliffe and colleagues263 was the only one not to clearly define LOS.
Effectiveness of enhanced recovery protocol interventions at improving clinical outcomes Report
Supplementary Material 6, Table 10, displays data for clinical outcomes reported in studies evaluating
the effectiveness of ERP interventions at improving recovery in patients undergoing upper abdominal
surgery in UK hospitals. LOS was significantly shorter in patients receiving ERP interventions in four of five
studies, with only Dasari and colleagues201 reporting a non-statistically significant effect. LOS outcomes are
presented in the forest plot in Figure 20. Where LOS was reduced, this was associated with a large effect
size.191,226,257 For the four groups from three studies presenting medians with IQR, the mean reduction in
LOS was 3.1 days (range 5.2–0.3 days).
In the four studies that reported re-admissions,191,201,226,263 numbers were similar between groups, with
no statistically significant differences identified. Complications were reported in four studies, with three
reporting no difference between groups.191,201,257 However, the odds of experiencing general complications
were statistically significantly lower in the study by Jones and colleagues,226 with patients 80% less likely
to experience a complication in the ERP group (OR 0.2, 95% CI 0.05 to 0.75). The forest plot in Figure 21
displays outcome data for both complications for the included studies.
Effectiveness of enhanced recovery protocol interventions at improving patient-reported
outcomes Report Supplementary Material 6, Table 11, displays data for patient-reported outcomes from
the studies trialling an ERP intervention to improve recovery from upper abdominal surgery in UK hospitals.
Abu Hilal and colleagues191 reported that all aspects of early recovery occurred earlier in the ERP group.
Patients were medically fit for discharge 3 days earlier when receiving ERP in the study by Jones and
colleagues;226 this difference was associated with a large effect size (d = –3.92, 96% CI –4.63 to –3.21;
p < 0.001). In the study by Richardson and colleagues,257 there was a mix of findings with regard to
markers of early recovery. No markers were achieved later in the ERP group than the usual care group.
Prehab interventions
One RCT trialled a prehab intervention to improve recovery from upper abdominal surgery, with 35 patients
included in the study.205 Patients in the experimental group performed 4 weeks of exercise sessions tailored
to their physical capacity.
Abu Hilal 2013191
Abu Hilal 2013191 (PWC)
Dasari 2015201
Jones 2013226
Richardson 2015257
Study ID
– 0.78 (– 1.39 to – 0.16)
– 1.36 (– 2.02 to – 0.70)
– 0.17 (– 0.46 to 0.12)
– 1.96 (– 2.46 to – 1.46)
– 1.16 (– 1.71 to – 0.61)
Cohen’s d (95% CI)
Shorter with ERP Shorter with usual care 
– 3 – 2 – 1 0 0.5
FIGURE 20 Forest plot showing standardised mean differences between ERP vs. usual care for LOS following upper
abdominal surgery in UK hospitals. PWC, patients without complications.
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Outcomes are presented in Report Supplementary Material 6, Table 12. There was no difference in LOS
or re-admissions between groups. Dunne and colleagues205 evaluated markers of physical conditioning for
all participants, also performing a subgroup analysis of ‘high-risk’ patients, as evaluated on study entry.
There were improvements in a number of these outcomes, associated with large effect sizes, with some
benefits also observed in high-risk patients.
Interventions to improve recovery from thoracic surgery: evidence from the UK
Three UK studies investigated the effectiveness of interventions to improve recovery from thoracic
surgery.197,212,228 All three studies utilised UBA designs to evaluate the implementation of an ERP, compared
with previous standard care. Data from 984 patients were analysed across the three studies, of whom
46.1% were female. Age distribution was provided by medians and means, available in Table 2. Patients
were admitted for thorascopic lobectomy,197 oesophageal and gastric cancer surgery212 and upper
gastrointestinal cancer surgery (total and subtotal gastrectomy228).
Quality assessment
All three studies were rated as ‘weak’ for study design and data collection and ‘moderate’ for selection
bias and reporting of withdrawals and dropouts. Only the paper by Brunelli and colleagues197 clearly
reported how LOS was defined or reported that assessors and patients were blinded to group allocation.
Gatenby and colleagues212 did not consider confounding variables, whereas Brunelli and colleagues197
reported and controlled for confounders.
Overview: thoracic surgery
Findings for thoracic surgery are summarised here and in Table 21. Full effectiveness details are available in
Enhanced recovery protocol interventions.
Three studies from the UK utilised UBA designs to compare LOS and other clinical outcomes in patients
receiving ERP with LOS and other outcoes in those who had previously received standard care. There was
a trend for LOS to be reduced with ERP, while evidence for re-admissions and complications was equivocal.
There was no evidence of detrimental effects with ERP. Components of ERP that differed between studies
included the absence of a pre-hospital nutrition and postoperative social worker input in the study conducted
by Brunelli and colleagues197 and lack of preoperative anaesthesia and analgesia, postoperative education/
counselling, early oral nutrition and post-discharge telephone follow-up in Karran and colleagues.228 These
two studies demonstrated no statistically significant difference in rates of re-admission between intervention
and comparator groups.197,228 These results indicate that an ERP pathway may have the potential to reduce
LOS for older adults undergoing thoracic surgery without affecting rates of re-admission; however, all of the
studies evaluating an ERP had a global quality rating of ‘weak’, which prevents firm conclusions being drawn.
Abu Hilal 2013191
Dasari 2015201
Jones 2013226
Richardson 2015257
Study ID
0.33 (0.10 to 1.14)
0.94 (0.51 to 1.73)
1.43 (0.41 to 4.91)
0.60 (0.19 to 1.82)
OR (95% CI)
Lower odds with ERP Lower odds with usual care 
0.2 0.5 1 2 5
FIGURE 21 Forest plot (without pooled effects) displaying the odds of experiencing complications in patients
receiving ERP to improve recovery following upper abdominal surgery in the UK.
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TABLE 21 Summary of studies, intervention components and findings of trials evaluating interventions to improve recovery from thoracic surgery in UK hospitals
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Brunelli
2017,197 UBA
600 ERP AEI CHL; AIE;
nFAST; MT
FM; ANA;
WARM; PONV
AEI; MT; nNGT TEL Postoperatively,
patients
reviewed daily
◁▷1/2
⇦⇨1/2
⇦⇨ ⇦⇨ ⇦⇨3/3
Gatenby
2015,212 UBA
132 ERP AEI; NUT CHL; nFAST;
PreM
CATH; nNGT;
FM; SURG;
PONV; ANE
DRA; EMOB;
NUT; ANA;
CATH; PT; EX
AEI; LIA;
FAPP;
NUT; TEL
x ⇦⇨ ⇦⇨ ⇦⇨
Karran
2016,228 UBA
252 ERP AEI; NUT AEI; PreM;
nFAST
nNGT; CATH;
SURG; FM;
PONV
DRA; CATH;
EMOB; FM;
NUT; ANA
Pathway
booklets created
▲3/3 Ç ⇦⇨ ⇦⇨3/3
AEI, assessment, education, counselling or information; ANA, analgesia protocol; CATH, catheter protocol; CHL, carbohydrate loading; DRA, drain protocol; EMOB, early mobilisation; EX, exercise programme; FM, fluid management protocol;
nFAST, avoidance of prolonged fasting; nNGT, nasogastric tube protocol; NUT, nutrition supplementation or diet management; PONV, active prevention of nausea and vomiting; PreM, pre-medication protocol; PT, physiotherapy; SURG, surgical
approach differs between groups; WARM, intraoperative warming protocol.
▲, standardised mean difference indicates significant medium beneficial effect size (Cohen’s d 0.50 to 0.79);◁▷, standardised mean difference indicates no significant difference between groups; Ç, OR indicates significant beneficial effect;
⇦⇨, OR indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], not reported; (x/y), finding for x of y measures (e.g. where multiple measures per outcome category).
Intervention components are listed where they only appear in the experimental arm of the study. Study quality is indicated by the colour of the study details cell: light blue, ‘weak’.
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Enhanced recovery protocol interventions
Components of the ERP interventions and comparators are mapped in Table 22 against ERAS recommended
components for gastrointestinal surgery, in lieu of specific guidelines for ‘thoracic’ surgery.276 Given the mix
of procedures in the included studies, this guideline was deemed most appropriate. In the study by Karran
and colleagues,228 three slightly different pathways were evaluated for oesophageal, subtotal gastrectomy
and total gastrectomy patients. Full details of the three pathways, and the other ERP interventions for
thoracic surgery, can be found in Report Supplementary Material 3, Table 19.
TABLE 22 Components of included ERP interventions and comparators, mapped against ERAS guidelines
gastrointestinal surgery
ERAS item
Study (first author and year)
Brunelli
2017197
Karran
2016228
Gatenby
2015212a
Risk assessment E E E
Preoperative information, education and counselling E E E
Preoperative optimisation E E E
Preoperative fasting minimised E E E
Pre-anaesthetic medication avoided E
Preoperative carbohydrate treatment E E E
Same day admission E
Discharge planning in advance
Preoperative warming E
Prophylaxis against thromboembolism
Antimicrobial prophylaxis and skin preparation E, C
Standard anaesthetic protocol E, C E E
PONV prophylaxis E E
Minimally invasive surgery E, C
Preventing intraoperative hypothermia E
Perioperative fluid management: judicious use of vasopressors
In the absence of surgical losses postoperative intravenous fluid
should be discontinued and oral intake (1.5 l/day) encouraged
0.9% saline should be avoided and balanced crystalloid solution
should be used in the preoperative period. The use of 0.9%
saline should be restricted in hypochloraemic and acidotic
patients
Perioperative fluid management: goal-directed E E E
Monitoring neuromuscular function
Reverse neuromuscular blockade
The inspired fractional concentration of oxygen should be
titrated to produce normal arterial oxygen levels and saturations
100% inspired oxygen concentrations can be used for
pre-oxygenation prior to anaesthesia or for short periods to
overcome hypoxia
Chest drains: early removal E, C E E
Measures to prevent postoperative delirium
RESULTS
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The following items were common to all three interventions: pre-admission risk assessment, information,
education and counselling; preoperative optimisation; minimal preoperative fasting; preoperative carbohydrate
treatment; standard anaesthetic protocol; goal-directed fluid management; early removal of chest drains;
perioperative nutritional care; and early mobilisation. Gatenby and colleagues212 described their intervention
as ERAS.
The interventions evaluated by the studies outlined in Table 22 adhered to a mean of 14 (46.2%) of the
31 ERAS guidelines (range 12228 to 18197). The comparator group in the study by Brunelli and colleagues197
adhered to seven (22.6%) ERAS guidelines. The comparator groups in the studies conducted by Karran
and colleagues228 and Gatenby and colleagues212 were not well reported, so adherence to ERAS guidelines
was not calculated.
Effectiveness of interventions
Report Supplementary Material 6, Table 13, displays data for all outcomes reported by the three studies
evaluating the effectiveness of ERP interventions for improving recovery from thoracic surgery in UK
hospitals. LOS was statistically significantly shorter with ERP in the study by Karran and colleagues228
(d = –0.69, 95% CI –0.95 to –0.43; p < 0.001) but did not differ statistically between groups in the study
by Brunelli and colleagues.197 Median LOS was 3 days shorter in the ERP group in the study by Gatenby
and colleagues.212
Re-admissions and mortality were reported in all studies but were not statistically different between
groups. The odds of experiencing a Clavien–Dindo grade C3 complication was 57% lower in the recipients
of ERP in the study by Karran and colleagues;228 however, the upper CI for this effect was 1.0, suggesting
that the true effect may not be statistically significant lower odds. The odds of experiencing complications
were similar in the remaining studies.197,212
Interventions to improve recovery from pelvic surgery, vascular surgery and mixed
procedures: evidence from the UK
Interventions to improve recovery from pelvic surgery,194,250 vascular surgery31 and various surgical procedures207
were found in only one or two trials, and these are summarised in this section. Full details of the effectiveness
of these interventions can be found in Pelvic surgery, Vascular surgery and Various procedures.
TABLE 22 Components of included ERP interventions and comparators, mapped against ERAS guidelines
gastrointestinal surgery (continued )
ERAS item
Study (first author and year)
Brunelli
2017197
Karran
2016228
Gatenby
2015212a
Attenuation and treatment of postoperative ileus: multimodal
strategies to facilitate return of gastrointestinal function
Postoperative analgesia: multimodal, avoidance of systemic
opioids
E
Postoperative analgesia: patient-controlled E, C E
Prevention of fluid overload E, C E
Perioperative nutritional care E E E
Early mobilisation: including written information setting daily
targets
E, C E E
C, component present in comparator arm; E, component present in experimental arm; PONV, postoperative nausea
and vomiting.
a Intervention described as ‘ERAS’.
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Overview: interventions to improve recovery from pelvic surgery, vascular surgery
and mixed procedures
Pelvic surgery
The two studies evaluating interventions to improve recovery after pelvic surgery in the UK194,250 used UBA
designs to investigate the impact of implementing an ERP to improve recovery from radical cystectomy.
Data suggest that LOS may be reduced with ERP, without detriment to other outcomes. However, the
assessment of broader patient outcomes was limited, with no consideration of patient satisfaction, quality
of life or mental health, as illustrated in Table 23.
Vascular surgery
The single study evaluating a CGA was also a RCT described in Interventions to improve recovery from
vascular surgery: randomised controlled trials.31 The intervention identified 58 more new comorbidities
than were diagnosed in the group receiving regular preoperative assessment. The odds of experiencing a
complication were lower with the intervention, but there were no statistically significant differences in any
other outcomes.
Various procedures
One study evaluated a PACP intervention using a UBA design.207 Participants were scheduled to undergo
various elective procedures, but were all ‘high-risk’ patients. The intervention led to reductions in LOS and
odds of experiencing complications, but was of ‘weak’ quality.
Interventions to improve recovery from pelvic surgery: evidence from the UK
Two studies194,250 from the UK sought to evaluate the effectiveness of interventions to improve recovery
from pelvic surgery. Both studies evaluated the effectiveness of recently implemented ERP for radical
cystectomy using UBA designs. Data from 189 patients were included across the two studies; 22.6% of
patients were female and the mean age was 66.9 years.
Quality assessment
Both studies scored ratings of ‘weak’ for study design; however, the study by Arumainayagam and
colleagues194 was rated as ‘strong’ for all other areas apart from selection bias (which received a
‘moderate’ rating). The study by Mukhtar and colleagues250 was rated as ‘weak’ for data collection
methods, ‘moderate’ for selection bias and ‘strong’ for all other domains.
Enhanced recovery protocol interventions Components of the ERP interventions and comparators are
mapped against ERAS Society guidelines for pelvic surgery272 and radical cystectomy279 in Table 24. In the
study by Arumainayagam and colleagues,194 nine ERAS items were implemented in the new pathway, with
a focus on post-admission/preoperative items, with early postoperative nutrition and mobilisation. The
usual care protocol was similar in terms of perioperative items. In the study by Mukhtar and colleagues,250
12 ERAS recommended items were implemented in their ERP pathway. These included pre-admission
information, education and optimisation, perioperative items and postoperative early mobilisation and
nutrition. Usual care was not described in the study by Mukhtar and colleagues.250
Interventions from the two studies involving patients undergoing radical cystectomy194,250 adhered to a
mean of 10 (38.5%) out of the 26 ERAS guideline items. The comparator group in the study conducted
by Arumainayagam and colleagues194 adhered to a mean of four (15.4%) items. The treatment received
by the comparator group in the study by Mukhtar and colleagues250 was not well reported and so the
adherence rate was not calculated.
Effectiveness of ERP interventions Report Supplementary Material 6, Table 13, displays all outcome
data for the two studies evaluating ERP interventions for recovery from pelvic surgery in UK hospitals.
RESULTS
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TABLE 23 Summary of studies, intervention components and findings for trials evaluating interventions to improve recovery from pelvic surgery, vascular surgery and various
surgeries in the UK
Study details Intervention components Outcome categories
First author,
year, country
(quality
assessment)
Sample
size
Intervention
category
Pre-hospital
admission Preoperative Perioperative Postoperative
Post
discharge Other LOS Complications Mortality Re-admissions
Markers of
recovery
Mental
health
Quality
of life
Use of
additional
care
Pelvic surgery
Arumainayagam
2008,194 UBA
112 ERP nMBP; CHL;
nFAST
DRA; DP; EON;
EMOB
Stoma
therapist sees
patient. Social
circumstances
assessed and
referrals made
if needed.
Protocol for
stent removal
▲(2/2) ⇦⇨(2/2) ⇦⇨ ⇦⇨ x
Mukhtar
2013,250 UBA
77 ERP AEI CHL; PreM FM; nNGT;
DRA; SURG;
WARM
ANA; CATH;
EMOB
CNS trained to
take final steps
in removing
ureteric stents
and for
practical stoma
education
x ⇦⇨ ▲(3/3)
Vascular surgery
Partridge
2017,31 RCT
209 PACP AEI FAPP Before surgery:
medications
changed and
level of care
required
advised. Post
discharge:
longer-term GP
follow-up
x Ç(3/8)
⇦⇨(5/8)
⇦⇨ ⇦⇨(2/2)
Various procedures
Ellis 2012,207
UBA
313 PACP AEI Referrals made
and acted on
on basis of
assessment
▲ Ç ⇦⇨
AEI, assessment, education, counselling or information; ANA, analgesia protocol; CATH, catheter protocol; CHL, carbohydrate loading; CNS, community nursing staff; DP, discharge planning; DRA, drain protocol; EON, early oral nutrition;
EMOB, early mobilisation; FM, fluid management protocol; nFAST, avoidance of prolonged fasting; nMPB, avoidance of mechanical bowel preparation; PACP, preoperative assessment with care plan; PreM, pre-medication protocol; SURG, surgical
approach differed between groups; WARM, intraoperative warming.
▲, standardised mean difference indicates significant large beneficial effect size (Cohen’s d > 0.80);◁▷, standardised mean difference indicates no significant difference between groups; Ç, OR indicates significant beneficial effect; ⇦⇨, OR
indicates no significant difference between groups; x, data but standardised mean difference or OR could not be calculated; [blank], not reported; (x/y), finding for x of y measures (e.g. where multiple measures per outcome category).
Intervention components are listed where they only appear in the experimental arm of the study. Study quality is indicated by the colour of the border of the study details cell: light green, ‘strong’; dark green, ‘moderate’; light blue, ‘weak’.
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TABLE 24 Components of included ERP interventions and comparators, mapped against ERAS guidelines for rectal/
pelvic surgery and radical cystectomy
ERAS item
Study (first author and year)
Arumainayagam 2008194 Mukhtar 2013250
Preoperative information, education and counselling E
Preoperative optimisation E
Preoperative mechanical bowel preparation avoided E
Preoperative fasting: clear fluids allowed up to 2 hours and
solids allowed up to 6 hours before the induction of
anaesthesia
Ea
Preoperative carbohydrate treatment for patients without
diabetes
E E
Pre-anaesthetic medication: avoidance of long-acting
sedatives
E
Prophylaxis against thromboembolism E, C
Antimicrobial prophylaxis and skin preparation
Standard anaesthetic protocol E, C
Epidural analgesia: TEA is superior to systemic opioids;
it should be continued for 72 hours
E, C E
PONV prophylaxis E, C
Laparoscopic resection recommended for benign disease
and rectal cancer (R/P). Minimally invasive approach not
recommended outside trial setting (RC)
E
Nasogastric intubation: nasogastric tubes not routinely used E
Nasogastric tubes removed before extubation
Prevention of intraoperative hypothermia E
Perioperative fluid management: intraoperative fluids guided
by flow measurements to optimise cardiac output (RC)
Perioperative fluid management: judicious use of
vasopressors (RC)
Transurethral catheter (R/P)
Suprapubic catheter (R/P)
Urinary drainage: transurethral catheter removal on POD1 in
low-risk patients
Early removal of bladder catheter E
Prevention of postoperative ileus: chewing gum (R/P),
oral magnesium, alvimopan
Postoperative laxatives and prokinetics (R/P)
Early oral intake 4 hours after surgery E
Early mobilisation E E
Audit: all patients should be audited for protocol compliance
and outcomes
E, C
C, present in comparator arm; E, present in experimental arm; POD, postoperative day; RC, radical cystectomy; R/P, items
from guidelines for rectal/pelvic elective surgery; TEA, thoracic epidural analgesia.
a 4 hours of fasting for clear liquids.
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Where standardised mean differences were calculable, statistically significant differences were seen
between groups, with large effect sizes in all cases. LOS was 4.7 days shorter in the ERP cohort in the
study by Arumainayagam and colleagues,194 associated with a large effect size (d = –0.85, 95% CI –1.24 to
–0.46; p < 0.001). The numbers of complications, re-admissions and deaths in each group were similar.
In the study by Mukhtar and colleagues,250 median LOS was 1.1 days shorter in the ERP cohort and mean
LOS was 1.4 days shorter when an outlier was removed. Standardised mean differences could not be
calculated for these outcomes. Markers of recovery were all achieved significantly earlier in the ERP group,
associated with very large effect sizes (range –3.43 to –5.66).
Interventions to improve recovery from vascular surgery: evidence from the UK
The single study from the UK investigating the effectiveness of an intervention to improve recovery
following vascular surgery was a RCT evaluating a preoperative assessment intervention.31 Most of the
patients in the study were male (24% were female), with a mean age of 75.5 years, and had been admitted
for endovascular/open aortic aneurysm repair or lower limb arterial bypass surgery. Two hundred and nine
participants were randomised to either preoperative CGA leading to an optimised care plan, or standard
preoperative assessment. The intervention is detailed in Report Supplementary Material 3, Table 18.
Quality assessment
The paper was rated as ‘strong’, with only blinding of assessors rated as ‘moderate’. However, it was
unclear how LOS was defined.
Effectiveness of intervention Report Supplementary Material 6, Table 15, displays outcome data for all
effectiveness outcomes in the study by Partridge and colleagues.31 Mean LOS was 2.3 days shorter in the
experimental group. The absence of variance data prevented a calculation of standardised mean difference.
The CGA identified 58 more new comorbidities than were diagnosed in the group receiving regular
preoperative assessment. Postoperatively, the odds of delirium (OR 0.39, 95% CI 0.17 to 0.9), cardiac
complications (OR 0.24, 95% CI 0.02 to 0.58), bowel and bladder complications (OR 0.4, 95% CI 0.22 to
0.74) were statistically significantly lower in the experimental group.
Interventions to improve recovery from various procedures: evidence from the UK
We identified one UBA study that evaluated the value of a PACP intervention in 313 patients undergoing
various elective surgeries in a UK hospital.207 Patients were admitted for total hip or knee replacement,
other orthopaedic surgeries, transurethral resection of the prostate or a bladder tumour, other renal
surgery and gastrointestinal surgery. Data were not presented by procedure and therefore could not be
separated into relevant sections of the report. The study authors sought patients who presented certain
‘red flags’, or risk factors for postoperative complications, during routine assessment. These included
cognitive or mobility problems, a history of falls and concerns regarding circumstances at home.
The intervention was an additional comprehensive review process following routine assessment, conducted
by a nurse experienced with working with patients living with frailty, and an occupational therapist. If
necessary, referral pathways were created to avoid unnecessarily lengthy stays in hospital postoperatively,
and to help the discharge process.
Quality assessment
The study was rated as ‘weak’ overall, achieving domain ratings of ‘weak’ for study design, confounders
and data collection methods, and ‘moderate’ ratings for selection bias and blinding of assessors. It was
unclear how LOS was defined.
Effectiveness of intervention Report Supplementary Material 6, Table 16, displays data for all outcomes
reported in the study by Ellis and colleagues.207 LOS was 2.7 days shorter in the intervention group,
associated with a medium effect size (d = –0.63, 95% CI –0.86 to –0.41; p < 0.001). Cognitive function
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was assessed using the Mini Mental State Examination, with scores similar between groups. There were
fewer referrals to all agencies in the intervention cohort, except those to carer support workers and ‘other’
agencies not specified.
Synthesis of cost-effectiveness evidence
Study selection
The PRISMA flow chart in Figure 22 summarises the study selection process. Bibliographic database
searches identified 2102 records and supplementary search methods identified 891 records. Following
the removal of duplicates, there were a total of 2681 unique records that were screened at title and
abstract against our inclusion and exclusion criteria. The full texts of 165 papers were sought for further
consideration. Of these, 163 (98.8%) full texts were successfully retrieved. Following full-text screening,
108 papers were excluded. In total, 54 studies, reported in 55 articles, met the inclusion criteria.57,58,67,71,74,
81–84,86,91,96,97,100,104–106,109,110,112,115,116,119–121,123,125,131,133,134,145,146,151,159,162,166,179,183,184,186,210,211,215,222–224,232,244,256,257,259,
264,268,280,281
Evaluations of cost-effectiveness not associated with studies that were in the prioritised batch in the
effectiveness review are tabulated and described in Report Supplementary Material 7.
Records after duplicates removed
(n = 2681)
Records identified through database
searching
(n = 2102)
Additional records identified
through other sources
(n = 904)
• Author reference lists, n = 1
• Backwards citation searching, n = 3
• Checking SRs, n = 2
• Effectiveness searches, n = 7
• Forwards citation searching, n = 891
Records screened
(n = 2681)
Records excluded
(n = 2516)
Full-text articles screened
(n = 165)
Articles included in total
(n = 55)
Articles included in
economic analysis
(n = 15)
Articles not prioritised for
economic analysis
(n = 40)
Full-text articles excluded,
with reasons
(n = 110)
• Average age < 60 years or
   NR, n = 31
• Foreign language, n = 3
• Full text not obtained, n = 2
• Intervention, n = 7
• No suitable LOS data, n = 2
• No overnight stay, n = 0
• Not all elective, n = 13
• Not high income, n = 2
• Not hospital based, n = 1
• Protocol/ongoing, n = 0
• Retraction, n = 0
• Study type, n = 6
• No cost data, n = 43
FIGURE 22 The PRISMA flow chart: identification process of economic studies. NR, not reported; SR, systematic review.
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Description of included studies
Fifteen studies were synthesised.210,211,215,222–224,232,244,256,257,259,264,268,280,281 Table 2 provides details of the
sample size, mean age and percentage female for each of these studies. Only six of the studies were
published after 2010,211,222,257,259,264,268 so the majority of economic evidence is relatively old, stemming from
a time when some surgical care was different.
Of the 15 studies, four evaluated interventions that were preoperative only,210,215,222,244 two were
postoperative only244,256 and five were delivered outside hospital.210,215,222,244,281 In terms of the broad type of
surgical procedure, seven of the economic studies included patients receiving lower limb arthroplasty,222–224,
244,256,280,281 three included patients receiving cardiac surgery,210,215,259 three included patients receiving
colorectal surgery211,232,268 and two included patients receiving upper abdominal surgery.257,264 Interventions
are summarised in Table 3 and described in detail in subsequent sections of the synthesis and in Report
Supplementary Material 3. Key characteristics are summarised here. The most frequently studied
intervention category was ERP (n = 49 studies191,192,194,196,197,199,201,203,206,208,209,211–213,216–218,224–232,234–239,241–243,245,
247,248,250–252,254,256,257,261–265). Thirteen studies193,198,200,204,205,210,214,215,221,222,244,258,269 evaluated prehab, two
studies207,220 evaluated PACPs, four studies202,253,266,267 evaluated rehab, three studies195,255,259 evaluated
specialist wards, and one study223 evaluated a staff mix intervention. The most common comparator was
standard care or pre-intervention pathway (in UBA designs), although study authors used a range of
descriptions (see Table 3).
Primary intervention delivery sites were at hospital, outpatient clinic, rehabilitation centre, the patient
home, or a combination of these (see Table 3). The patient usually received the intervention alone, except
in 14 studies31,193,195,200,206,211,216,221,232,234,235,245,254,258 where a family member or carer was actively involved in
the intervention; in two interventions216,267 that included the involvement of friends or a non-specified
support person; in two studies31,245 that involved carers; and in one study31 that involved GPs in the
intervention. Ten studies did not report the intervention recipient, in which case we assumed that this was
just the patient.197,209,241,244,247,248,251,261,266,269 Table 3 shows the characteristics of the interventions and the
health system and service settings for the 15 studies contributing towards the economic analysis. The
interventions evaluated in each study are described more fully in each of the procedural categories below
and in Report Supplementary Material 3.
Only three studies included full economic evaluations (two cost–utility analyses and one cost-effectiveness
analysis),210,280,281 the remainder being cost-minimisation analyses,215,244 cost–consequences analyses223,224,232,
257,259,264 or cost analyses.222,256 The last three approaches provided mainly visual juxtaposition of the cost and
effectiveness data (e.g. in a single table) without incremental analysis or calculation of cost-effectiveness
ratios. The methods used in the 15 included economic evaluations are detailed in Report Supplementary
Material 7, Table 2. The quality of the economic studies (as assessed using the 19 questions of the CHEC
criteria list47) was extremely varied, meeting between two215,257,259 and 17280 of the quality criteria (Table 25).
Synthesis of cost-effectiveness evidence
Cost data and primary outcomes for each of the included studies are presented in Report Supplementary
Material 7, Table 3, and summarised in each procedural category below.
Cost-effectiveness evidence: cardiac surgery
Of the eight studies evaluating interventions to improve recovery from cardiac surgery, three reported cost
outcomes.210,215,259 All were conducted in the UK. They were based on clinical effectiveness studies judged
to be of ‘moderate’215 or ‘weak’210,259 overall quality.
The study by Salhiyyah and colleagues259 was an evaluation of a specialist ward initiative, a ‘fast-track’ care
pathway via a ‘theatre recovery unit’ (rather than to the cardiac intensive care unit) and then same-day
transfer to an intermediate care unit. By contrast, both of the other two economic studies in cardiac
surgery patients evaluated pre-admission prehab interventions to give support and education, intended to
reduce anxiety and improve lifestyle.210,215
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TABLE 25 Quality assessment of prioritised economic studies
CHEC list item
Broad procedural category
Cardiac surgery Colorectal surgery Lower limb arthroplasty
Upper abdominal
surgery
Furze
2009210
Goodman
2008215
Salhiyyah
2011259
García-Botello
2011211
King
2006232
Vlug
2011268
Huang
2012222
Huddleston
2004223
Hunt
2009224
Larsen
2009280
McGregor
2004244
Reilly
2005256
Sigurdsson,
2008281
Richardson
2015257
Tanaka
2017264
Is the study population clearly
described?
Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y
Are competing alternatives
clearly described?
Y Y N Y Y Y Y Y Y Y Y Y Y N Y
Is a well-defined research
question posed in answerable
form?
Y N N Y Y Y N N Y Y Y Y Y Y Y
Is the economic study design
appropriate to the stated
objective?
N CT N N Y Y N CT Y Y Y CT Y N CT
Is the chosen time horizon
appropriate to include relevant
costs and consequences?
N NR N NR Y N N N Y Y Y NR Y N N
Is the actual perspective chosen
appropriate?
Y CT N N Y N N CT Y Y Y CT Y N CT
Are all important and relevant
costs for each alternative
identified?
N N N N Y Y N N Y Y Y N Y N N
Are all resources measured
appropriately in physical units?
Y N N N Y N N N Y Y NR N Y N Y
Are resources valued
appropriately?
Y N N Y Y N N N Y Y NR CT Y N Y
Are all important and relevant
outcomes for each alternative
identified?
Y N N N NA Y NA NA Y Y N N Y N N
Are all outcomes measured
appropriately in physical units?
Y N N NA NA N NA NA Y Ya Y N Y N N
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CHEC list item
Broad procedural category
Cardiac surgery Colorectal surgery Lower limb arthroplasty
Upper abdominal
surgery
Furze
2009210
Goodman
2008215
Salhiyyah
2011259
García-Botello
2011211
King
2006232
Vlug
2011268
Huang
2012222
Huddleston
2004223
Hunt
2009224
Larsen
2009280
McGregor
2004244
Reilly
2005256
Sigurdsson,
2008281
Richardson
2015257
Tanaka
2017264
Are outcomes valued
appropriately?
Y NA NA NA NA NA NA NA NA Y NR NA NA NA NA
Is an incremental analysis of
costs and outcomes performed?
Y N N N N N N N N Y NA NA Y N N
Are all future costs and
outcomes discounted
appropriately?
NA NA NA NA NA NA N NA NA NA NA NA NA NA NA
Are all important variables,
whose values are uncertain,
appropriately subjected to
sensitivity analysis?
Y N Y N Y N N N N Y N N N N N
Do the [cost-effectiveness]
conclusions follow from the data
reported?
N N N N Y Y N Y Y Y Y Y Y N Y
Does the study discuss the
generalisability of the results to
other settings and patient/client
groups?
Y N N N Y Y N Y Y Y N Y Y N Y
Does the article indicate that
there is not potential conflict of
interest of study researcher(s)
and funder(s)?
N N N Y Y Y Y Y Y Y N N Y N Y
Are ethical and distributional
issues discussed appropriately?
N N N N N Y Y Y N Y N Y N N Y
CT, can’t tell; N, no, NA, not applicable; NR, not reported; Y, yes.
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The two studies evaluating prehab interventions were a high-quality cost–utility analysis210 and a low-quality
and poorly reported cost-minimisation analysis,215 both of which were based on RCTs. The cost-minimisation
analysis of the nurse-led programme of support and lifestyle management provided only one sentence of
cost methods, but included costs of outpatient, community contacts and home-care contacts (i.e. not just
hospital costs).215 By contrast, the cost–utility analysis of prehab to reduce anxiety or depression and increase
physical activity prior to CABG surgery was relatively well described and was conducted and reported
according to current best practice standards for cost-effectiveness analyses. This included calculation of
both an incremental cost-effectiveness ratio and a cost-effectiveness acceptability curve; however, both
were based on only 8 weeks’ follow-up and therefore included only costs while waiting for admission for
surgery. This time horizon for the cost study makes this study very different from the other cost studies
included in this review: there is no effect on costs of different LOS.
Cost results: prehab
The two studies of preoperative education and support reported contrasting cost outcomes.210,215 In the
lower-quality study, the preoperative programme was associated with statistically significantly lower costs
(£1817 lower per patient; 95% CI £3238 to –£396; p < 0.05), which were mostly accounted for by in-hospital
costs.215 Although this represents a considerable cost saving, it must be noted that the study was of low
quality, scoring only 2 out of 19 on the CHEC list assessment.
In the cost–utility analysis by Furze and colleagues,210 the mean per-patient cost of the intervention arm
was £24.10, or £1.73 higher than routine nurse counselling.
Cost results: specialist ward
The study by Salhiyyah and colleagues259 was a low-quality economic study, based on only the average
cost per day in the different units; in addition, crucially, the cost per day of the new theatre recovery unit
was assumed to be the same as that of the cardiac intensive care unit. The authors’ estimation of the
statistical significance of the cost difference is incorrect, so their conclusion that the fast-track pathway
was cheaper than the conventional pathway is flawed.
Cost-effectiveness evidence: colorectal surgery
Of the 19 studies evaluating effectiveness evidence about multicomponent initiatives to enhance recovery
after colorectal surgery, only three also reported cost outcomes.211,232,268 All three studies evaluated changes to
care spanning preoperative preparation and support, intraoperative elements and postoperative components
to enhance recovery in single hospitals in the UK,232 the Netherlands268 and Spain.211 They were either cost
analyses211 or cost–consequences analyses232,268 reported within the main clinical effectiveness evaluation
paper. They were based on clinical effectiveness studies judged to be of ‘moderate’ overall quality.
The highest quality of the three studies (the study from the UK) showed a non-statistically significant lower
cost of ERP compared with conventional care (–£671) for patients undergoing colorectal surgery for cancer.232
This was despite ERP patients having a much lower and statistically significantly fewer postoperative stays
(between 48% and 66% of the length of postoperative stay with conventional care, whether including or
excluding convalescence stays or re-admissions). This mainly reflects that this study, unlike most in this review,
had separate, much lower unit costs for ward hotel costs (£162/day) compared with the per-hour or per-day
costs of patients while in theatre, recovery or intensive care.
The other two studies of ERP in colorectal surgery were of lower quality, mainly as a result of poor
reporting (in a paper mainly reporting clinical effectiveness methods and results). The study in a single
hospital in Spain estimated that those receiving ERP incurred hospital costs that were 55% lower than
those for patients receiving traditional surgical care (difference –€1735, 95% CI –€2370 to –€1102;
p < 0.001).211 This is driven purely by the statistically significant 5.1-day-shorter mean LOS and the use
of the same unit cost for all days in hospital. Costs associated with complications or re-admissions were
not included.
RESULTS
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The study by Vlug and colleagues,268 conducted in nine university and teaching hospitals in the Netherlands,
evaluated the clinical and hospital cost outcomes of four surgical and care strategies, comparing ERP with
standard care in laparoscopic or open surgery. ERP patients had statistically significantly slightly shorter
median total LOS or postoperative LOS for comparisons between some groups; however, it was not possible
to evaluate the four possible cost comparisons (laparoscopic/open surgery; university/teaching hospital)
between fast-track and standard care, because the group numbers were not reported.
Cost-effectiveness evidence: lower limb arthroplasty
Of the 25 studies evaluating effectiveness evidence about multicomponent initiatives to enhance recovery
after orthopaedic surgery, seven studies reported cost outcomes.222–224,244,256,280,281 There were four ERP
interventions,224,256,280,281 two studies evaluating prehab222,244 and one staff mix intervention.223 Studies were
diverse in origin, coming from the UK,224,244,256 Denmark,280 Iceland,281 the USA223 and Taiwan.222 The study
by Larsen and colleagues280 was a cost–utility analysis, and the study by McGregor and colleagues244
was a cost-minimisation analysis, with the other five studies being simpler comparative cost analyses or
cost–consequences analyses.
The studies were of variable quality, with only the studies by Larsen280 (17/19), Sigurdsson281 (15/19) and
Hunt224 (14/19) meeting the majority of the CHEC quality assessment criteria. They were based on clinical
effectiveness studies judged to be of ‘moderate’222,223,256,280 or ‘weak’224,244,281 overall quality.
Cost results: prehab
Two studies evaluated both the clinical outcomes and the cost impact of prehab. Huang and colleagues222
evaluated a 4-week programme of strength training and education for total knee arthroplasty patients in
Taiwan; McGregor244 evaluated a one-off preoperative physical training class and booklet for total hip
arthroplasty patients in the UK. Both gave minimal description of the costing methods and both met fewer
than half of the CHEC study quality criteria.
The small (n = 35) randomised UK hip arthroplasty study reported a 17% lower cost in the prehab study
group.244 This was mainly attributed to the 3-day-shorter LOS following the preoperative training and also
to this group requiring less occupational therapy. The RCT of 243 hip arthroplasty patients in Taiwan
reported a 1.7% lower medical cost in the intervention group (difference –NT$2112; 95% CI –NT$3337 to
–NT$886; p < 0.001), which the authors attributed to the shorter mean LOS in the intervention group.222
However, given the range of LOS in each group, the standard deviations of the mean medical costs in each
group seem unusually small, so this finding should be treated with caution.
Cost results: enhanced recovery protocol
Four studies evaluated ERP interventions.224,256,257,280 Two studies in UK hospitals evaluated the patient
outcomes and cost impacts of early discharge and enhanced rehabilitation initiatives: one for patients
having primary hip arthroplasty224 and the other for patients having unicompartmental knee arthroplasty.256
The ERP evaluation reported by Hunt and colleagues224 involved spinal analgesia with sedation
intraoperatively, and mobilisation on day 1 post operation, target discharge by post-operation day 3, and
other differences from surgical care at two other UK hospitals with different operative and rehabilitation
approaches (see Table 3). The ERP intervention evaluated by Reilly and colleagues involved targeted
discharge within 24 hours postoperatively, supported by early mobilisation, pain diary and enhanced pain
control, a booklet for comprehensive rehabilitation advice and a 24-hour emergency contact telephone
number.256
The study by Hunt and colleagues224 was assessed as a high-quality economic study (meeting 14/19 of
CHEC criteria), whereas the study by Reilly and colleagues256 was much lower quality (6/19 CHEC criteria
met); it described its cost analysis methods in one 10-word sentence, and the cost differences between the
study groups were calculated by multiplying a standard cost per inpatient day (£487) by the difference in
mean LOS. The study by Hunt and colleagues,224 comparing hip arthroplasty rehabilitation in three UK
hospitals, showed that health-care costs in the hospital with the shortened stay (Belfast, median stay 3 days;
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cost £4909) were lower than those in the two other hospitals, which had longer median LOS (Liverpool,
south-west London, median stay 6 and 5 days; cost £5070 and £5970 – no variance reported).224 These
estimates conceal wide variation in the costs of prosthetic and cements; however, the shortened median
stay in Belfast was associated with notably lower costs of hospital staff input, which accounted for between
23% and 34% of the totals cost at each hospital.
Larsen and colleagues280 evaluated an ERP intervention in a regional hospital in Denmark for hip and knee
arthroplasty patients, including pre-admission outpatient information visit, surgery on day of admission,
controlled fluid and protein consumption, and earlier and more intensive mobilisation, which included a
cost–utility analysis (see Report Supplementary Material 3, Table 5, for full details). This Danish cost–utility
study was the highest-quality economic study in this review, meeting all but 2 of the 19 CHEC criteria.
It was also the only study whose journal paper was devoted exclusively to describing the methods and
results of an economic evaluation. The ERP intervention was associated with a statistically significant 3-day
shorter LOS, and the study authors reported the intervention to be statistically significantly cheaper than the
standard protocol (DKK18,880 less), based on univariate analysis. There were also sustained (12-month)
gains in EQ-5D-assessed quality of life for total hip arthroplasty patients undergoing the accelerated
protocol, but not for knee arthroplasty patients. The multivariate incremental cost-effectiveness analyses
showed that, for total hip arthroplasty, for 98% of the cost and effectiveness probabilistic estimates the ERP
both was cheaper and generated more QALYs than usual care. For the same analysis of knee arthroplasty
patients, although for 93% of the cost and effectiveness probabilistic estimates ERP was cheaper than usual
care, there was no statistically significant or clinically relevant difference in effect.
A cost analysis by Sigurdsson and colleagues281 (linked to the effectiveness paper by Siggeirsdottir261)
evaluated an ERP intervention comprising both preoperative education and training and home-based rehab
after discharge for total hip arthroplasty patients at two hospitals in Iceland. The costing study was reported
in detail in the cost analysis paper and therefore was judged as high quality because it met 15 out of
19 of the CHEC criteria. However, the cost-effectiveness ratios calculated on the basis of between-group
differences in gains in the Oxford Hip Score were average cost-effectiveness ratios, which are much less
meaningful and useful than cost-effectiveness ratios based on an incremental analysis.282 Nevertheless, the
total care costs of the early discharge with ERP were statistically significantly 28.5% lower than those of
conventional care (difference –US$3402, 95% CI –US$5000 to –US$1804; p < 0.001) when including
patient costs such as productivity/employment losses, and 30.8% lower when including only health-care
costs (difference –US$2543, 95% CI –US$3505 to –US$1581; p < 0.001). This was attributable mostly to
differences in inpatient hospital costs, which in turn were strongly driven by the statistically significantly
shorter mean LOS with the intervention (difference –3.6, 95% CI –5.29 to –1.91; p < 0.001).
Cost results: staff mix
One study evaluated a staff-mix intervention or ‘medical and surgical comanagement team’ at a tertiary
care teaching hospital in the USA, which meant that care before and after surgery was led by general
internal medicine faculty and orthopaedic physicians rather than by orthopaedic surgeons.223 Although
the study was based on a RCT, the cost evidence was low quality, with costing methods and results very
minimally described, and meeting only 6 of the 19 CHEC criteria.
The staff-mix intervention was associated with no difference in the total cost of care compared with
standard orthopaedic surgical care (US$15,373 vs. US$15,283; difference US$90), although this concealed
that statistically significantly higher physician costs were compensated for by lower hospital costs.
Cost-effectiveness evidence: upper abdominal surgery
Of the eight studies evaluating effectiveness evidence for multicomponent recovery enhancement
interventions in upper abdominal surgery, only two257,264 reported cost outcomes. One study reported cost
outcomes as part of a related paper on the implementation, feasibility and safety of the ERP initiative for
patients undergoing laparoscopic pancreatectomy in a UK hospital,257 and another reported limited data on
cost outcomes for patients undergoing surgery for gastric cancer at a single hospital in Japan.264
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Both studies were classified as cost–consequences analyses and were of relatively low quality in relation to
the CHEC criteria for assessing the quality of economic evaluations. In large part this was because the cost
methods were minimally described (see Table 25); however, the Japanese study was a larger (n = 148)
prospective randomised study, and the UK study was based on a small uncontrolled before (n = 44) and
after (n = 22) study. They were based on clinical effectiveness studies judged to be of ‘moderate’264 or
‘weak’257 overall quality.
In terms of the impact of ERP on LOS, the trial in Japan of gastric cancer patients showed postoperative
hospital stay 1 day shorter than with usual care (median 9 vs. 10 days; p < 0.001), and the study in UK
patients undergoing distal pancreatectomy showed postoperative stay 3 days shorter (median 6 vs. 3 days;
p < 0.001).264
Cost results
In both studies, ERP interventions were associated with statistically significantly lower hospital admission
costs,257,264 or total costs including re-admission costs,257 than the usual/previous care protocols (see Report
Supplementary Material 7, Table 3). However, for gastric cancer surgical patients in Japan, the median cost
of the hospital admission was only 2% lower, so this cost difference is smaller and more uncertain. In the
UK study, most of the difference in median cost was from postoperative costs (53% lower with ERP),
which reflects that median postoperative LOS was halved after the introduction of the ERP.257
Summary of cost-effectiveness evidence
It is very difficult to draw firm and widely generalisable conclusions about the cost impact or cost-
effectiveness of multicomponent interventions to improve recovery after elective surgery. This is because:
l The effectiveness evaluations that also presented cost data or cost-effectiveness analyses are a small
subset (one-quarter or less) of all of the effectiveness studies relating to a particular type of surgery.
In addition, there were no economic studies of interventions in several of the procedural groups.
l Of the 15 economic studies, only three were full economic evaluations, and only one of these was of
sufficient quality. The other 12 studies were comparative cost analyses reported in papers primarily
reporting clinical effectiveness, feasibility and safety/complications.
l There was considerable diversity within the evidence base in terms of anatomical site (colorectal,
lower limb, cardiac, upper abdominal), type of procedure (e.g. open vs. laparoscopic, hip vs. knee
arthroplasty) and intervention characteristics. There would also be inevitable international differences in
hospital organisation and clinical team composition.
l Two-thirds of the economic studies were of poor quality (meeting between 2 and 10 of the 19 CHEC
quality criteria).
With the exception of the four costing studies of ERP for lower limb arthroplasty, it was difficult to identify
even a pair of studies that were convincingly similar enough in intervention, care/hospital context and methods
to be comparable and, therefore, to allow a plausible synthesis of findings. Furthermore, although most of the
economic studies attributed health-care costs to the number of days spent in hospital, few studies:
l used different unit costs to reflect the relatively lower costs of pre-discharge days compared with
surgical or immediately post-surgical days in hospital
l included costs associated with treating complications or for re-admissions
l included any non-hospital care costs (e.g. community rehabilitation or primary care costs)
l had a time horizon of > 3 months post surgery or post admission
l estimated the additional cost (e.g. additional staff time, different analgesia, nutritional differences) of
providing different ERP components or other components of the new care pathways/protocols.
Given the heterogeneity of the evidence, the methodological flaws in calculating costs and the
inconsistency of findings, it is not possible to conclude whether or not interventions to improve recovery
from planned admissions are more cost-effective than usual care.
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Chapter 5 Discussion
Main findings
To our knowledge this systematic review is the first to consider the effectiveness and cost-effectiveness of
multicomponent interventions to improve recovery and/or reduce LOS for older adults undergoing elective
hospital treatments that require an overnight stay. We identified 208 studies reported across 218 articles
evaluating such interventions, of which 73 studies were prioritised for synthesis, including 15 studies
reporting costs. The 73 prioritised studies represented the highest-quality evidence available, RCTs from
any ‘high-income’ country, as well as the most relevant evidence to the UK context, including a number of
RCTs, controlled trials and uncontrolled studies, which often represent the most ethical, if not scientifically
rigorous, approach to evaluating the implementation of care pathways in hospital settings.
The prioritised evidence pertained to eight broad types of surgical procedure (cardiac, colorectal, lower
limb arthroplasty, pelvic, upper abdominal, thoracic, vascular and various), the most common being either
lower limb arthroplasty (34% of studies) or colorectal surgery (25% of studies). The prevalence of evidence
within these procedural categories appears to reflect the most common reasons for hospital admission
among older adults.5 Interventions were grouped into six categories (ERP, prehab, rehab, specialist ward,
staff mix and PACP), but ERP (67% of studies) and prehab (18% of studies) interventions far outweighed any
other category. Overall, the evidence suggests that interventions generally have a beneficial effect on one or
more clinical or patient-reported outcomes, and very rarely lead to inferior outcomes for any measure, in a
variety of health systems. It is notable, however, that the outcomes reported were almost exclusively
concerned with the treatment course from pre-admission to discharge, with few studies reporting outcomes
beyond 30-day statistics for mortality, re-admissions and complications.
Despite this observation of general effectiveness (or at least a lack of detrimental effects) with most types
of interventions, the evidence is heterogeneous and, thus, limits the generalisability of this statement.
The most consistent evidence from international RCTs was for ERP to be associated with reduced LOS
after both colorectal surgery and upper abdominal surgery. In patients undergoing colorectal surgery,
there was additional evidence that markers of physical recovery before discharge may be improved with
ERP. The evidence for reduced LOS after upper abdominal surgery came from five patient groups across
four studies, which also indicated that the odds of sustaining complications were reduced with ERP.
Evidence from other procedure groups was limited by small numbers of studies and the presentation of
data that could not be combined in meta-analyses. In addition to the pooled data for RCTs, there were
numerous studies that could not be meta-analysed that provided evidence of improved outcomes with
ERP and prehab interventions in particular. There were relatively few studies of other intervention types,
limiting the strength of conclusions about their effectiveness, despite a number of single studies reporting
positive results.
The evidence from the UK was similarly dominated by evaluations of ERP and, to a lesser extent, prehab
interventions for colorectal surgery and lower limb arthroplasty. The evidence for ERP interventions to
improve recovery from colorectal surgery came from only seven studies but usually indicated improvement
with intervention, or equivalence with usual care for LOS and complications. Thirteen UK-based ERP
interventions to improve recovery from lower limb arthroplasty were identified, and although standardised
mean differences could not be calculated for nearly half of the studies, the evidence was consistently
in favour of ERP in reducing LOS. The seven studies presenting analysable LOS data indicated a mean
reduction in LOS of > 4 days, compared with usual care. Some additional outcomes in these studies
improved with ERP, but there were few of these outcomes to analyse. As with the RCT-only evidence,
studies from the UK showed that LOS may be reduced in upper abdominal surgery with ERP interventions.
There was also evidence of markers of recovery improving with ERP.
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The effectiveness evidence from the UK and international RCTs showed broadly similar findings and similar
distributions of studies between surgical specialties, with UK studies slightly more focused on evaluations
of ERP interventions for patients undergoing lower limb arthroplasty. The two types of procedure that
accounted for nearly 60% of the evidence (colorectal and lower limb arthroplasty) arguably do not require
further evaluations of the effectiveness of ERP interventions. However, the heterogeneity of interventions
makes it difficult to identify optimal combinations of components and thus further analysis such as meta-
regression may contribute to this understanding. The focus of any future trials in these surgical specialties
should, however, be more towards aspects of implementation and scaling up of interventions, assessment
of wider patient outcomes such as patient satisfaction and mental health, and consideration of the effect
of shorter LOS on the broader health and social care system and on long-term patient outcomes.
It is unclear whether or not the evidence from colorectal surgery and lower limb arthroplasty is transferable
to other surgical specialties. Aside from these procedure categories, the evidence for ERP interventions was
most positive for upper abdominal surgery, although this was based on only seven studies and with some
equivocal findings. There were no other clusters of evidence that could allow comprehensive evaluation of
interventions for other surgical specialties; however, there may be evidence-based intervention components
that can reasonably be expected to benefit older adults undergoing different procedures. Further research
is required to determine this.
Cost-effectiveness evidence was derived from only 15 studies, which were highly heterogeneous in terms
of population, intervention and location. Although the general suggestion was that interventions led to
cost savings, findings were often the result of basic alignment with daily costs, and not the result of
rigorously performed economic evaluations. The majority of cost-effectiveness evidence was of low quality,
and, in the light of the aforementioned limitations, may be considered inconclusive with regard to research
question 2.
The effectiveness of ERP interventions for optimising LOS without having a detrimental effect on other
outcomes is consistent with other systematic reviews that have demonstrated the effectiveness of this
type of intervention for surgical patients26 and for patients admitted for elective colorectal surgery.28
One systematic review283 of RCTs evaluating prehabilitation interventions for individuals undergoing
joint-replacement surgery indicated some small effect on postoperative pain, function and mobility but no
statistically significant impact on LOS or cost, which is, again, broadly consistent with the findings of this
review. The cost-effectiveness findings are less conclusive than those of other recent systematic reviews
for ERP in colorectal cancer,116 and various abdominal surgical procedures.284 These reviews concluded that
ERP/ERAS programmes appear to be cost-effective, at least in the short term in relation to hospital costs,
but with strong caveats about the lack of inclusion of non-hospital costs, costs to patients, or the cost of
providing the ERP itself. Both of these systematic reviews, and our own, clearly show that the research
recommendations outlined by Jönsson and Lindgren285 almost 40 years ago have rarely been heeded.
Limitations of the evidence
Study authors defined LOS in a number of ways, such as the time from admission to discharge, the length
of time spent in hospital after surgery or the total time in hospital with re-admissions included. However,
> 40% of studies did not offer a clear definition of LOS, limiting comparability between studies. Furthermore,
only 12% of studies addressed either the reliability or the validity of the primary outcome. In many cases, it
could be supposed that data obtained from a database are reliable and valid; however, without descriptions
of the definition of LOS, or of how data were recorded, we chose not to make this assumption. We note
that a generous approach to this item would have resulted in 20 more studies achieving a global rating of
‘moderate’ or ‘strong’.196,199,202,205,211,213,217,220,222,223,225,227,234,235,239,242,243,256,258,268 Additional clarification about
data collection tools and definitions of LOS would benefit future studies in this area.
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Comparator groups were often poorly reported. It was frequently difficult to determine which intervention
components were present only in the intervention group, and often the comparator was not described at
all. This limits the extent to which the effectiveness of intervention components can be determined.
Studies almost exclusively failed to consider longer-term patient outcomes. Only two studies investigated
outcomes at 12 months, with the vast majority of studies ending their consideration of patient outcomes
30 days after discharge. Although this may be understandable in many cases, as a result of the specific
aims of studies, it means that the wider impact of reduced LOS is unknown in this body of evidence.
Given that we sought any related or ‘sibling’ articles for all included studies, we are confident that there
is a dearth of such research. Although earlier discharge from hospital may be desirable, the impact of this
on other health and social care services must be examined, particularly in the wider context of the NHS.
Only six studies assessed the use of additional care (follow-up appointments, GP visits, etc.) after discharge.
In addition, we sought information on discharge destination, but this was reported very rarely. Ideally,
the patient should be followed over the course of at least 1 month following discharge and ideally for
3–6 months, with assessments of their outcomes, such as quality of life, mental health, satisfaction with
surgical outcomes and physical activity, as relevant to the procedure, and with documentation of their
health and social care resource use.
Non-clinical patient outcomes were not measured routinely. The evidence was dominated by evaluations of
ERP interventions, which were heavily focused on perioperative components, with a lack of consideration of
broader patient outcomes. In particular, measures of mental health, quality of life and satisfaction with care
were scant, whereas short-term markers of physical recovery were often included. Non-ERP studies tended
to give greater attention to these outcomes, possibly because interventions such as prehab, rehab and
PACPs focus more on non-perioperative aspects of patient care, and thus seek to measure effectiveness in
those terms. There may be mutual opportunities for learning for ERP and non-ERP interventionists alike,
where aspects of prehab and PACP in particular offer promise of improvement of patient care, and could be
integrated into existing pathways. The evidence for non-ERP interventions is limited and requires further
study.
Around one-third of studies presented LOS without variance data, or with range data that could not be
used to calculate standardised mean differences. Although median and range data provide a valuable
metric, range data are often highly skewed by long LOS, and, as such, additional variance statistics can
give readers extra insight. For example, this type of data is useful to systematic reviewers examining a
collective body of evidence with a view to providing a cohesive/comprehensive message to organisations
developing health policy recommendations. In addition, one metric that would enhance the interpretation
of LOS data, particularly when high upper ranges are reported, is the number of patients experiencing
‘long LOS’, as reported by Starks and colleagues.262 These data are available from hospital records and
should be considered in future studies.
Studies frequently deliberately excluded patients who were over a certain age or who had complex, or
potentially complex, needs, with a number of studies also choosing to exclude ‘outliers’ or patients who
experienced severe complications. This reduces the validity of the evidence, as patients with complex needs
are a regular occurrence in public health-care systems. By contrast, a small number of studies (n = 7199,200,
207,215,218,221,223) selected individuals who were at greatest risk of postoperative complications, or who were
likely to have complex needs or multimorbidities. For example, very few studies mentioned delirium,
despite its prevalence and negative sequelae among older adults undergoing elective procedures. One
reason for this was the choice in a number of studies (n = 1831,196,200,202,209,210,226,229,231,234,236,244,254,259,261,262,266,267)
to exclude patients who had risk factors for delirium, such as cognitive impairment. It could be considered
that studies that embrace the complexity of typical patients offer more valuable evidence about real-world
situations and manage the likely confounders that introduce variation in LOS.
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Certain surgical specialties or procedures requiring elective inpatient admission were not identified. For
example, no studies evaluated neurosurgical or neurorehabilitation pathways for planned neurosurgery
procedures, despite efforts to develop these in areas such as the south-west of the UK. This particular
area has relatively low patient volume and a mix of elective and acute patients within surgical units,
compared with other surgical specialties. This means that effectiveness evaluations of rehabilitation
pathways were unlikely to meet our inclusion criteria. As such, we recognise that there is likely to be
useful research into elective procedures that did not fit the remit of this review. A significant body of
high-quality cost-effectiveness evidence, directly based on high-quality effectiveness studies, would have
been a valuable facet of the evaluation of interventions in this review. However, the lack of high-quality
cost-effectiveness evidence limits the conclusions that can be made.
Strengths and limitations of this review
We included studies published in 2000 or later to focus on organisational strategies that are currently used
in health-care organisations in high-income economies. However, it could be argued that this limit was too
generous, with data collection in some included studies taking place in the 1990s. As > 80% of articles
were published within the past 10 years, this might have been a more prudent date restriction.
A strength of this review was that we included non-RCT study designs, acknowledging an ethical dilemma
researchers face about whether or not to randomise patients to care that may be suboptimal. However,
we were unable to consider non-randomised trials from outside the UK because we had insufficient
resources to carry out a review on such a scale. As a result, there may be useful international evidence that
we have not synthesised. However, the studies utilising non-randomised trial designs included in the UK
tranche are vulnerable to selection bias and influence from confounding variables across different
participant groups.
It was also beyond the scope of this review to conduct any additional analysis, such as metaregression.
This might have allowed further exploration of the particular intervention components associated with
successful ERP interventions in terms of reducing LOS and improving other outcomes for patients
undergoing colorectal surgery or lower limb arthroplasty. It could also be beneficial to conduct subgroup
analysis by considering whether the findings differ among ‘the oldest-old’, people with various
comorbidities or people living with frailty.
Although we contacted the authors of studies that had missing data, we did not do this when only
median and range outcomes were presented. Given the number of studies falling into this category, such
an approach would have demanded significant extra resources, and we felt that this was not justifiable.
To our knowledge, this is the first systematic review to bring together and evaluate evidence about
multicomponent interventions of any type, aiming to improve recovery and reduce LOS following elective
procedures in older adults. We used best practice methods to identify, select, appraise and synthesise the
evidence and have incorporated the views of both clinical experts in the field and patients with experience
throughout the review process. Our findings are based on both the highest-quality and the most relevant
evidence to the UK audience, which was identified using extensive search methods.
DISCUSSION
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Chapter 6 Conclusions
Overall, the evidence in this review suggests that ERP and, to an extent, prehab interventions, may helpoptimise the LOS of older adults in hospital following admission for a planned procedure. In general,
these interventions appear to improve recovery from surgical procedures, often by reducing LOS without
increasing the odds of complications or re-admissions, as well as improving or maintaining other clinical
and patient-reported outcomes. These findings were also shown across other procedure and intervention
categories that we identified, with the UK research base broadly echoing the findings from the RCT evidence.
Little evidence was available to evaluate the cost-effectiveness of interventions, coming from 15 studies
and being of generally poor quality, highlighting the need for economic evaluations to be incorporated
alongside any further evaluations of organisational interventions to optimise hospital LOS for older adults.
We believe that further studies evaluating the effectiveness of implementing full protocols for enhanced
recovery in colorectal surgery and lower limb arthroplasty are not warranted, although other surgical
specialties, such as cardiac, vascular and lower abdominal surgeries, still lack evidence of this. Evidence of
the effectiveness of other types of intervention within these specialties is also scarce, including rehabilitation,
staff-mix and specialist ward interventions. There is a case for future research to move towards a focus on
the processes of implementing or scaling up interventions, which should include mixed-methods approaches.
Patient outcomes and longer-term implications were rarely considered within the body of research in this
review and should be brought into focus in future studies. This is necessary to fully evaluate the impact of
hospital-based organisational strategies to optimise LOS on patient experience and community health and
social care services.
Implications for further research
Further research is required in the following areas:
l More evidence is needed about under-represented interventions, such as rehabilitation, staff-mix
interventions and enhanced preoperative assessments, as well as about how they may integrate with
existing ERPs to maximise effect.
l More evidence is needed to determine the effectiveness and transferability of interventions outside the
areas of colorectal surgery and lower limb arthroplasty. Some surgical specialties or reasons for planned
admission were not represented in the evidence at all.
l Studies should include the long-term follow-up of patient outcomes for at least 1 month after surgery,
and ideally for 3–6 months, with additional investigation of the implications for society, such as the use
of extra resources, need for support, and use of social care.
l More studies evaluating intervention effectiveness should embrace (rather than screen out) the likely
complexities of the older adult population in order to improve the treatment of suboptimal conditions.
l Further research evaluating the effectiveness of ERPs for colorectal surgery and lower limb arthroplasty
should be stepped down. However, evidence is needed about how to effectively implement such
protocols and scale up across surgical specialties. This may require the consideration of qualitative
experiences of the patients and staff involved in the implementation of such protocols.
l Further research is needed on the patient experience of a shorter stay in hospital. This may involve
interviewing patients treated within the organisational interventions identified by this review and
exploring their experiences of the care they received both in hospital and post discharge. A systematic
review of existing primary qualitative approaches may help to identify where further primary research
is required.
l Robust evidence about the cost-effectiveness of interventions is required, and may be particularly
valuable in the context of a financially pressured NHS.
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Implications for clinical practice
Acceptance is growing of the need to provide standardised approaches to surgical care. Unwarranted
variation is thought to have an impact on both clinical outcomes and patient safety. Additionally,
the cost of health care is growing exponentially, while health-care budgets have failed to keep pace.
Enhanced recovery programmes afford the opportunity to improve the quality of clinical care while
reducing health-care costs.
Organisational initiatives to accelerate recovery and/or reduce LOS have been widely implemented in
Europe and the UK, as well as further afield under the label of ‘quality improvement’ in North America.
However, significant variation in LOS exists for procedures across the UK, and the extent to which such
interventions are embedded and standardised between and within hospital sites in the UK is not known.22
No core configuration of intervention components emerges for the populations included in this review.
Indeed, despite variation in individual elements, similar benefits are realised, suggesting that endeavours
to find the ‘ideal protocol’ are less important than the act of whole-team engagement in scrutinising and
measuring the patient pathway. The lack of detrimental outcomes as a result of these interventions further
supports this notion. A gap in understanding is the level of compliance with which the interventions
identified within this review are implemented.
Warranted variation in protocols may exist where the elements within enhanced recovery pathways need
to be adapted to the needs of patients, for example those with complex needs. We note that only a
handful of studies embraced the challenge of patients with complex needs such as multimorbidity,
frailty or dementia. This may be because these patients are deemed unsuitable for non-critical surgical
intervention; however, even in life-saving situations, minimal guidance remains about how to adapt
recovery pathways for these patients.
The findings of this review support the use of multicomponent interventions, particularly ERP, to improve
clinical outcomes for patients undergoing colorectal surgery and lower limb arthroplasty, while there are
suggestions of similar benefits for other types of surgery. However, we are unable to comment with
certainty about the effects of interventions on patient-reported outcomes, such as quality of life, or on
costs, and recommend further research on these aspects.
CONCLUSIONS
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Appendix 1 Literature search strategies
Bibliographic databases
Database: MEDLINE.
Host: Ovid.
Date parameters: 1946 to August week 5 2017.
Date searched: 12 September 2017.
Searcher: SB.
Hits: 4227.
Search strategy
1. ((older or frail or elderly) adj2 (person* or people or patient* or population* or adult*)).tw.
2. geriatric*.tw.
3. *aged/
4. *”Aged, 80 and over”/
5. *frail elderly/
6. *Geriatrics/
7. or/1-6
8. ((eye* or sclera or iris or retina or cataract or ophthalmol*) adj3 (surgery or surgical* or procedur*)).tw.
9. exp *ophthalmologic surgical procedures/
10. ((heart or cardiac or coronary) adj3 (surgery or surgical* or procedur* or transplant* or angiography or
angioplasty or bypass)).tw.
11. (aortic adj3 (replacement or surgery or surgical* or procedur*)).tw.
12. (carotid adj3 endarterectomy).tw.
13. ((arterial or artery or arteries) adj3 (bypass or surgery or surgical* or angioplasty or embolectomy)).tw.
14. *coronary artery bypass/
15. ((urinary or urologic* or genitourinary or bladder or prostate) adj3 (surgery or surgical* or procedur*)).tw.
16. (urethrotomy or prostatectomy).tw.
17. exp *Urologic Surgical Procedures/
18. (meningioma* adj3 (surgery or surgical* or procedur*)).tw.
19. craniotomy.tw.
20. *craniotomy/
21. ((lung or thoracic or thorax or cardiothoracic or pulmonary or chest or diaphragm) adj3 (surgery or
surgical* or resection* or procedur*)).tw.
22. (thoracotomy or pneumonectomy).tw.
23. *Thoracic Surgery/
24. (‘bile duct’ adj3 (resection* or surgery or surgical* or procedur*)).tw.
25. ((pancreas or pancreatic) adj3 (surgery or surgical* or resection* or procedur*)).tw.
26. (pancreatectomy or pancreaticoduodenectomy).tw.
27. *Pancreatectomy/
28. “endovascular aortic aneurysm repair*”.tw.
29. ”endovascular abdominal aneurysm repair*”.tw.
30. ((hip or knee or “lower limb*”) adj3 (replacement* or restructur* or arthroplasty or hemiarthroplasty
or surgery or surgical* or procedur*)).tw.
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31. *arthroplasty, replacement, hip/
32. *arthroplasty, replacement, knee/
33. or/8-32
34. 7 or 33
35. (“enhanced recovery after” adj3 surgery).tw.
36. ERAS.tw.
37. ((enhanced or early or earlier) adj3 (recovery or mobili?ation or ambulation or rehab*)).tw.
38. ERP.tw.
39. (“proactive care” adj2 “older people”).tw.
40. POPS.tw.
41. (“fast track” adj3 (surgery or surgical* or program* or management or “patient care”)).tw.
42. (multimodal adj3 (rehab* or perioperative or postoperative or “post operative” or optimi?ation or care
or convalesc*)).tw.
43. (optimal adj2 (“preoperative assessment” or “preoperative management”)).tw.
44. ((accelerated or optimi?ed or rapid or “fast track”) adj3 (care or rehab* or recovery or mobili?ation or
ambulation or convalesc*)).tw.
45. ((improved or improving) adj2 recovery).tw.
46. “comprehensive geriatric assessment*”.tw.
47. “short acting an?esthetic*”.tw.
48. ((integrated or managed) adj1 “care pathway*”).tw.
49. ((multidisciplinary or “multi disciplinary”) adj1 assessment*).tw.
50. ((physiotherap* or exercise*) adj3 (augment* or increas* or “higher frequency”)).tw.
51. (“pressure ulcer*” adj3 “risk assessment”).tw.
52. ((nutrition* or feed* or eat*) adj3 support*).tw.
53. *Nutritional Support/
54. “supported discharge”.tw.
55. or/35-54
56. ((length or duration) adj4 stay adj8 (reduce* or reduction* or reducing or shorter or shortening or
“positive effect*” or prolong* or increas* or decreas* or improve* or improving or “patient
outcome*” or ‘clinical outcome*’ or ‘clinical indicator*’ or ‘outcome measure*’)).tw.
57. (hospital* adj3 stay adj8 (reduce* or reduction* or reducing or shorter or shortening or ‘positive
effect’ or prolong* or increas* or decreas* or improve or improving or “patient outcome*” or “clinical
outcome*” or “clinical indicator*” or “outcome measure*”)).tw.
58. (time adj3 discharg*).tw.
59. *”Length of Stay”/
60. or/56-59
61. 55 or 60
62. randomi?ed.tw.
63. rct*.tw.
64. trial*.tw.
65. ((single or doubl* or tripl* or treb*) and (blind* or mask*)).tw.
66. (“4 arm” or “four arm”).tw.
67. ((before adj4 after) or “BA stud*” or “CBA stud*”).tw.
68. (“pre post” or “pre test*” or pretest* or posttest* or “post test*” or (pre adj3 post)).tw.
69. (interrupt* adj2 “time series”).tw.
70. (“time points” adj3 (over or multiple or three or four or five or six or seven or eight or nine or ten or
eleven or twelve or month* or hour* or day* or “more than”)).tw.
71. ((“quasi experiment*” or quasiexperiment* or “quasi random*” or quasirandom* or “quasi control*”
or quasicontrol*) adj3 (method* or stud* or design*)).tw.
72. randomized controlled trial.pt.
73. controlled clinical trial.pt.
74. or/62-73
75. 34 and 61 and 74
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Bibliographic database search results
Web search engine searches
Google Scholar
Data parameters: not applicable.
Date searched: 20 September 2017.
Searcher: SB.
Hits: Google Scholar results are limited to 999.
Search strategy
(older OR frail OR elderly OR geriatric) (reduce OR reducing OR improve OR improving) (“length of stay”
OR “duration of stay”) trial*
Notes: number of records screened following application of date limit (2000 to date of search) and
de-duplication against bibliographic database results = 694.
Google
Data parameters: search activity based search results = off.
Date searched: 21 November 2017.
Searcher: SB.
Hits: we copied and pasted the first 100 results into a Microsoft Word document for screening.
TABLE 26 Bibliographic database search results
Database Number of results
MEDLINE 4227
MEDLINE In-Process & Other Non-Indexed Citations 459
HMIC 69
EMBASE 7194
CENTRAL 3603
CINAHL 1422
AMED 176
Total number of results 17,150
Duplicate results 7875
Total number of unique results 9275
Total number of unique results from 2000 to date 8038
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Search strategy
(older OR frail OR elderly OR geriatric) (reduce OR reducing OR improve OR improving) (“length of stay”
OR “duration of stay”) trial*
Notes: number of records screened following application of date limit (2000 to date of search) and
de-duplication against bibliographic database results = 23.
Forwards citation chasing
Citation index: Web of Science (Core Collection); Scopus; Google Scholar.
Date searched: 14 and 15 December 2017.
Searcher: SB.
Search strategy
SB searched for studies identified by bibliographic databases that met the inclusion criteria of our review in
Web of Science. If a study was indexed in Web of Science, SB exported the citations to EndNote. If a study
was not indexed in Web of Science, SB searched for it in Scopus; if it was not indexed in Scopus, SB
searched for it in Google Scholar.
TABLE 27 Effectiveness forwards citation searching results
Number of citations
Total citations 2316
Duplicate citations (including duplicates with bibliographic database and Google Scholar results) 785
Unique results 1531
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Appendix 2 Definitions of outcome categories
TABLE 28 Outcome categories used in the effectiveness review, with definitions and examples
Outcome category Description of category Examples of outcomes presented
Additional care Need for additional care after discharge Additional GP visits; 30-day emergency visits; patient
called ward
Complications Complications occurring during or after
surgery and reported as such by study authors.
In reporting complications, we prioritised
summary outcomes over specific complications
Summary outcomes: number of major complications;
number of patients presenting more than one
complication; reoperations; comprehensive
complication index. Specific complications: wound
infections; ileus; myocardial infarction; death during
initial hospital stay
LOS Any markers of duration of stay within
hospital
Total LOS; postoperative LOS; stay in intensive care
unit; total LOS, including 30-day re-admissions
Markers of recovery Markers of physical recovery after surgery,
prior to discharge
Hand grip strength; gut function; 6-Minute Walk
Test; time to first bowel movement; pain; timed up
and go test; C-reactive protein levels
Mental health Assessments of mental health Hospital Anxiety and Depression Scale; SF-36 mental
subscale
Morbidity Morbidity after discharge Morbidity within 30 days; morbidity within 90 days
Mortality Incidence of death after treatment Mortality within 30 days; mortality within 90 days
Patient satisfaction Assessment of patient satisfaction or feedback Patient satisfaction questionnaire
Quality of life Any outcomes that either are explicitly quality-
of-life measures, or relate to the impact of
surgery on daily living
SF-36; EORTC quality-of-life questionnaire; markers
of physical activity; gastrointestinal quality-of-life
index; physical work capacity; WOMAC, Harris Hip
Score
Re-admissions Additional stay in hospital following initial
discharge
Re-admissions within 30 days; need for reoperation
Surgical Indicators of surgical performance and markers
of implementation of the surgical protocol
Duration of surgery; blood loss; time at which
intravenous fluids discontinued; fluid given; time
catheterised; urinary output
EORTC, European Organisation for Research and Treatment.
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Appendix 3 Data treatment
TABLE 29 Approaches to data provided in included studies
Data provided Method to obtain mean Method to obtain SD
Mean with SD Not required Not required
Mean with standard error Not required SD = SE ×
ffiffiffi
n
p
Mean with 95% CI Not required
SD =
ffiffiffi
n
p
×
(UpperCI− LowerCI) / 2
t-distribution
Note: t-distribution assumed to be 3.92 for total samples
over n = 122, otherwise calculated manually
Median with range Do not impute, describe in text Do not impute, describe in text
Median with interquartile
rangea x =
∑(median, q1, q3)
3
SD =
q3− q1
2Ø−1( 0.75n− 0.125n+ 0.25 )
Mean difference with CI,
p-value
Cannot impute group means;
report mean difference in
outcome table instead
First calculate SE for difference in means:
SE =
Upper limit− lower limit
t-distribution
Then calculate SD from SE:
SD =
SEffiffiffiffiffiffiffiffiffiffiffiffi
1
nE
+ 1nC
q
Finally, apply SD to both groups before calculation of
standardised mean difference
Note: t-distribution assumed to be 3.92 for total samples
over n = 122, otherwise calculated manually
Ø–1(z), upper z th percentile of the standard normal distribution; C, comparator group; E, experimental group; n, sample
size; q1, first quartile; q3, third quartile; SE, standard error; x, sample mean.
a See Wan et al.49 for details.
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Appendix 4 Sensitivity analyses for length of stay
meta-analyses
The following forest plots show meta-analysis results when different levels of data imputation areperformed, and the result included in the analyses. In the main report, we chose not to use data
imputed from medians and ranges because upper ranges often highly skew the data. For comparison,
we provide forest plots that include ‘all imputable outcomes’, meaning that data from medians and ranges
are included. We also display meta-analyses performed with only the studies that provided mean and
standard deviation, where possible.
Note: weights are from random-effects analysis
Overall (I 2 = 87.7%; p = 0.000)
Study ID
Forsmo 2016209
Lee 2011235
Gatt 2005213
Vlug 2011268 – open
Vlug 2011268 – lap
Mari 2016242
Anderson 2003192
Chen 2017199 – LH
García-Botello 2011211
Lidder 2013236
Muller 2009251
Maggiori 2017239
Chen 2017199 – RH
Khoo 2007231
Mari 2014243
– 0.68 (– 0.96 to – 0.39)
– 0.06 (– 0.28 to 0.17)
– 2.17 (– 2.67 to – 1.68)
– 1.65 (– 2.38 to – 0.92)
– 0.20 (– 0.49 to 0.08)
– 0.29 (– 0.57 to – 0.02)
– 0.91 (– 1.37 to – 0.46)
– 1.60 (– 2.53 to – 0.66)
0.00 (– 0.34 to 0.34)
– 0.99 (– 1.37 to – 0.61)
– 0.39 (– 0.92 to 0.13)
– 0.55 (– 0.88 to – 0.23)
– 0.06 (– 0.30 to 0.18)
– 0.32 (– 0.82 to 0.17)
– 0.68 (– 1.16 to – 0.19)
Cohen’s d (95% CI)
– 1.23 (– 1.84 to – 0.62)
– 3 – 2 – 1 0 0.5
FIGURE 23 Forest plot showing the results of meta-analysis of the effect of ERP interventions on LOS following
colorectal surgery, compared with usual treatment. All imputable outcomes are included. Lap, laparoscopic surgery
group; LH, left hemicolectomy/high anterior resection; open, open surgery group; RH, right hemicolectomy.
DOI: 10.3310/hsdr07400 HEALTH SERVICES AND DELIVERY RESEARCH 2019 VOL. 7 NO. 40
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Nunns et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
175
Note: weights are from random-effects analysis
Overall (I 2 = 78.9%; p = 0.000)
Vlug 2011268 – lap
Study ID
Maggiori 2017239
Chen 2017199 – LH
Lidder 2013236
Mari 2016242
García-Botello 2011211
Chen 2017199 – RH
Mari 2014243
Anderson 2003192
Vlug 2011268 – open
– 0.51 (– 0.78 to – 0.24)
– 0.29 (– 0.57 to – 0.02)
– 0.06 (– 0.30 to 0.18)
0.00 (– 0.34 to 0.34)
Cohen’s d (95% CI)
– 0.39 (– 0.92 to 0.13)
– 0.91 (– 1.37 to – 0.46)
– 0.99 (– 1.37 to – 0.61)
– 0.32 (– 0.82 to 0.17)
– 1.23 (– 1.84 to – 0.62)
– 1.60 (– 2.53 to – 0.66)
– 0.20 (– 0.49 to 0.08)
Shorter with ERP Shorter with comparator 
– 3 – 2 – 1 0 1
FIGURE 24 Forest plot showing the results of meta-analysis of the effect of ERP interventions on LOS following
colorectal surgery, compared with usual treatment. Data imputed from medians and ranges are removed
(i.e. this is the method used in the main report). Lap, laparoscopic surgery group; open, open surgery group.
Note: weights are from random-effects analysis
Overall (I 2 = 87.9%; p = 0.000)
García-Botello 2011211
Study ID
Mari 2014243
Maggiori 2017239
Anderson 2003192
Mari 2016242
– 0.89 (– 1.47 to – 0.32)
– 0.99 (– 1.37 to – 0.61)
– 1.23 (– 1.84 to – 0.62)
– 0.06 (– 0.30 to 0.18)
– 1.60 (– 2.53 to – 0.66)
Cohen’s d (95% CI)
– 0.91 (– 1.37 to – 0.46)
Shorter with ERP Shorter with comparator 
– 3 – 2 – 1 0 1
FIGURE 25 Forest plot showing the results of meta-analysis of the effect of ERP interventions on LOS following
colorectal surgery, compared with usual treatment. Only studies providing means and standard deviations for LOS
are included.
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Note: weights are from random-effects analysis
Overall (I 2 = 91.4%; p = 0.000)
Larsen 2008234
Reilly 2005256
Pour 2007254
Siggeirsdottir 2005261
Borgwardt 2009196
Study ID
– 1.94 (– 2.87 to – 1.00)
– 1.28 (– 1.75 to – 0.82)
– 1.77 (– 2.50 to – 1.05)
– 0.75 (– 1.17 to – 0.33)
– 1.22 (– 1.83 to – 0.61)
– 5.95 (– 7.43 to – 4.47)
Cohen’s d (95% CI)
Shorter with ERP Shorter with comparator 
– 6 – 4 – 2 0 2
FIGURE 26 Forest plot showing the results of meta-analysis of the effect of ERP interventions on LOS following
lower limb arthroplasty, compared with usual treatment. All imputable outcomes are included.
Note: weights are from random-effects analysis
Overall (I 2 = 0.0%; p = 0.868)
Siggeirsdottir 2005261
Study ID
Larsen 2008234
– 1.26 (– 1.63 to – 0.89)
– 1.22 (– 1.83 to – 0.61)
– 1.28 (– 1.75 to – 0.82)
Cohen’s d (95% CI)
Shorter with ERP Longer with ERP 
– 1– 2 0
FIGURE 27 Forest plot showing the results of meta-analysis of the effect of ERP interventions on LOS following
lower limb arthroplasty, compared with usual treatment. Only studies providing means and standard deviations for
LOS are included (this is the method used in the main report).
Note: weights are from random-effects analysis
Overall (I 2 = 24.4%; p = 0.250)
Crowe 2003200 (total LOS)
Huang 2012222 (LOS)
– 0.53 (– 0.77 to – 0.28)
– 0.37 (– 0.72 to – 0.03)
– 0.63 (– 0.88 to – 0.37)
Shorter with prehab Shorter with usual care 
– 1 – 0.5 0
Study ID Cohen’s d (95% CI)
FIGURE 28 Forest plot showing the results of meta-analysis of the effect of prehab interventions on LOS following
lower limb arthroplasty, compared with usual treatment. All imputable outcomes are included.
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Note: weights are from random-effects analysis
Overall (I 2 = 83.5%; p = 0.002)
Huang 2012222 (LOS)
Hoogeboom 2010221 (LOS)
Study ID
Crowe 2003200 (LOS)
– 0.17 (– 0.76 to 0.42)
– 0.63 (– 0.88 to – 0.37)
1.04 (0.12 to 1.96)
– 0.37 (– 0.71 to – 0.03)
Cohen’s d (95% CI)
Shorter with prehab Shorter with comparator 
– 1 0 1 2
FIGURE 29 Forest plot showing the results of meta-analysis of the effect of prehab interventions on LOS following
lower limb arthroplasty, compared with usual treatment. Only studies providing means and standard deviations for
LOS are included (this is the method used in the main report).
Note: weights are from random-effects analysis
Overall (I 2 = 74.7%; p = 0.008)
Rosenfeldt 2011258
Furze 2009210
Arthur 2000193
Goodman 2008215
Study ID
– 0.27 (– 0.56 to 0.02)
0.00 (– 0.36 to 0.36)
– 0.16 (– 0.43 to 0.12)
Cohen’s d (95% CI)
– 0.67 (– 0.92 to – 0.41)
– 0.21 (– 0.50 to 0.08)
Shorter with ERP Shorter with comparator 
– 2 – 1 0 1
FIGURE 30 Forest plot showing the results of meta-analysis of the effect of prehab interventions on LOS following
cardiac surgery, compared with usual treatment. All imputable outcomes are included.
Note: weights are from random-effects analysis
Overall (I 2 = 76.6%; p = 0.014)
Arthur 2000193
Goodman 2008215
Furze 2009210
Study ID
– 0.35 (– 0.68 to – 0.02)
Cohen’s d (95% CI)
– 0.67 (– 0.92 to – 0.41)
– 0.21 (– 0.50 to 0.08)
– 0.16 (– 0.43 to 0.12)
– 1 – 0.5 0 0.5
Shorter with prehab Shorter with comparator
FIGURE 31 Forest plot showing the results of meta-analysis of the effect of prehab interventions on LOS following
cardiac surgery, compared with usual treatment. Data imputed from medians and ranges are removed (i.e. this is
the method used in the main report).
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